P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
8.096e-09 | -18.63 | synapse pruning | biological process | GO:0098883 | 10 | 4 | 18204 | 47 |
TREM2,C1QA,C1QB,C1QC |
1.585e-08 | -17.96 | complement component C1 complex | cellular component | GO:0005602 | 3 | 3 | 19108 | 49 |
C1QC,C1QB,C1QA |
1.585e-08 | -17.96 | complement component C1q complex | cellular component | GO:0062167 | 3 | 3 | 19108 | 49 |
C1QA,C1QB,C1QC |
3.830e-08 | -17.08 | cell junction disassembly | biological process | GO:0150146 | 14 | 4 | 18204 | 47 |
TREM2,C1QA,C1QC,C1QB |
1.607e-07 | -15.64 | chylomicron remnant clearance | biological process | GO:0034382 | 5 | 3 | 18204 | 47 |
APOC1,APOE,APOC2 |
2.825e-07 | -15.08 | defense response | biological process | GO:0006952 | 1431 | 16 | 18204 | 47 |
TREM2,RNASET2,WNT5A,C1QC,AXL,CSF1R,FOLR2,CXCL12,HAVCR2,CD68,ALPK1,C3AR1,C1QA,CH25H,ADORA3,C1QB |
3.209e-07 | -14.95 | triglyceride-rich lipoprotein particle clearance | biological process | GO:0071830 | 6 | 3 | 18204 | 47 |
APOC1,APOE,APOC2 |
4.045e-07 | -14.72 | response to external stimulus | biological process | GO:0009605 | 1882 | 18 | 18204 | 47 |
WNT5A,PDGFA,RNASET2,TREM2,C1QC,CSF1R,AXL,FOLR2,CXCL12,USP53,C3AR1,ALPK1,CD68,HAVCR2,CH25H,MEF2C,C1QA,C1QB |
4.142e-07 | -14.70 | regulation of lipid localization | biological process | GO:1905952 | 183 | 7 | 18204 | 47 |
ABCB4,SPP1,APOC2,APOC1,TREM2,APOE,PPARD |
8.458e-07 | -13.98 | cellular response to lipid | biological process | GO:0071396 | 534 | 10 | 18204 | 47 |
KCNMB1,SPP1,MEF2C,AXL,ABCB4,PPARD,HAVCR2,CD68,WNT5A,TREM2 |
1.000e-06 | -13.82 | Classical antibody-mediated complement activation | REACTOME pathways | R-HSA-173623 | 6 | 3 | 10285 | 39 |
C1QC,C1QA,C1QB |
1.280e-06 | -13.57 | inflammatory response | biological process | GO:0006954 | 559 | 10 | 18204 | 47 |
C3AR1,HAVCR2,CD68,WNT5A,TREM2,FOLR2,ADORA3,C1QA,AXL,CSF1R |
1.585e-06 | -13.36 | regulation of sterol transport | biological process | GO:0032371 | 77 | 5 | 18204 | 47 |
APOC1,TREM2,ABCB4,APOE,APOC2 |
1.585e-06 | -13.36 | regulation of cholesterol transport | biological process | GO:0032374 | 77 | 5 | 18204 | 47 |
APOC1,ABCB4,TREM2,APOE,APOC2 |
2.485e-06 | -12.91 | regulation of lipid transport | biological process | GO:0032368 | 152 | 6 | 18204 | 47 |
APOE,SPP1,APOC2,TREM2,APOC1,ABCB4 |
3.201e-06 | -12.65 | APOA1 (apolipoprotein A1) | protein interactions | 335 | 159 | 6 | 19454 | 50 |
C1QC,SPP1,APOC1,C1QA,APOC2,TREM2 |
3.237e-06 | -12.64 | env (Envelope surface glycoprotein gp160, precursor) | protein interactions | 155971 | 1501 | 15 | 19454 | 50 |
ADORA3,APOC1,ITM2B,CXCL12,C1QC,C1QB,FOLR2,ABCB4,WNT5A,DHRS9,GPR34,TREM2,OSBPL1A,APOE,C1QA |
3.313e-06 | -12.62 | cellular response to chemical stimulus | biological process | GO:0070887 | 2411 | 19 | 18204 | 47 |
WNT5A,CSF2RA,TREM2,PPARD,APOE,CSF1R,ABCB4,AXL,SPP1,FOLR2,CXCL12,LTC4S,RGS10,P2RY13,CD68,HAVCR2,CH25H,MEF2C,KCNMB1 |
3.832e-06 | -12.47 | positive regulation of mononuclear cell migration | biological process | GO:0071677 | 92 | 5 | 18204 | 47 |
WNT5A,TREM2,CSF1R,C3AR1,CXCL12 |
4.105e-06 | -12.40 | steroid metabolic process | biological process | GO:0008202 | 258 | 7 | 18204 | 47 |
CH25H,SPP1,OSBPL1A,APOC1,DHRS9,APOE,PPARD |
4.239e-06 | -12.37 | biological process involved in interspecies interaction between organisms | biological process | GO:0044419 | 1540 | 15 | 18204 | 47 |
ALPK1,CD68,HAVCR2,C1QB,CH25H,MEF2C,C1QA,C1QC,APOE,WNT5A,RNASET2,TREM2,CXCL12,CSF1R,AXL |
4.451e-06 | -12.32 | chylomicron | cellular component | GO:0042627 | 13 | 3 | 19108 | 49 |
APOC1,APOC2,APOE |
4.530e-06 | -12.30 | phospholipid efflux | biological process | GO:0033700 | 13 | 3 | 18204 | 47 |
APOC1,APOE,APOC2 |
4.655e-06 | -12.28 | cell periphery | cellular component | GO:0071944 | 6020 | 31 | 19108 | 49 |
GPR34,KCNMB1,C3AR1,ACY3,AXL,TSPAN15,CXCL12,OSBPL1A,IFITM10,ITM2B,COL18A1,ADORA3,RGS10,TREM2,WNT5A,SIGLEC8,C1QA,CD68,ADAP2,APOE,FOLR2,RGL3,CSF1R,EPB41L2,C1QB,DCBLD1,HAVCR2,CSF2RA,C1QC,ABCB4,P2RY13 |
4.703e-06 | -12.27 | immune response | biological process | GO:0006955 | 1349 | 14 | 18204 | 47 |
HAVCR2,CD68,ALPK1,C1QA,MEF2C,CH25H,C1QB,TREM2,WNT5A,RNASET2,C1QC,AXL,CSF1R,CXCL12 |
5.304e-06 | -12.15 | response to other organism | biological process | GO:0051707 | 1363 | 14 | 18204 | 47 |
TREM2,RNASET2,WNT5A,C1QC,AXL,CSF1R,CXCL12,HAVCR2,ALPK1,CD68,MEF2C,C1QA,CH25H,C1QB |
5.350e-06 | -12.14 | positive regulation of immune system process | biological process | GO:0002684 | 986 | 12 | 18204 | 47 |
WNT5A,TREM2,C1QC,CSF1R,AXL,CXCL12,C3AR1,ALPK1,HAVCR2,MEF2C,C1QA,C1QB |
5.441e-06 | -12.12 | response to external biotic stimulus | biological process | GO:0043207 | 1366 | 14 | 18204 | 47 |
C1QC,TREM2,WNT5A,RNASET2,CXCL12,CSF1R,AXL,CD68,ALPK1,HAVCR2,C1QB,C1QA,MEF2C,CH25H |
7.724e-06 | -11.77 | response to biotic stimulus | biological process | GO:0009607 | 1408 | 14 | 18204 | 47 |
HAVCR2,CD68,ALPK1,C1QB,C1QA,MEF2C,CH25H,C1QC,TREM2,RNASET2,WNT5A,CXCL12,AXL,CSF1R |
9.500e-06 | -11.56 | response to stress | biological process | GO:0006950 | 3388 | 22 | 18204 | 47 |
COL18A1,C3AR1,ALPK1,CD68,HAVCR2,ADORA3,CH25H,C1QA,MEF2C,C1QB,KCNMB1,PDGFA,WNT5A,RNASET2,TREM2,PPARD,APOE,C1QC,CSF1R,AXL,CXCL12,FOLR2 |
1.006e-05 | -11.51 | negative regulation of lipid metabolic process | biological process | GO:0045833 | 112 | 5 | 18204 | 47 |
APOE,APOC2,APOC1,PDGFA,CH25H |
1.083e-05 | -11.43 | Creation of C4 and C2 activators | REACTOME pathways | R-HSA-166786 | 12 | 3 | 10285 | 39 |
C1QA,C1QB,C1QC |
1.285e-05 | -11.26 | LETMD1 (LETM1 domain containing 1) | protein interactions | 25875 | 56 | 4 | 19454 | 50 |
C3AR1,APOC1,TSPAN15,APOC2 |
1.351e-05 | -11.21 | cholesterol metabolic process | biological process | GO:0008203 | 119 | 5 | 18204 | 47 |
APOE,PPARD,OSBPL1A,APOC1,CH25H |
1.380e-05 | -11.19 | endoplasmic reticulum lumen | cellular component | GO:0005788 | 312 | 7 | 19108 | 49 |
RNASET2,TSPAN15,PDGFA,APOE,WNT5A,COL18A1,SPP1 |
1.551e-05 | -11.07 | innate immune response | biological process | GO:0045087 | 741 | 10 | 18204 | 47 |
WNT5A,RNASET2,HAVCR2,C1QC,ALPK1,AXL,C1QA,CSF1R,CH25H,C1QB |
1.583e-05 | -11.05 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 15 | 18204 | 47 |
PPARD,WNT5A,CSF2RA,TREM2,SPP1,CXCL12,FOLR2,ABCB4,CSF1R,AXL,CD68,HAVCR2,P2RY13,KCNMB1,MEF2C |
1.752e-05 | -10.95 | triglyceride-rich plasma lipoprotein particle | cellular component | GO:0034385 | 20 | 3 | 19108 | 49 |
APOE,APOC2,APOC1 |
1.752e-05 | -10.95 | very-low-density lipoprotein particle | cellular component | GO:0034361 | 20 | 3 | 19108 | 49 |
APOC1,APOE,APOC2 |
1.920e-05 | -10.86 | regulation of lipid metabolic process | biological process | GO:0019216 | 327 | 7 | 18204 | 47 |
APOC2,CH25H,PPARD,APOE,PDGFA,APOC1,TREM2 |
1.954e-05 | -10.84 | primary heart field specification | biological process | GO:0003138 | 3 | 2 | 18204 | 47 |
MEF2C,WNT5A |
1.954e-05 | -10.84 | very-low-density lipoprotein particle clearance | biological process | GO:0034447 | 3 | 2 | 18204 | 47 |
APOC1,APOE |
2.073e-05 | -10.78 | secondary alcohol metabolic process | biological process | GO:1902652 | 130 | 5 | 18204 | 47 |
APOC1,CH25H,APOE,PPARD,OSBPL1A |
2.120e-05 | -10.76 | cellular response to molecule of bacterial origin | biological process | GO:0071219 | 221 | 6 | 18204 | 47 |
CD68,HAVCR2,TREM2,WNT5A,AXL,MEF2C |
2.156e-05 | -10.74 | immune system process | biological process | GO:0002376 | 1991 | 16 | 18204 | 47 |
C1QC,TREM2,WNT5A,RNASET2,FOLR2,CXCL12,AXL,CSF1R,HAVCR2,CD68,ALPK1,C3AR1,C1QB,MEF2C,C1QA,CH25H |
2.242e-05 | -10.71 | response to oxygen-containing compound | biological process | GO:1901700 | 1546 | 14 | 18204 | 47 |
MEF2C,KCNMB1,COL18A1,CD68,HAVCR2,ABCB4,AXL,SPP1,FOLR2,CXCL12,RGS10,WNT5A,TREM2,APOE |
2.315e-05 | -10.67 | sterol metabolic process | biological process | GO:0016125 | 133 | 5 | 18204 | 47 |
CH25H,APOC1,OSBPL1A,PPARD,APOE |
2.352e-05 | -10.66 | Complement cascade | REACTOME pathways | R-HSA-166658 | 45 | 4 | 10285 | 39 |
C1QC,C3AR1,C1QB,C1QA |
2.353e-05 | -10.66 | negative regulation of lipid localization | biological process | GO:1905953 | 65 | 4 | 18204 | 47 |
TREM2,APOC1,APOC2,PPARD |
2.720e-05 | -10.51 | negative regulation of cell population proliferation | biological process | GO:0008285 | 791 | 10 | 18204 | 47 |
CSF1R,MEF2C,ADORA3,TREM2,WNT5A,COL18A1,APOE,WDR77,HAVCR2,PPARD |
2.914e-05 | -10.44 | Classical Complement Pathway | SMPDB pathways | SMP0064047 | 14 | 3 | 1369 | 7 |
C1QA,C1QC,C1QB |
2.944e-05 | -10.43 | regulation of immune system process | biological process | GO:0002682 | 1584 | 14 | 18204 | 47 |
TREM2,WNT5A,C1QC,APOE,CSF1R,AXL,CXCL12,CD68,ALPK1,HAVCR2,C3AR1,C1QA,MEF2C,C1QB |
3.066e-05 | -10.39 | positive regulation of chemotaxis | biological process | GO:0050921 | 141 | 5 | 18204 | 47 |
C3AR1,CXCL12,WNT5A,CSF1R,TREM2 |
3.143e-05 | -10.37 | plasma lipoprotein particle clearance | biological process | GO:0034381 | 24 | 3 | 18204 | 47 |
APOE,APOC2,APOC1 |
3.195e-05 | -10.35 | positive regulation of immune response | biological process | GO:0050778 | 640 | 9 | 18204 | 47 |
C1QA,MEF2C,TREM2,WNT5A,HAVCR2,C1QC,ALPK1,C1QB,C3AR1 |
3.280e-05 | -10.33 | regulation of mononuclear cell migration | biological process | GO:0071675 | 143 | 5 | 18204 | 47 |
CXCL12,C3AR1,CSF1R,TREM2,WNT5A |
3.853e-05 | -10.16 | intermediate-density lipoprotein particle | cellular component | GO:0034363 | 4 | 2 | 19108 | 49 |
APOC2,APOE |
3.856e-05 | -10.16 | defense response to other organism | biological process | GO:0098542 | 1006 | 11 | 18204 | 47 |
C1QC,WNT5A,RNASET2,TREM2,AXL,CSF1R,HAVCR2,ALPK1,C1QB,CH25H,C1QA |
3.902e-05 | -10.15 | cellular response to bile acid | biological process | GO:1903413 | 4 | 2 | 18204 | 47 |
ABCB4,KCNMB1 |
3.902e-05 | -10.15 | negative regulation of very-low-density lipoprotein particle clearance | biological process | GO:0010916 | 4 | 2 | 18204 | 47 |
APOC1,APOC2 |
3.902e-05 | -10.15 | complement-mediated synapse pruning | biological process | GO:0150062 | 4 | 2 | 18204 | 47 |
TREM2,C1QA |
3.953e-05 | -10.14 | high-density lipoprotein particle | cellular component | GO:0034364 | 26 | 3 | 19108 | 49 |
APOC1,APOC2,APOE |
3.957e-05 | -10.14 | cellular response to biotic stimulus | biological process | GO:0071216 | 247 | 6 | 18204 | 47 |
CD68,HAVCR2,WNT5A,TREM2,AXL,MEF2C |
3.994e-05 | -10.13 | positive regulation of leukocyte migration | biological process | GO:0002687 | 149 | 5 | 18204 | 47 |
WNT5A,TREM2,CSF1R,C3AR1,CXCL12 |
4.023e-05 | -10.12 | positive regulation of macrophage migration | biological process | GO:1905523 | 26 | 3 | 18204 | 47 |
CSF1R,TREM2,C3AR1 |
4.085e-05 | -10.11 | activation of immune response | biological process | GO:0002253 | 368 | 7 | 18204 | 47 |
C1QB,MEF2C,C1QA,C1QC,ALPK1,HAVCR2,C3AR1 |
4.866e-05 | -9.93 | response to chemical | biological process | GO:0042221 | 3743 | 22 | 18204 | 47 |
MEF2C,HAVCR2,CD68,P2RY13,RGS10,FOLR2,CSF1R,ABCB4,TREM2,KCNMB1,CH25H,C3AR1,COL18A1,SPP1,LTC4S,CXCL12,AXL,APOE,PPARD,CSF2RA,WNT5A,PDGFA |
5.050e-05 | -9.89 | purinergic nucleotide receptor signaling pathway | biological process | GO:0035590 | 28 | 3 | 18204 | 47 |
ADORA3,P2RY13,GPR34 |
5.176e-05 | -9.87 | negative regulation of multicellular organismal process | biological process | GO:0051241 | 1237 | 12 | 18204 | 47 |
SPP1,APOC2,AXL,APOE,C1QC,WDR77,TREM2,PDGFA,WNT5A,MEF2C,HAVCR2,APOC1 |
5.392e-05 | -9.83 | ITGAV (integrin subunit alpha V) | protein interactions | 3685 | 159 | 5 | 19454 | 50 |
CSF1R,CXCL12,SPP1,COL18A1,C1QA |
5.551e-05 | -9.80 | cellular response to oxygen-containing compound | biological process | GO:1901701 | 1047 | 11 | 18204 | 47 |
WNT5A,TREM2,HAVCR2,CD68,MEF2C,AXL,ABCB4,KCNMB1,RGS10,FOLR2,SPP1 |
5.562e-05 | -9.80 | Staphylococcus aureus infection | KEGG pathways | hsa05150 | 55 | 4 | 7161 | 28 |
C3AR1,C1QC,C1QA,C1QB |
5.562e-05 | -9.80 | Staphylococcus aureus infection | KEGG pathways | ko05150 | 55 | 4 | 7161 | 28 |
C1QB,C1QA,C3AR1,C1QC |
5.623e-05 | -9.79 | cholesterol efflux | biological process | GO:0033344 | 29 | 3 | 18204 | 47 |
APOC1,APOE,APOC2 |
5.641e-05 | -9.78 | response to lipid | biological process | GO:0033993 | 862 | 10 | 18204 | 47 |
TREM2,WNT5A,CD68,HAVCR2,PPARD,ABCB4,AXL,MEF2C,SPP1,KCNMB1 |
5.786e-05 | -9.76 | Collagen | interpro domains | IPR008160 | 78 | 4 | 18521 | 50 |
COL18A1,C1QC,C1QA,C1QB |
5.979e-05 | -9.72 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 10 | 18204 | 47 |
APOC2,RGS10,ADORA3,MEF2C,AXL,CSF1R,APOE,PDGFA,WNT5A,TREM2 |
6.176e-05 | -9.69 | C1QC (complement C1q C chain) | protein interactions | 714 | 30 | 3 | 19454 | 50 |
C1QA,COL18A1,C1QB |
6.236e-05 | -9.68 | positive regulation of macrophage activation | biological process | GO:0043032 | 30 | 3 | 18204 | 47 |
HAVCR2,TREM2,WNT5A |
6.492e-05 | -9.64 | CXCL12-activated CXCR4 signaling pathway | biological process | GO:0038160 | 5 | 2 | 18204 | 47 |
TREM2,CXCL12 |
6.492e-05 | -9.64 | regulation of very-low-density lipoprotein particle clearance | biological process | GO:0010915 | 5 | 2 | 18204 | 47 |
APOC1,APOC2 |
6.749e-05 | -9.60 | Collagen | pfam domains | PF01391 | 78 | 4 | 17795 | 50 |
COL18A1,C1QA,C1QB,C1QC |
6.892e-05 | -9.58 | plasma lipoprotein particle remodeling | biological process | GO:0034369 | 31 | 3 | 18204 | 47 |
APOC1,APOC2,APOE |
6.892e-05 | -9.58 | protein-lipid complex remodeling | biological process | GO:0034368 | 31 | 3 | 18204 | 47 |
APOC2,APOE,APOC1 |
6.892e-05 | -9.58 | complement activation, classical pathway | biological process | GO:0006958 | 31 | 3 | 18204 | 47 |
C1QA,C1QC,C1QB |
6.943e-05 | -9.58 | collagen trimer | cellular component | GO:0005581 | 86 | 4 | 19108 | 49 |
C1QA,COL18A1,C1QC,C1QB |
7.092e-05 | -9.55 | positive regulation of lipid transport | biological process | GO:0032370 | 86 | 4 | 18204 | 47 |
TREM2,ABCB4,APOE,SPP1 |
7.110e-05 | -9.55 | lipid binding | molecular function | GO:0008289 | 861 | 10 | 18094 | 48 |
PPARD,WNT5A,AXL,OSBPL1A,APOC2,APOE,ADAP2,TREM2,LTC4S,APOC1 |
7.386e-05 | -9.51 | Initial triggering of complement | REACTOME pathways | R-HSA-166663 | 22 | 3 | 10285 | 39 |
C1QC,C1QA,C1QB |
7.585e-05 | -9.49 | cell surface | cellular component | GO:0009986 | 896 | 10 | 19108 | 49 |
PDGFA,FOLR2,AXL,TSPAN15,CSF1R,CXCL12,TREM2,HAVCR2,WNT5A,CSF2RA |
7.656e-05 | -9.48 | defense response to symbiont | biological process | GO:0140546 | 894 | 10 | 18204 | 47 |
CH25H,CSF1R,AXL,C1QA,C1QB,WNT5A,RNASET2,C1QC,ALPK1,HAVCR2 |
8.108e-05 | -9.42 | regulation of leukocyte apoptotic process | biological process | GO:2000106 | 89 | 4 | 18204 | 47 |
WNT5A,AXL,MEF2C,CXCL12 |
8.348e-05 | -9.39 | negative regulation of epithelial cell proliferation | biological process | GO:0050680 | 174 | 5 | 18204 | 47 |
WNT5A,MEF2C,PPARD,WDR77,APOE |
8.876e-05 | -9.33 | C1q | pfam domains | PF00386 | 31 | 3 | 17795 | 50 |
C1QC,C1QA,C1QB |
9.007e-05 | -9.31 | Complement Pathway | SMPDB pathways | SMP0063814 | 20 | 3 | 1369 | 7 |
C1QC,C1QA,C1QB |
9.020e-05 | -9.31 | amyloid-beta binding | molecular function | GO:0001540 | 89 | 4 | 18094 | 48 |
C1QA,APOE,ITM2B,TREM2 |
9.125e-05 | -9.30 | regulation of phospholipid metabolic process | biological process | GO:1903725 | 34 | 3 | 18204 | 47 |
APOC2,PDGFA,APOC1 |
9.125e-05 | -9.30 | protein-containing complex remodeling | biological process | GO:0034367 | 34 | 3 | 18204 | 47 |
APOE,APOC2,APOC1 |
9.126e-05 | -9.30 | C1Q | smart domains | SM00110 | 31 | 3 | 9717 | 28 |
C1QB,C1QC,C1QA |
9.227e-05 | -9.29 | positive regulation of leukocyte chemotaxis | biological process | GO:0002690 | 92 | 4 | 18204 | 47 |
WNT5A,CSF1R,C3AR1,CXCL12 |
9.332e-05 | -9.28 | response to organic substance | biological process | GO:0010033 | 2498 | 17 | 18204 | 47 |
WNT5A,CSF2RA,TREM2,PPARD,CSF1R,ABCB4,AXL,CXCL12,SPP1,FOLR2,RGS10,P2RY13,CD68,HAVCR2,CH25H,MEF2C,KCNMB1 |
9.540e-05 | -9.26 | C1q_dom | interpro domains | IPR001073 | 33 | 3 | 18521 | 50 |
C1QB,C1QA,C1QC |
9.623e-05 | -9.25 | regulation of extent of cell growth | biological process | GO:0061387 | 93 | 4 | 18204 | 47 |
APOE,CXCL12,SPP1,WNT5A |
9.722e-05 | -9.24 | C-X-C chemokine receptor CXCR4 signaling pathway | biological process | GO:0038159 | 6 | 2 | 18204 | 47 |
CXCL12,TREM2 |
9.722e-05 | -9.24 | negative regulation of phospholipid metabolic process | biological process | GO:1903726 | 6 | 2 | 18204 | 47 |
PDGFA,APOC1 |
9.866e-05 | -9.22 | regulation of response to external stimulus | biological process | GO:0032101 | 1116 | 11 | 18204 | 47 |
C3AR1,ALPK1,HAVCR2,SPP1,CXCL12,CSF1R,PPARD,APOE,WNT5A,PDGFA,TREM2 |
1.027e-04 | -9.18 | phosphatidylcholine-sterol O-acyltransferase activator activity | molecular function | GO:0060228 | 6 | 2 | 18094 | 48 |
APOE,APOC1 |
1.027e-04 | -9.18 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 7 | 19108 | 49 |
C1QB,APOE,C1QC,WNT5A,COL18A1,CXCL12,C1QA |
1.036e-04 | -9.17 | Complement Activation | WikiPathways | WP545 | 22 | 3 | 5310 | 23 |
C1QC,C1QB,C1QA |
1.055e-04 | -9.16 | negative regulation of response to external stimulus | biological process | GO:0032102 | 428 | 7 | 18204 | 47 |
APOE,HAVCR2,PPARD,TREM2,PDGFA,WNT5A,SPP1 |
1.057e-04 | -9.15 | regulation of endocytosis | biological process | GO:0030100 | 295 | 6 | 18204 | 47 |
AXL,APOC2,APOC1,TREM2,WNT5A,APOE |
1.066e-04 | -9.15 | plasma lipoprotein particle | cellular component | GO:0034358 | 36 | 3 | 19108 | 49 |
APOC1,APOC2,APOE |
1.066e-04 | -9.15 | lipoprotein particle | cellular component | GO:1990777 | 36 | 3 | 19108 | 49 |
APOC2,APOE,APOC1 |
1.085e-04 | -9.13 | positive regulation of cholesterol transport | biological process | GO:0032376 | 36 | 3 | 18204 | 47 |
ABCB4,TREM2,APOE |
1.085e-04 | -9.13 | humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002455 | 36 | 3 | 18204 | 47 |
C1QC,C1QB,C1QA |
1.085e-04 | -9.13 | regulation of lipoprotein particle clearance | biological process | GO:0010984 | 36 | 3 | 18204 | 47 |
APOC1,TREM2,APOC2 |
1.085e-04 | -9.13 | positive regulation of sterol transport | biological process | GO:0032373 | 36 | 3 | 18204 | 47 |
ABCB4,TREM2,APOE |
1.111e-04 | -9.10 | Complement and Coagulation Cascades | WikiPathways | WP558 | 60 | 4 | 5310 | 23 |
C1QA,C1QB,C1QC,C3AR1 |
1.114e-04 | -9.10 | positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051897 | 185 | 5 | 18204 | 47 |
PPARD,CSF1R,TREM2,AXL,PDGFA |
1.128e-04 | -9.09 | regulation of cell population proliferation | biological process | GO:0042127 | 1790 | 14 | 18204 | 47 |
APOE,WDR77,PPARD,TREM2,PDGFA,WNT5A,CSF2RA,FOLR2,CXCL12,CSF1R,HAVCR2,COL18A1,MEF2C,ADORA3 |
1.139e-04 | -9.08 | plasma membrane | cellular component | GO:0005886 | 5538 | 27 | 19108 | 49 |
P2RY13,ABCB4,HAVCR2,CSF2RA,DCBLD1,CSF1R,EPB41L2,RGL3,FOLR2,APOE,CD68,ADAP2,WNT5A,SIGLEC8,TREM2,RGS10,ADORA3,ITM2B,OSBPL1A,IFITM10,TSPAN15,CXCL12,ACY3,AXL,C3AR1,GPR34,KCNMB1 |
1.203e-04 | -9.03 | regulation of immune response | biological process | GO:0050776 | 944 | 10 | 18204 | 47 |
C1QB,C1QA,MEF2C,ALPK1,C1QC,APOE,HAVCR2,C3AR1,TREM2,WNT5A |
1.227e-04 | -9.01 | phospholipid transport | biological process | GO:0015914 | 99 | 4 | 18204 | 47 |
ABCB4,APOC1,APOC2,APOE |
1.320e-04 | -8.93 | C1Q | prosite domains | PS50871 | 33 | 3 | 12186 | 37 |
C1QB,C1QC,C1QA |
1.357e-04 | -8.90 | protein-lipid complex | cellular component | GO:0032994 | 39 | 3 | 19108 | 49 |
APOC1,APOE,APOC2 |
1.359e-04 | -8.90 | chemokine (C-X-C motif) ligand 12 signaling pathway | biological process | GO:0038146 | 7 | 2 | 18204 | 47 |
CXCL12,TREM2 |
1.359e-04 | -8.90 | regulation of phospholipid catabolic process | biological process | GO:0060696 | 7 | 2 | 18204 | 47 |
APOC2,APOC1 |
1.359e-04 | -8.90 | high-density lipoprotein particle clearance | biological process | GO:0034384 | 7 | 2 | 18204 | 47 |
APOE,APOC2 |
1.359e-04 | -8.90 | response to bile acid | biological process | GO:1903412 | 7 | 2 | 18204 | 47 |
ABCB4,KCNMB1 |
1.359e-04 | -8.90 | very-low-density lipoprotein particle remodeling | biological process | GO:0034372 | 7 | 2 | 18204 | 47 |
APOC2,APOE |
1.448e-04 | -8.84 | molecular function activator activity | molecular function | GO:0140677 | 1132 | 11 | 18094 | 48 |
RGS10,APOC1,LTC4S,TREM2,ADAP2,APOE,SPP1,APOC2,WNT5A,PDGFA,CXCL12 |
1.484e-04 | -8.82 | regulation of chemokine production | biological process | GO:0032642 | 104 | 4 | 18204 | 47 |
WNT5A,CSF1R,TREM2,HAVCR2 |
1.487e-04 | -8.81 | regulation of developmental growth | biological process | GO:0048638 | 314 | 6 | 18204 | 47 |
MEF2C,SPP1,CXCL12,WNT5A,PPARD,APOE |
1.525e-04 | -8.79 | COL6A1 (collagen type VI alpha 1 chain) | protein interactions | 1291 | 105 | 4 | 19454 | 50 |
PDGFA,WNT5A,C1QC,COL18A1 |
1.568e-04 | -8.76 | positive regulation of ERK1 and ERK2 cascade | biological process | GO:0070374 | 199 | 5 | 18204 | 47 |
HAVCR2,APOE,TREM2,CSF1R,PDGFA |
1.640e-04 | -8.72 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 12 | 18204 | 47 |
APOE,WNT5A,PDGFA,APOC1,TREM2,APOC2,RGS10,ADORA3,ADAP2,MEF2C,AXL,CSF1R |
1.704e-04 | -8.68 | alcohol metabolic process | biological process | GO:0006066 | 322 | 6 | 18204 | 47 |
APOE,PPARD,OSBPL1A,APOC1,CH25H,DHRS9 |
1.739e-04 | -8.66 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 7 | 18204 | 47 |
PPARD,P2RY13,SPP1,FOLR2,KCNMB1,ABCB4,MEF2C |
1.806e-04 | -8.62 | positive regulation of cell population proliferation | biological process | GO:0008284 | 992 | 10 | 18204 | 47 |
CSF1R,MEF2C,FOLR2,CXCL12,WNT5A,PDGFA,CSF2RA,WDR77,HAVCR2,PPARD |
1.809e-04 | -8.62 | positive regulation of amyloid-beta clearance | biological process | GO:1900223 | 8 | 2 | 18204 | 47 |
TREM2,APOE |
1.809e-04 | -8.62 | triglyceride-rich lipoprotein particle remodeling | biological process | GO:0034370 | 8 | 2 | 18204 | 47 |
APOC2,APOE |
1.888e-04 | -8.57 | human chr1p36.12 | chromosome location | human chr1p36.12 | 58 | 3 | 26134 | 50 |
C1QC,C1QB,C1QA |
1.908e-04 | -8.56 | positive regulation of lipid localization | biological process | GO:1905954 | 111 | 4 | 18204 | 47 |
SPP1,APOE,ABCB4,TREM2 |
1.927e-04 | -8.55 | cellular response to lipopolysaccharide | biological process | GO:0071222 | 208 | 5 | 18204 | 47 |
HAVCR2,CD68,WNT5A,MEF2C,AXL |
1.957e-04 | -8.54 | positive regulation of MAPK cascade | biological process | GO:0043410 | 473 | 7 | 18204 | 47 |
MEF2C,CSF1R,HAVCR2,APOE,PDGFA,WNT5A,TREM2 |
1.971e-04 | -8.53 | regulation of chemotaxis | biological process | GO:0050920 | 209 | 5 | 18204 | 47 |
CXCL12,C3AR1,CSF1R,TREM2,WNT5A |
1.979e-04 | -8.53 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 6 | 18204 | 47 |
CH25H,APOC2,APOC1,TREM2,APOE,PPARD |
2.044e-04 | -8.50 | synapse organization | biological process | GO:0050808 | 333 | 6 | 18204 | 47 |
WNT5A,TREM2,C1QA,C1QB,APOE,C1QC |
2.044e-04 | -8.50 | response to lipopolysaccharide | biological process | GO:0032496 | 333 | 6 | 18204 | 47 |
WNT5A,TREM2,CD68,HAVCR2,AXL,MEF2C |
2.121e-04 | -8.46 | regulation of macrophage migration | biological process | GO:1905521 | 45 | 3 | 18204 | 47 |
C3AR1,TREM2,CSF1R |
2.199e-04 | -8.42 | negative regulation of cell activation | biological process | GO:0050866 | 214 | 5 | 18204 | 47 |
PDGFA,TREM2,AXL,APOE,HAVCR2 |
2.265e-04 | -8.39 | plasma lipoprotein particle organization | biological process | GO:0071827 | 46 | 3 | 18204 | 47 |
APOE,APOC2,APOC1 |
2.297e-04 | -8.38 | Complement and coagulation cascades | KEGG pathways | ko04610 | 79 | 4 | 7161 | 28 |
C1QB,C1QA,C1QC,C3AR1 |
2.297e-04 | -8.38 | Complement and coagulation cascades | KEGG pathways | hsa04610 | 79 | 4 | 7161 | 28 |
C1QA,C3AR1,C1QC,C1QB |
2.322e-04 | -8.37 | microglial cell proliferation | biological process | GO:0061518 | 9 | 2 | 18204 | 47 |
CSF1R,TREM2 |
2.322e-04 | -8.37 | negative regulation of dendritic cell apoptotic process | biological process | GO:2000669 | 9 | 2 | 18204 | 47 |
CXCL12,AXL |
2.322e-04 | -8.37 | macrophage proliferation | biological process | GO:0061517 | 9 | 2 | 18204 | 47 |
CSF1R,TREM2 |
2.474e-04 | -8.30 | chemotaxis | biological process | GO:0006935 | 345 | 6 | 18204 | 47 |
CH25H,WNT5A,PDGFA,C3AR1,CXCL12,FOLR2 |
2.552e-04 | -8.27 | taxis | biological process | GO:0042330 | 347 | 6 | 18204 | 47 |
C3AR1,CXCL12,FOLR2,WNT5A,PDGFA,CH25H |
2.734e-04 | -8.20 | protein-lipid complex organization | biological process | GO:0071825 | 49 | 3 | 18204 | 47 |
APOC1,APOC2,APOE |
2.734e-04 | -8.20 | complement activation | biological process | GO:0006956 | 49 | 3 | 18204 | 47 |
C1QA,C1QC,C1QB |
2.741e-04 | -8.20 | regulation of leukocyte chemotaxis | biological process | GO:0002688 | 122 | 4 | 18204 | 47 |
WNT5A,CSF1R,C3AR1,CXCL12 |
2.817e-04 | -8.17 | positive regulation of intracellular signal transduction | biological process | GO:1902533 | 1048 | 10 | 18204 | 47 |
AXL,MEF2C,CSF1R,PPARD,HAVCR2,APOE,ALPK1,PDGFA,WNT5A,TREM2 |
2.840e-04 | -8.17 | response to molecule of bacterial origin | biological process | GO:0002237 | 354 | 6 | 18204 | 47 |
MEF2C,AXL,HAVCR2,CD68,TREM2,WNT5A |
2.845e-04 | -8.16 | phospholipid binding | molecular function | GO:0005543 | 489 | 7 | 18094 | 48 |
APOC1,TREM2,APOE,ADAP2,WNT5A,OSBPL1A,AXL |
2.874e-04 | -8.15 | COMPLEMNTC1Q | prints domains | PR00007 | 29 | 3 | 5227 | 24 |
C1QA,C1QC,C1QB |
2.898e-04 | -8.15 | regulation of behavioral fear response | biological process | GO:2000822 | 10 | 2 | 18204 | 47 |
MEF2C,APOE |
2.898e-04 | -8.15 | regulation of fat cell proliferation | biological process | GO:0070344 | 10 | 2 | 18204 | 47 |
TREM2,PPARD |
2.898e-04 | -8.15 | vagina development | biological process | GO:0060068 | 10 | 2 | 18204 | 47 |
WNT5A,AXL |
3.131e-04 | -8.07 | regulation of leukocyte migration | biological process | GO:0002685 | 231 | 5 | 18204 | 47 |
CSF1R,TREM2,WNT5A,CXCL12,C3AR1 |
3.223e-04 | -8.04 | Prion diseases | KEGG pathways | ko05020 | 35 | 3 | 7161 | 28 |
C1QA,C1QC,C1QB |
3.223e-04 | -8.04 | Prion diseases | KEGG pathways | hsa05020 | 35 | 3 | 7161 | 28 |
C1QB,C1QA,C1QC |
3.444e-04 | -7.97 | locomotion | biological process | GO:0040011 | 367 | 6 | 18204 | 47 |
FOLR2,CXCL12,CH25H,C3AR1,PDGFA,WNT5A |
3.536e-04 | -7.95 | negative regulation of cholesterol metabolic process | biological process | GO:0090206 | 11 | 2 | 18204 | 47 |
APOE,CH25H |
3.536e-04 | -7.95 | negative regulation of cholesterol storage | biological process | GO:0010887 | 11 | 2 | 18204 | 47 |
PPARD,TREM2 |
3.536e-04 | -7.95 | regulation of fear response | biological process | GO:1903365 | 11 | 2 | 18204 | 47 |
MEF2C,APOE |
3.536e-04 | -7.95 | secondary heart field specification | biological process | GO:0003139 | 11 | 2 | 18204 | 47 |
MEF2C,WNT5A |
3.559e-04 | -7.94 | Statin Pathway | WikiPathways | WP430 | 33 | 3 | 5310 | 23 |
APOC1,APOC2,APOE |
3.587e-04 | -7.93 | molecular transducer activity | molecular function | GO:0060089 | 1474 | 12 | 18094 | 48 |
FOLR2,DCBLD1,GPR34,P2RY13,AXL,ADORA3,C3AR1,TREM2,SIGLEC8,CSF1R,CSF2RA,PPARD |
3.587e-04 | -7.93 | signaling receptor activity | molecular function | GO:0038023 | 1474 | 12 | 18094 | 48 |
FOLR2,DCBLD1,GPR34,P2RY13,ADORA3,AXL,C3AR1,TREM2,SIGLEC8,PPARD,CSF1R,CSF2RA |
3.857e-04 | -7.86 | positive regulation of response to stimulus | biological process | GO:0048584 | 2266 | 15 | 18204 | 47 |
WNT5A,PDGFA,TREM2,PPARD,APOE,C1QC,CSF1R,AXL,CXCL12,C3AR1,ALPK1,HAVCR2,MEF2C,C1QA,C1QB |
3.944e-04 | -7.84 | Tumour_necrosis_fac-like_dom | interpro domains | IPR008983 | 53 | 3 | 18521 | 50 |
C1QB,C1QA,C1QC |
3.993e-04 | -7.83 | cell junction organization | biological process | GO:0034330 | 532 | 7 | 18204 | 47 |
C1QC,APOE,TREM2,WNT5A,C1QB,CSF1R,C1QA |
4.184e-04 | -7.78 | response to stimulus | biological process | GO:0050896 | 7803 | 32 | 18204 | 47 |
C3AR1,RGL3,COL18A1,KCNMB1,C1QB,SIGLEC8,C1QA,CH25H,C1QC,APOE,PPARD,CSF2RA,WNT5A,PDGFA,SPP1,CXCL12,LTC4S,AXL,HAVCR2,ALPK1,CD68,USP53,P2RY13,GPR34,MEF2C,ADORA3,TREM2,RNASET2,RGS10,FOLR2,CSF1R,ABCB4 |
4.203e-04 | -7.77 | positive regulation of transferase activity | biological process | GO:0051347 | 381 | 6 | 18204 | 47 |
AXL,CSF1R,TREM2,PDGFA,WNT5A,APOE |
4.206e-04 | -7.77 | regulation of localization | biological process | GO:0032879 | 2028 | 14 | 18204 | 47 |
APOC1,MEF2C,ADORA3,KCNMB1,TREM2,WNT5A,APOE,PPARD,ABCB4,AXL,SPP1,CXCL12,EPB41L2,APOC2 |
4.236e-04 | -7.77 | response to macrophage colony-stimulating factor | biological process | GO:0036005 | 12 | 2 | 18204 | 47 |
SPP1,CSF1R |
4.236e-04 | -7.77 | heart field specification | biological process | GO:0003128 | 12 | 2 | 18204 | 47 |
WNT5A,MEF2C |
4.236e-04 | -7.77 | regulation of dendritic cell apoptotic process | biological process | GO:2000668 | 12 | 2 | 18204 | 47 |
CXCL12,AXL |
4.239e-04 | -7.77 | COL2A1 (collagen type II alpha 1 chain) | protein interactions | 1280 | 57 | 3 | 19454 | 50 |
PDGFA,C1QA,C1QC |
4.255e-04 | -7.76 | humoral immune response | biological process | GO:0006959 | 247 | 5 | 18204 | 47 |
C1QB,C1QC,TREM2,C1QA,MEF2C |
4.381e-04 | -7.73 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 18 | 18204 | 47 |
AXL,CSF1R,APOC2,SPP1,CXCL12,WNT5A,PDGFA,TREM2,PPARD,C1QC,APOE,WDR77,ADORA3,MEF2C,APOC1,C3AR1,HAVCR2,BHLHE41 |
4.505e-04 | -7.71 | maternal process involved in female pregnancy | biological process | GO:0060135 | 58 | 3 | 18204 | 47 |
PPARD,SPP1,HAVCR2 |
4.738e-04 | -7.65 | regulation of plasma lipoprotein particle levels | biological process | GO:0097006 | 59 | 3 | 18204 | 47 |
APOC1,APOC2,APOE |
4.879e-04 | -7.63 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 4 | 18204 | 47 |
TREM2,APOE,APOC2,PPARD |
4.978e-04 | -7.61 | regulation of macrophage activation | biological process | GO:0043030 | 60 | 3 | 18204 | 47 |
TREM2,WNT5A,HAVCR2 |
4.978e-04 | -7.61 | positive regulation of cytokine-mediated signaling pathway | biological process | GO:0001961 | 60 | 3 | 18204 | 47 |
TREM2,AXL,WNT5A |
4.998e-04 | -7.60 | negative regulation of amyloid fibril formation | biological process | GO:1905907 | 13 | 2 | 18204 | 47 |
APOE,TREM2 |
4.998e-04 | -7.60 | G protein-coupled purinergic nucleotide receptor signaling pathway | biological process | GO:0035589 | 13 | 2 | 18204 | 47 |
GPR34,P2RY13 |
5.225e-04 | -7.56 | - | gene3d domains | 2.60.120.40 | 52 | 3 | 14470 | 44 |
C1QA,C1QC,C1QB |
5.225e-04 | -7.56 | extracellular matrix | cellular component | GO:0031012 | 559 | 7 | 19108 | 49 |
C1QB,C1QA,WNT5A,COL18A1,C1QC,APOE,CXCL12 |
5.276e-04 | -7.55 | G protein-coupled purinergic nucleotide receptor activity | molecular function | GO:0045028 | 13 | 2 | 18094 | 48 |
GPR34,P2RY13 |
5.281e-04 | -7.55 | external encapsulating structure | cellular component | GO:0030312 | 560 | 7 | 19108 | 49 |
CXCL12,C1QC,APOE,C1QA,COL18A1,WNT5A,C1QB |
5.482e-04 | -7.51 | macrophage activation | biological process | GO:0042116 | 62 | 3 | 18204 | 47 |
C1QA,TREM2,HAVCR2 |
5.483e-04 | -7.51 | amide binding | molecular function | GO:0033218 | 254 | 5 | 18094 | 48 |
C1QA,APOE,ITM2B,TREM2,FOLR2 |
5.661e-04 | -7.48 | positive regulation of response to external stimulus | biological process | GO:0032103 | 564 | 7 | 18204 | 47 |
ALPK1,HAVCR2,C3AR1,TREM2,WNT5A,CXCL12,CSF1R |
5.691e-04 | -7.47 | PTX3 (pentraxin 3) | protein interactions | 5806 | 63 | 3 | 19454 | 50 |
C1QB,C1QA,C1QC |
5.821e-04 | -7.45 | positive regulation of phospholipid transport | biological process | GO:2001140 | 14 | 2 | 18204 | 47 |
ABCB4,APOE |
5.821e-04 | -7.45 | cellular response to oxidised low-density lipoprotein particle stimulus | biological process | GO:0140052 | 14 | 2 | 18204 | 47 |
CD68,TREM2 |
5.821e-04 | -7.45 | regulation of lipoprotein lipase activity | biological process | GO:0051004 | 14 | 2 | 18204 | 47 |
APOC2,APOC1 |
6.237e-04 | -7.38 | COLGALT2 (collagen beta(1-O)galactosyltransferase 2) | protein interactions | 23127 | 65 | 3 | 19454 | 50 |
C1QA,COL18A1,C1QB |
6.377e-04 | -7.36 | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | biological process | GO:0051896 | 270 | 5 | 18204 | 47 |
PPARD,AXL,TREM2,CSF1R,PDGFA |
6.461e-04 | -7.34 | organophosphate ester transport | biological process | GO:0015748 | 153 | 4 | 18204 | 47 |
APOC2,APOE,APOC1,ABCB4 |
6.537e-04 | -7.33 | regulation of transport | biological process | GO:0051049 | 1621 | 12 | 18204 | 47 |
APOC1,KCNMB1,MEF2C,ADORA3,APOE,TREM2,WNT5A,CXCL12,SPP1,APOC2,ABCB4,AXL |
6.586e-04 | -7.33 | response to ischemia | biological process | GO:0002931 | 66 | 3 | 18204 | 47 |
CSF1R,TREM2,MEF2C |
6.593e-04 | -7.32 | regulation of epithelial cell proliferation | biological process | GO:0050678 | 415 | 6 | 18204 | 47 |
WDR77,CXCL12,APOE,PPARD,MEF2C,WNT5A |
6.622e-04 | -7.32 | low-density lipoprotein particle | cellular component | GO:0034362 | 15 | 2 | 19108 | 49 |
APOC2,APOE |
6.654e-04 | -7.32 | C1R (complement C1r) | protein interactions | 715 | 15 | 2 | 19454 | 50 |
C1QB,C1QA |
6.706e-04 | -7.31 | regulation of phospholipid transport | biological process | GO:2001138 | 15 | 2 | 18204 | 47 |
APOE,ABCB4 |
6.882e-04 | -7.28 | cholesterol transport | biological process | GO:0030301 | 67 | 3 | 18204 | 47 |
APOC1,APOE,APOC2 |
6.882e-04 | -7.28 | positive regulation of response to cytokine stimulus | biological process | GO:0060760 | 67 | 3 | 18204 | 47 |
AXL,TREM2,WNT5A |
7.117e-04 | -7.25 | positive regulation of endocytosis | biological process | GO:0045807 | 157 | 4 | 18204 | 47 |
APOE,AXL,TREM2,WNT5A |
7.186e-04 | -7.24 | negative regulation of lipid biosynthetic process | biological process | GO:0051055 | 68 | 3 | 18204 | 47 |
APOE,PDGFA,APOC1 |
7.651e-04 | -7.18 | regulation of axon extension involved in axon guidance | biological process | GO:0048841 | 16 | 2 | 18204 | 47 |
WNT5A,CXCL12 |
7.747e-04 | -7.16 | C1QA (complement C1q A chain) | protein interactions | 712 | 70 | 3 | 19454 | 50 |
C1QB,C1QC,WNT5A |
7.787e-04 | -7.16 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 10 | 18204 | 47 |
ADORA3,AXL,MEF2C,CSF1R,APOC2,RGS10,WNT5A,PDGFA,TREM2,APOE |
8.032e-04 | -7.13 | response to wounding | biological process | GO:0009611 | 431 | 6 | 18204 | 47 |
WNT5A,ADORA3,PDGFA,TREM2,AXL,PPARD |
8.076e-04 | -7.12 | lipase inhibitor activity | molecular function | GO:0055102 | 16 | 2 | 18094 | 48 |
APOC1,APOC2 |
8.377e-04 | -7.08 | positive regulation of leukocyte proliferation | biological process | GO:0070665 | 164 | 4 | 18204 | 47 |
MEF2C,CSF1R,CSF2RA,HAVCR2 |
8.410e-04 | -7.08 | NDUFC2 (NADH:ubiquinone oxidoreductase subunit C2) | protein interactions | 4718 | 72 | 3 | 19454 | 50 |
TSPAN15,C3AR1,GPR34 |
8.491e-04 | -7.07 | positive regulation of chemokine production | biological process | GO:0032722 | 72 | 3 | 18204 | 47 |
HAVCR2,CSF1R,WNT5A |
8.561e-04 | -7.06 | human chr19q13.32 | chromosome location | human chr19q13.32 | 97 | 3 | 26134 | 50 |
APOC1,APOE,APOC2 |
8.657e-04 | -7.05 | regulation of amyloid fibril formation | biological process | GO:1905906 | 17 | 2 | 18204 | 47 |
TREM2,APOE |
8.657e-04 | -7.05 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 2 | 18204 | 47 |
APOC2,APOE |
8.657e-04 | -7.05 | high-density lipoprotein particle remodeling | biological process | GO:0034375 | 17 | 2 | 18204 | 47 |
APOE,APOC1 |
8.657e-04 | -7.05 | specification of animal organ identity | biological process | GO:0010092 | 17 | 2 | 18204 | 47 |
MEF2C,WNT5A |
8.754e-04 | -7.04 | GAS6 (growth arrest specific 6) | protein interactions | 2621 | 73 | 3 | 19454 | 50 |
C1QB,AXL,WNT5A |
9.140e-04 | -7.00 | lipid metabolic process | biological process | GO:0006629 | 1217 | 10 | 18204 | 47 |
APOC1,DHRS9,APOE,PPARD,ABCB4,CH25H,SPP1,LTC4S,APOC2,OSBPL1A |
9.195e-04 | -6.99 | sterol transport | biological process | GO:0015918 | 74 | 3 | 18204 | 47 |
APOC2,APOE,APOC1 |
9.470e-04 | -6.96 | CRP (C-reactive protein) | protein interactions | 1401 | 75 | 3 | 19454 | 50 |
COL18A1,C1QA,HS3ST1 |
9.494e-04 | -6.96 | regulation of ERK1 and ERK2 cascade | biological process | GO:0070372 | 295 | 5 | 18204 | 47 |
PDGFA,CSF1R,TREM2,APOE,HAVCR2 |
9.525e-04 | -6.96 | enzyme activator activity | molecular function | GO:0008047 | 599 | 7 | 18094 | 48 |
APOE,ADAP2,APOC1,TREM2,LTC4S,APOC2,RGS10 |
9.723e-04 | -6.94 | negative regulation of platelet activation | biological process | GO:0010544 | 18 | 2 | 18204 | 47 |
PDGFA,APOE |
9.723e-04 | -6.94 | heart formation | biological process | GO:0060914 | 18 | 2 | 18204 | 47 |
WNT5A,MEF2C |
9.936e-04 | -6.91 | regulation of axon extension | biological process | GO:0030516 | 76 | 3 | 18204 | 47 |
WNT5A,APOE,CXCL12 |
1.022e-03 | -6.89 | regulation of cell size | biological process | GO:0008361 | 173 | 4 | 18204 | 47 |
WNT5A,APOE,CXCL12,SPP1 |
1.040e-03 | -6.87 | cell junction | cellular component | GO:0030054 | 2224 | 14 | 19108 | 49 |
MEF2C,APOE,EPB41L2,TSPAN15,KCNMB1,C1QA,WNT5A,ABCB4,RGS10,USP53,C1QC,C1QB,ADORA3,HAVCR2 |
1.054e-03 | -6.86 | positive regulation of kinase activity | biological process | GO:0033674 | 302 | 5 | 18204 | 47 |
CSF1R,TREM2,AXL,WNT5A,PDGFA |
1.066e-03 | -6.84 | epithelial cell proliferation | biological process | GO:0050673 | 175 | 4 | 18204 | 47 |
WDR77,PPARD,MEF2C,WNT5A |
1.071e-03 | -6.84 | negative regulation of tumor necrosis factor production | biological process | GO:0032720 | 78 | 3 | 18204 | 47 |
AXL,TREM2,HAVCR2 |
1.081e-03 | -6.83 | Differentiation Pathway | WikiPathways | WP2848 | 48 | 3 | 5310 | 23 |
PDGFA,WNT5A,CSF1R |
1.085e-03 | -6.83 | regulation of cholesterol storage | biological process | GO:0010885 | 19 | 2 | 18204 | 47 |
TREM2,PPARD |
1.085e-03 | -6.83 | positive regulation of macrophage chemotaxis | biological process | GO:0010759 | 19 | 2 | 18204 | 47 |
CSF1R,C3AR1 |
1.085e-03 | -6.83 | macrophage activation involved in immune response | biological process | GO:0002281 | 19 | 2 | 18204 | 47 |
TREM2,HAVCR2 |
1.085e-03 | -6.83 | female genitalia development | biological process | GO:0030540 | 19 | 2 | 18204 | 47 |
WNT5A,AXL |
1.085e-03 | -6.83 | regulation of amyloid-beta clearance | biological process | GO:1900221 | 19 | 2 | 18204 | 47 |
TREM2,APOE |
1.085e-03 | -6.83 | notochord development | biological process | GO:0030903 | 19 | 2 | 18204 | 47 |
WNT5A,COL18A1 |
1.085e-03 | -6.83 | astrocyte activation | biological process | GO:0048143 | 19 | 2 | 18204 | 47 |
C1QA,TREM2 |
1.085e-03 | -6.83 | regulation of cell activation | biological process | GO:0050865 | 630 | 7 | 18204 | 47 |
WNT5A,PDGFA,TREM2,HAVCR2,APOE,MEF2C,AXL |
1.089e-03 | -6.82 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002460 | 176 | 4 | 18204 | 47 |
C1QC,C1QB,C1QA,MEF2C |
1.153e-03 | -6.77 | negative regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903556 | 80 | 3 | 18204 | 47 |
HAVCR2,TREM2,AXL |
1.159e-03 | -6.76 | lipid homeostasis | biological process | GO:0055088 | 179 | 4 | 18204 | 47 |
APOC2,APOE,ABCB4,TREM2 |
1.203e-03 | -6.72 | regulation of antigen processing and presentation | biological process | GO:0002577 | 20 | 2 | 18204 | 47 |
CD68,TREM2 |
1.205e-03 | -6.72 | response to cytokine | biological process | GO:0034097 | 834 | 8 | 18204 | 47 |
CSF2RA,WNT5A,TREM2,CH25H,AXL,CSF1R,SPP1,CXCL12 |
1.252e-03 | -6.68 | regulation of cell development | biological process | GO:0060284 | 839 | 8 | 18204 | 47 |
SPP1,CXCL12,AXL,MEF2C,C1QC,BHLHE41,WNT5A,TREM2 |
1.270e-03 | -6.67 | nucleotide receptor activity | molecular function | GO:0016502 | 20 | 2 | 18094 | 48 |
GPR34,P2RY13 |
1.270e-03 | -6.67 | purinergic nucleotide receptor activity | molecular function | GO:0001614 | 20 | 2 | 18094 | 48 |
GPR34,P2RY13 |
1.295e-03 | -6.65 | regulation of molecular function | biological process | GO:0065009 | 2005 | 13 | 18204 | 47 |
ADAP2,ADORA3,MEF2C,HAVCR2,APOC1,APOC2,RGS10,AXL,CSF1R,APOE,WNT5A,PDGFA,TREM2 |
1.301e-03 | -6.64 | positive regulation of transport | biological process | GO:0051050 | 844 | 8 | 18204 | 47 |
KCNMB1,SPP1,CXCL12,AXL,ABCB4,APOE,WNT5A,TREM2 |
1.328e-03 | -6.62 | positive regulation by host of viral process | biological process | GO:0044794 | 21 | 2 | 18204 | 47 |
APOE,CSF1R |
1.328e-03 | -6.62 | negative regulation of lipoprotein particle clearance | biological process | GO:0010985 | 21 | 2 | 18204 | 47 |
APOC1,APOC2 |
1.336e-03 | -6.62 | regulation of endothelial cell proliferation | biological process | GO:0001936 | 186 | 4 | 18204 | 47 |
MEF2C,WNT5A,CXCL12,APOE |
1.374e-03 | -6.59 | regulation of cell migration | biological process | GO:0030334 | 1061 | 9 | 18204 | 47 |
CXCL12,ADORA3,CSF1R,MEF2C,C3AR1,APOE,PDGFA,WNT5A,TREM2 |
1.384e-03 | -6.58 | extracellular region | cellular component | GO:0005576 | 4350 | 21 | 19108 | 49 |
C1QC,ABCB4,APOC2,CSF2RA,APOC1,COL18A1,OSBPL1A,SPP1,ITM2B,C1QB,RNASET2,ACY3,EPB41L2,AXL,CXCL12,PDGFA,APOE,FOLR2,TREM2,C1QA,WNT5A |
1.384e-03 | -6.58 | organic hydroxy compound metabolic process | biological process | GO:1901615 | 479 | 6 | 18204 | 47 |
APOC1,CH25H,DHRS9,APOE,PPARD,OSBPL1A |
1.417e-03 | -6.56 | regulation of tumor necrosis factor production | biological process | GO:0032680 | 189 | 4 | 18204 | 47 |
WNT5A,TREM2,AXL,HAVCR2 |
1.417e-03 | -6.56 | regulation of lipid biosynthetic process | biological process | GO:0046890 | 189 | 4 | 18204 | 47 |
APOC2,APOE,PDGFA,APOC1 |
1.447e-03 | -6.54 | TPRG1 (tumor protein p63 regulated 1) | protein interactions | 285386 | 22 | 2 | 19454 | 50 |
APOC1,APOC2 |
1.447e-03 | -6.54 | RSAD2 (radical S-adenosyl methionine domain containing 2) | protein interactions | 91543 | 22 | 2 | 19454 | 50 |
APOC2,APOC1 |
1.455e-03 | -6.53 | C1QB (complement C1q B chain) | protein interactions | 713 | 87 | 3 | 19454 | 50 |
COL18A1,C1QA,C1QC |
1.458e-03 | -6.53 | negative regulation of lipid storage | biological process | GO:0010888 | 22 | 2 | 18204 | 47 |
TREM2,PPARD |
1.535e-03 | -6.48 | regulation of MAPK cascade | biological process | GO:0043408 | 669 | 7 | 18204 | 47 |
APOE,HAVCR2,TREM2,PDGFA,WNT5A,CSF1R,MEF2C |
1.552e-03 | -6.47 | endoplasmic reticulum | cellular component | GO:0005783 | 2051 | 13 | 19108 | 49 |
WNT5A,DHRS9,CH25H,APOE,PDGFA,TSPAN15,RNASET2,LTC4S,SPP1,OSBPL1A,COL18A1,APOC1,P2RY13 |
1.589e-03 | -6.44 | regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903555 | 195 | 4 | 18204 | 47 |
WNT5A,TREM2,AXL,HAVCR2 |
1.626e-03 | -6.42 | Nucleotide-like (purinergic) receptors | REACTOME pathways | R-HSA-418038 | 16 | 2 | 10285 | 39 |
ADORA3,P2RY13 |
1.708e-03 | -6.37 | APOA2 (apolipoprotein A2) | protein interactions | 336 | 92 | 3 | 19454 | 50 |
TREM2,APOC2,APOC1 |
1.737e-03 | -6.36 | plasma lipoprotein particle assembly | biological process | GO:0034377 | 24 | 2 | 18204 | 47 |
APOC1,APOE |
1.756e-03 | -6.34 | lipid transport | biological process | GO:0006869 | 339 | 5 | 18204 | 47 |
APOC1,ABCB4,PPARD,APOC2,APOE |
1.757e-03 | -6.34 | carboxylic acid binding | molecular function | GO:0031406 | 195 | 4 | 18094 | 48 |
SIGLEC8,FOLR2,APOC1,PPARD |
1.885e-03 | -6.27 | decidualization | biological process | GO:0046697 | 25 | 2 | 18204 | 47 |
SPP1,PPARD |
1.885e-03 | -6.27 | steroid catabolic process | biological process | GO:0006706 | 25 | 2 | 18204 | 47 |
APOE,SPP1 |
1.913e-03 | -6.26 | human chr6q23.1-q23.2 | chromosome location | human chr6q23.1-q23.2 | 1 | 1 | 26134 | 50 |
EPB41L2 |
1.939e-03 | -6.25 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 7 | 18204 | 47 |
AXL,MEF2C,CSF1R,APOC2,TREM2,WNT5A,PDGFA |
1.939e-03 | -6.25 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 7 | 18204 | 47 |
TREM2,WNT5A,PDGFA,APOC2,MEF2C,AXL,CSF1R |
1.948e-03 | -6.24 | negative regulation of response to wounding | biological process | GO:1903035 | 96 | 3 | 18204 | 47 |
PDGFA,SPP1,APOE |
1.948e-03 | -6.24 | immunoglobulin mediated immune response | biological process | GO:0016064 | 96 | 3 | 18204 | 47 |
C1QB,C1QC,C1QA |
2.018e-03 | -6.21 | regulation of vesicle-mediated transport | biological process | GO:0060627 | 516 | 6 | 18204 | 47 |
TREM2,APOC1,WNT5A,APOE,AXL,APOC2 |
2.023e-03 | -6.20 | regulation of cell motility | biological process | GO:2000145 | 1122 | 9 | 18204 | 47 |
CXCL12,CSF1R,MEF2C,ADORA3,APOE,C3AR1,TREM2,PDGFA,WNT5A |
2.038e-03 | -6.20 | positive regulation of mesenchymal cell proliferation | biological process | GO:0002053 | 26 | 2 | 18204 | 47 |
PDGFA,WNT5A |
2.047e-03 | -6.19 | SLC7A2 (solute carrier family 7 member 2) | protein interactions | 6542 | 98 | 3 | 19454 | 50 |
C3AR1,TSPAN15,ANKRD22 |
2.073e-03 | -6.18 | G alpha (i) signalling events | REACTOME pathways | R-HSA-418594 | 242 | 5 | 10285 | 39 |
RGS10,ADORA3,C3AR1,CXCL12,P2RY13 |
2.107e-03 | -6.16 | DEFA1 (defensin alpha 1) | protein interactions | 1667 | 99 | 3 | 19454 | 50 |
COL18A1,C1QB,WNT5A |
2.127e-03 | -6.15 | regulation of fatty acid metabolic process | biological process | GO:0019217 | 99 | 3 | 18204 | 47 |
PPARD,APOC2,APOC1 |
2.136e-03 | -6.15 | negative regulation of cellular component organization | biological process | GO:0051129 | 709 | 7 | 18204 | 47 |
CH25H,SPP1,APOC2,TREM2,APOC1,WNT5A,APOE |
2.181e-03 | -6.13 | NSG2 (neuronal vesicle trafficking associated 2) | protein interactions | 51617 | 27 | 2 | 19454 | 50 |
APOC1,ITM2B |
2.184e-03 | -6.13 | organic acid binding | molecular function | GO:0043177 | 207 | 4 | 18094 | 48 |
PPARD,APOC1,FOLR2,SIGLEC8 |
2.198e-03 | -6.12 | positive regulation of leukocyte apoptotic process | biological process | GO:2000108 | 27 | 2 | 18204 | 47 |
MEF2C,WNT5A |
2.198e-03 | -6.12 | positive regulation of cholesterol efflux | biological process | GO:0010875 | 27 | 2 | 18204 | 47 |
APOE,TREM2 |
2.198e-03 | -6.12 | regulation of membrane protein ectodomain proteolysis | biological process | GO:0051043 | 27 | 2 | 18204 | 47 |
APOE,TSPAN15 |
2.198e-03 | -6.12 | protein-lipid complex assembly | biological process | GO:0065005 | 27 | 2 | 18204 | 47 |
APOC1,APOE |
2.252e-03 | -6.10 | B cell mediated immunity | biological process | GO:0019724 | 101 | 3 | 18204 | 47 |
C1QB,C1QC,C1QA |
2.286e-03 | -6.08 | negative regulation of immune system process | biological process | GO:0002683 | 529 | 6 | 18204 | 47 |
TREM2,AXL,C1QC,CXCL12,CD68,HAVCR2 |
2.330e-03 | -6.06 | regulation of kinase activity | biological process | GO:0043549 | 531 | 6 | 18204 | 47 |
WNT5A,PDGFA,TREM2,APOE,AXL,CSF1R |
2.338e-03 | -6.06 | positive regulation of leukocyte activation | biological process | GO:0002696 | 362 | 5 | 18204 | 47 |
WNT5A,TREM2,AXL,MEF2C,HAVCR2 |
2.347e-03 | -6.05 | molecular function regulator activity | molecular function | GO:0098772 | 2079 | 13 | 18094 | 48 |
RGL3,TREM2,LTC4S,APOC1,RGS10,SPP1,APOE,ADAP2,PDGFA,WNT5A,APOC2,CXCL12,KCNMB1 |
2.363e-03 | -6.05 | regulation of macrophage chemotaxis | biological process | GO:0010758 | 28 | 2 | 18204 | 47 |
C3AR1,CSF1R |
2.363e-03 | -6.05 | glial cell proliferation | biological process | GO:0014009 | 28 | 2 | 18204 | 47 |
CSF1R,TREM2 |
2.366e-03 | -6.05 | adaptive immune response | biological process | GO:0002250 | 363 | 5 | 18204 | 47 |
C1QA,MEF2C,C1QB,HAVCR2,C1QC |
2.413e-03 | -6.03 | human chr10q23.31 | chromosome location | human chr10q23.31 | 38 | 2 | 26134 | 50 |
CH25H,ANKRD22 |
2.451e-03 | -6.01 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 9 | 18204 | 47 |
TREM2,APOC1,PDGFA,WNT5A,APOE,MEF2C,AXL,CSF1R,APOC2 |
2.465e-03 | -6.01 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 9 | 18204 | 47 |
AXL,MEF2C,CSF1R,APOC2,PDGFA,WNT5A,TREM2,APOC1,APOE |
2.472e-03 | -6.00 | Golgi lumen | cellular component | GO:0005796 | 105 | 3 | 19108 | 49 |
PDGFA,HS3ST1,WNT5A |
2.503e-03 | -5.99 | modified amino acid binding | molecular function | GO:0072341 | 102 | 3 | 18094 | 48 |
FOLR2,TREM2,AXL |
2.514e-03 | -5.99 | MMP10 (matrix metallopeptidase 10) | protein interactions | 4319 | 29 | 2 | 19454 | 50 |
HS3ST1,APOE |
2.534e-03 | -5.98 | androgen metabolic process | biological process | GO:0008209 | 29 | 2 | 18204 | 47 |
SPP1,DHRS9 |
2.550e-03 | -5.97 | HDL-mediated lipid transport | REACTOME pathways | R-HSA-194223 | 20 | 2 | 10285 | 39 |
APOC2,APOE |
2.559e-03 | -5.97 | USP30 (ubiquitin specific peptidase 30) | protein interactions | 84749 | 106 | 3 | 19454 | 50 |
C1QA,C1QC,C1QB |
2.570e-03 | -5.96 | LPL (lipoprotein lipase) | protein interactions | 280843 | 1 | 1 | 19454 | 50 |
APOC2 |
2.582e-03 | -5.96 | regulation of collateral sprouting of intact axon in response to injury | biological process | GO:0048683 | 1 | 1 | 18204 | 47 |
SPP1 |
2.582e-03 | -5.96 | positive regulation of CD40 signaling pathway | biological process | GO:2000350 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | biological process | GO:0061350 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | planar cell polarity pathway involved in ventricular septum morphogenesis | biological process | GO:0061348 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | negative regulation of cell proliferation in midbrain | biological process | GO:1904934 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | planar cell polarity pathway involved in cardiac right atrium morphogenesis | biological process | GO:0061349 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | negative regulation of interleukin-3 production | biological process | GO:0032712 | 1 | 1 | 18204 | 47 |
HAVCR2 |
2.582e-03 | -5.96 | positive regulation of synapse pruning | biological process | GO:1905808 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | regulation of cellular response to very-low-density lipoprotein particle stimulus | biological process | GO:1905890 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling | biological process | GO:0060683 | 1 | 1 | 18204 | 47 |
PDGFA |
2.582e-03 | -5.96 | positive regulation of heparan sulfate proteoglycan binding | biological process | GO:1905860 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | non-canonical Wnt signaling pathway involved in heart development | biological process | GO:0061341 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | positive regulation of lipid transport across blood-brain barrier | biological process | GO:1903002 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | planar cell polarity pathway involved in heart morphogenesis | biological process | GO:0061346 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | excitatory synapse pruning | biological process | GO:1905805 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | positive regulation of transport across blood-brain barrier | biological process | GO:0150201 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | sinoatrial valve morphogenesis | biological process | GO:0003185 | 1 | 1 | 18204 | 47 |
MEF2C |
2.582e-03 | -5.96 | regulation of transport across blood-brain barrier | biological process | GO:0150200 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | positive regulation of complement activation, classical pathway | biological process | GO:0045960 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | negative regulation of collateral sprouting of intact axon in response to injury | biological process | GO:0048685 | 1 | 1 | 18204 | 47 |
SPP1 |
2.582e-03 | -5.96 | negative regulation of granulocyte colony-stimulating factor production | biological process | GO:0071656 | 1 | 1 | 18204 | 47 |
HAVCR2 |
2.582e-03 | -5.96 | positive regulation of CAMKK-AMPK signaling cascade | biological process | GO:1905291 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | negative regulation of fusion of virus membrane with host plasma membrane | biological process | GO:1903914 | 1 | 1 | 18204 | 47 |
CH25H |
2.582e-03 | -5.96 | regulation of fusion of virus membrane with host plasma membrane | biological process | GO:1903913 | 1 | 1 | 18204 | 47 |
CH25H |
2.582e-03 | -5.96 | regulation of lipid transport across blood-brain barrier | biological process | GO:1903000 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | regulation of C-C chemokine receptor CCR7 signaling pathway | biological process | GO:1903080 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | detection of lipoteichoic acid | biological process | GO:0070392 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | planar cell polarity pathway involved in outflow tract morphogenesis | biological process | GO:0061347 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | positive regulation of C-C chemokine receptor CCR7 signaling pathway | biological process | GO:1903082 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | chemoattraction of serotonergic neuron axon | biological process | GO:0036517 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | regulation of heparan sulfate proteoglycan binding | biological process | GO:1905858 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | Wnt signaling pathway involved in heart development | biological process | GO:0003306 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | regulation of toll-like receptor 6 signaling pathway | biological process | GO:0034151 | 1 | 1 | 18204 | 47 |
TREM2 |
2.582e-03 | -5.96 | planar cell polarity pathway involved in pericardium morphogenesis | biological process | GO:0061354 | 1 | 1 | 18204 | 47 |
WNT5A |
2.582e-03 | -5.96 | intermediate-density lipoprotein particle clearance | biological process | GO:0071831 | 1 | 1 | 18204 | 47 |
APOE |
2.582e-03 | -5.96 | negative regulation of phosphatidylcholine catabolic process | biological process | GO:0010900 | 1 | 1 | 18204 | 47 |
APOC1 |
2.599e-03 | -5.95 | regulation of locomotion | biological process | GO:0040012 | 1164 | 9 | 18204 | 47 |
TREM2,PDGFA,WNT5A,APOE,C3AR1,CSF1R,MEF2C,ADORA3,CXCL12 |
2.653e-03 | -5.93 | linoleic acid binding | molecular function | GO:0070539 | 1 | 1 | 18094 | 48 |
PPARD |
2.653e-03 | -5.93 | ribonuclease T2 activity | molecular function | GO:0033897 | 1 | 1 | 18094 | 48 |
RNASET2 |
2.653e-03 | -5.93 | cholesterol 25-hydroxylase activity | molecular function | GO:0001567 | 1 | 1 | 18094 | 48 |
CH25H |
2.653e-03 | -5.93 | receptor tyrosine kinase-like orphan receptor binding | molecular function | GO:0005115 | 1 | 1 | 18094 | 48 |
WNT5A |
2.653e-03 | -5.93 | metal chelating activity | molecular function | GO:0046911 | 1 | 1 | 18094 | 48 |
APOE |
2.653e-03 | -5.93 | complement component C3a receptor activity | molecular function | GO:0004876 | 1 | 1 | 18094 | 48 |
C3AR1 |
2.692e-03 | -5.92 | lipid localization | biological process | GO:0010876 | 374 | 5 | 18204 | 47 |
APOC2,PPARD,APOE,ABCB4,APOC1 |
2.700e-03 | -5.91 | RNase_T2_His_AS_2 | interpro domains | IPR033130 | 1 | 1 | 18521 | 50 |
RNASET2 |
2.700e-03 | -5.91 | ApoC-1_sf | interpro domains | IPR043081 | 1 | 1 | 18521 | 50 |
APOC1 |
2.700e-03 | -5.91 | RNase_T2-like | interpro domains | IPR001568 | 1 | 1 | 18521 | 50 |
RNASET2 |
2.700e-03 | -5.91 | 1Cnucl_rcpt_B | interpro domains | IPR003075 | 1 | 1 | 18521 | 50 |
PPARD |
2.700e-03 | -5.91 | Collagen_XVIII_Fz | interpro domains | IPR035523 | 1 | 1 | 18521 | 50 |
COL18A1 |
2.700e-03 | -5.91 | DUF959_COL18_N | interpro domains | IPR010363 | 1 | 1 | 18521 | 50 |
COL18A1 |
2.700e-03 | -5.91 | ANR22 | interpro domains | IPR042802 | 1 | 1 | 18521 | 50 |
ANKRD22 |
2.700e-03 | -5.91 | ALPK1 | interpro domains | IPR043529 | 1 | 1 | 18521 | 50 |
ALPK1 |
2.700e-03 | -5.91 | GPR34_7tmA | interpro domains | IPR048057 | 1 | 1 | 18521 | 50 |
GPR34 |
2.700e-03 | -5.91 | ApoC-I | interpro domains | IPR006781 | 1 | 1 | 18521 | 50 |
APOC1 |
2.700e-03 | -5.91 | Osteopontin_CS | interpro domains | IPR019841 | 1 | 1 | 18521 | 50 |
SPP1 |
2.700e-03 | -5.91 | Osteopontin | interpro domains | IPR002038 | 1 | 1 | 18521 | 50 |
SPP1 |
2.700e-03 | -5.91 | Ribonuclease_T2_eukaryotic | interpro domains | IPR033697 | 1 | 1 | 18521 | 50 |
RNASET2 |
2.700e-03 | -5.91 | Adeno_A3_rcpt | interpro domains | IPR000466 | 1 | 1 | 18521 | 50 |
ADORA3 |
2.700e-03 | -5.91 | RGL3_RA | interpro domains | IPR030750 | 1 | 1 | 18521 | 50 |
RGL3 |
2.700e-03 | -5.91 | Apo-CII | interpro domains | IPR008019 | 1 | 1 | 18521 | 50 |
APOC2 |
2.700e-03 | -5.91 | CSF-1_receptor | interpro domains | IPR030658 | 1 | 1 | 18521 | 50 |
CSF1R |
2.700e-03 | -5.91 | RNase_T2-like_sf | interpro domains | IPR036430 | 1 | 1 | 18521 | 50 |
RNASET2 |
2.700e-03 | -5.91 | RNase_H1_euk | interpro domains | IPR017067 | 1 | 1 | 18521 | 50 |
RNASEH1 |
2.700e-03 | -5.91 | RNase_T2_His_AS_1 | interpro domains | IPR018188 | 1 | 1 | 18521 | 50 |
RNASET2 |
2.700e-03 | -5.91 | RGS10_RGS | interpro domains | IPR037879 | 1 | 1 | 18521 | 50 |
RGS10 |
2.700e-03 | -5.91 | ApoC-II_dom_sf | interpro domains | IPR023121 | 1 | 1 | 18521 | 50 |
APOC2 |
2.700e-03 | -5.91 | Anaphtx_C3AR1 | interpro domains | IPR001644 | 1 | 1 | 18521 | 50 |
C3AR1 |
2.700e-03 | -5.91 | KLHL5_BTB/POZ | interpro domains | IPR030606 | 1 | 1 | 18521 | 50 |
KLHL5 |
2.710e-03 | -5.91 | mammary gland duct morphogenesis | biological process | GO:0060603 | 30 | 2 | 18204 | 47 |
WNT5A,CSF1R |
2.710e-03 | -5.91 | negative regulation of sterol transport | biological process | GO:0032372 | 30 | 2 | 18204 | 47 |
APOC2,APOC1 |
2.710e-03 | -5.91 | negative regulation of cholesterol transport | biological process | GO:0032375 | 30 | 2 | 18204 | 47 |
APOC1,APOC2 |
2.713e-03 | -5.91 | Lipoprotein metabolism | REACTOME pathways | R-HSA-174824 | 74 | 3 | 10285 | 39 |
APOC1,APOC2,APOE |
2.786e-03 | -5.88 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 5 | 18204 | 47 |
BHLHE41,SPP1,CXCL12,WNT5A,TREM2 |
2.796e-03 | -5.88 | postsynapse organization | biological process | GO:0099173 | 109 | 3 | 18204 | 47 |
TREM2,WNT5A,APOE |
2.801e-03 | -5.88 | regulation of secretion by cell | biological process | GO:1903530 | 551 | 6 | 18204 | 47 |
TREM2,MEF2C,ADORA3,CXCL12,APOE,SPP1 |
2.810e-03 | -5.87 | Osteopontin | pfam domains | PF00865 | 1 | 1 | 17795 | 50 |
SPP1 |
2.810e-03 | -5.87 | Ribonuclease_T2 | pfam domains | PF00445 | 1 | 1 | 17795 | 50 |
RNASET2 |
2.810e-03 | -5.87 | Apo-CII | pfam domains | PF05355 | 1 | 1 | 17795 | 50 |
APOC2 |
2.810e-03 | -5.87 | RNase_H | pfam domains | PF00075 | 1 | 1 | 17795 | 50 |
RNASEH1 |
2.810e-03 | -5.87 | ApoC-I | pfam domains | PF04691 | 1 | 1 | 17795 | 50 |
APOC1 |
2.810e-03 | -5.87 | DUF959 | pfam domains | PF06121 | 1 | 1 | 17795 | 50 |
COL18A1 |
2.882e-03 | -5.85 | OSTEO | smart domains | SM00017 | 1 | 1 | 9717 | 28 |
SPP1 |
2.892e-03 | -5.85 | microglial cell activation | biological process | GO:0001774 | 31 | 2 | 18204 | 47 |
C1QA,TREM2 |
2.898e-03 | -5.84 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 26 | 18204 | 47 |
P2RY13,ALPK1,CD68,HAVCR2,ADORA3,MEF2C,GPR34,TREM2,CSF1R,ABCB4,FOLR2,RGS10,RGL3,C3AR1,CH25H,SIGLEC8,KCNMB1,PDGFA,WNT5A,CSF2RA,PPARD,APOE,AXL,LTC4S,CXCL12,SPP1 |
2.916e-03 | -5.84 | positive regulation of cell activation | biological process | GO:0050867 | 381 | 5 | 18204 | 47 |
MEF2C,AXL,TREM2,WNT5A,HAVCR2 |
3.036e-03 | -5.80 | RNASE_T2_2 | prosite domains | PS00531 | 1 | 1 | 12186 | 37 |
RNASET2 |
3.036e-03 | -5.80 | OSTEOPONTIN | prosite domains | PS00884 | 1 | 1 | 12186 | 37 |
SPP1 |
3.036e-03 | -5.80 | RNASE_T2_1 | prosite domains | PS00530 | 1 | 1 | 12186 | 37 |
RNASET2 |
3.041e-03 | -5.80 | Apolipoprotein C-I | gene3d domains | 4.10.260.30 | 1 | 1 | 14470 | 44 |
APOC1 |
3.041e-03 | -5.80 | Ribonuclease T2-like | gene3d domains | 3.90.730.10 | 1 | 1 | 14470 | 44 |
RNASET2 |
3.041e-03 | -5.80 | Apolipoprotein C-II | gene3d domains | 1.10.1440.10 | 1 | 1 | 14470 | 44 |
APOC2 |
3.051e-03 | -5.79 | lipoprotein particle binding | molecular function | GO:0071813 | 31 | 2 | 18094 | 48 |
APOE,TREM2 |
3.051e-03 | -5.79 | protein-lipid complex binding | molecular function | GO:0071814 | 31 | 2 | 18094 | 48 |
TREM2,APOE |
3.074e-03 | -5.78 | regulation of response to stress | biological process | GO:0080134 | 1431 | 10 | 18204 | 47 |
PPARD,HAVCR2,APOE,ALPK1,PDGFA,WNT5A,TREM2,CXCL12,SPP1,MEF2C |
3.110e-03 | -5.77 | Pertussis | KEGG pathways | ko05133 | 76 | 3 | 7161 | 28 |
C1QB,C1QA,C1QC |
3.110e-03 | -5.77 | Pertussis | KEGG pathways | hsa05133 | 76 | 3 | 7161 | 28 |
C1QC,C1QA,C1QB |
3.174e-03 | -5.75 | negative regulation of small molecule metabolic process | biological process | GO:0062014 | 114 | 3 | 18204 | 47 |
CH25H,APOC1,APOE |
3.188e-03 | -5.75 | immune effector process | biological process | GO:0002252 | 389 | 5 | 18204 | 47 |
C1QC,HAVCR2,C1QB,TREM2,C1QA |
3.241e-03 | -5.73 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 11 | 18204 | 47 |
APOE,TREM2,WNT5A,CXCL12,SPP1,APOC2,CSF1R,AXL,HAVCR2,C3AR1,MEF2C |
3.255e-03 | -5.73 | signaling | biological process | GO:0023052 | 4968 | 22 | 18204 | 47 |
TREM2,RGS10,CSF1R,ALPK1,HAVCR2,P2RY13,GPR34,ADORA3,MEF2C,PPARD,APOE,PDGFA,WNT5A,CSF2RA,SPP1,CXCL12,AXL,C3AR1,RGL3,KCNMB1,C1QA,SIGLEC8 |
3.274e-03 | -5.72 | regulation of mesenchymal cell proliferation | biological process | GO:0010464 | 33 | 2 | 18204 | 47 |
WNT5A,PDGFA |
3.278e-03 | -5.72 | blood microparticle | cellular component | GO:0072562 | 116 | 3 | 19108 | 49 |
C1QB,APOE,C1QC |
3.473e-03 | -5.66 | negative regulation of steroid metabolic process | biological process | GO:0045939 | 34 | 2 | 18204 | 47 |
CH25H,APOE |
3.473e-03 | -5.66 | leukocyte activation involved in inflammatory response | biological process | GO:0002269 | 34 | 2 | 18204 | 47 |
C1QA,TREM2 |
3.498e-03 | -5.66 | regulation of type II interferon production | biological process | GO:0032649 | 118 | 3 | 18204 | 47 |
HAVCR2,AXL,WNT5A |
3.622e-03 | -5.62 | Pathways in cancer | KEGG pathways | hsa05200 | 395 | 6 | 7161 | 28 |
WNT5A,CSF1R,PPARD,PDGFA,CXCL12,CSF2RA |
3.644e-03 | -5.61 | cell communication | biological process | GO:0007154 | 5010 | 22 | 18204 | 47 |
CSF1R,AXL,SPP1,CXCL12,RGS10,WNT5A,PDGFA,CSF2RA,TREM2,PPARD,APOE,ADORA3,C1QA,MEF2C,SIGLEC8,GPR34,KCNMB1,RGL3,P2RY13,C3AR1,ALPK1,HAVCR2 |
3.677e-03 | -5.61 | positive regulation of T cell migration | biological process | GO:2000406 | 35 | 2 | 18204 | 47 |
CXCL12,WNT5A |
3.677e-03 | -5.61 | maternal placenta development | biological process | GO:0001893 | 35 | 2 | 18204 | 47 |
PPARD,SPP1 |
3.681e-03 | -5.60 | regulation of synapse organization | biological process | GO:0050807 | 246 | 4 | 18204 | 47 |
MEF2C,TREM2,WNT5A,APOE |
3.815e-03 | -5.57 | regulation of developmental process | biological process | GO:0050793 | 2540 | 14 | 18204 | 47 |
PPARD,C1QC,WDR77,APOE,PDGFA,WNT5A,TREM2,SPP1,CXCL12,CSF1R,AXL,C3AR1,BHLHE41,MEF2C |
3.857e-03 | -5.56 | CCL3L1 (C-C motif chemokine ligand 3 like 1) | protein interactions | 6349 | 36 | 2 | 19454 | 50 |
COL18A1,WNT5A |
3.857e-03 | -5.56 | SC5D (sterol-C5-desaturase) | protein interactions | 6309 | 36 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
3.858e-03 | -5.56 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 12 | 18204 | 47 |
CSF1R,AXL,CXCL12,TREM2,WNT5A,PDGFA,CSF2RA,MEF2C,ADORA3,GPR34,P2RY13,C3AR1 |
3.887e-03 | -5.55 | dendritic cell differentiation | biological process | GO:0097028 | 36 | 2 | 18204 | 47 |
AXL,TREM2 |
3.955e-03 | -5.53 | extracellular space | cellular component | GO:0005615 | 3443 | 17 | 19108 | 49 |
COL18A1,APOC1,C1QB,SPP1,OSBPL1A,ITM2B,C1QC,APOC2,ABCB4,WNT5A,AXL,EPB41L2,CXCL12,ACY3,RNASET2,PDGFA,APOE |
3.988e-03 | -5.52 | positive regulation of cell migration | biological process | GO:0030335 | 592 | 6 | 18204 | 47 |
C3AR1,TREM2,WNT5A,PDGFA,CXCL12,CSF1R |
3.997e-03 | -5.52 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 10 | 18204 | 47 |
AXL,MEF2C,CXCL12,SPP1,WNT5A,TREM2,PPARD,C3AR1,BHLHE41,C1QC |
4.010e-03 | -5.52 | regulation of synapse structure or activity | biological process | GO:0050803 | 252 | 4 | 18204 | 47 |
APOE,MEF2C,TREM2,WNT5A |
4.020e-03 | -5.52 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 3 | 18204 | 47 |
APOE,APOC2,PPARD |
4.071e-03 | -5.50 | TMEM68 (transmembrane protein 68) | protein interactions | 137695 | 37 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
4.071e-03 | -5.50 | DGAT1 (diacylglycerol O-acyltransferase 1) | protein interactions | 8694 | 37 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
4.102e-03 | -5.50 | regulation of macrophage cytokine production | biological process | GO:0010935 | 37 | 2 | 18204 | 47 |
AXL,WNT5A |
4.102e-03 | -5.50 | astrocyte development | biological process | GO:0014002 | 37 | 2 | 18204 | 47 |
TREM2,C1QA |
4.102e-03 | -5.50 | cellular response to low-density lipoprotein particle stimulus | biological process | GO:0071404 | 37 | 2 | 18204 | 47 |
CD68,TREM2 |
4.102e-03 | -5.50 | positive regulation of potassium ion transmembrane transport | biological process | GO:1901381 | 37 | 2 | 18204 | 47 |
KCNMB1,TREM2 |
4.102e-03 | -5.50 | olfactory bulb development | biological process | GO:0021772 | 37 | 2 | 18204 | 47 |
WNT5A,CSF1R |
4.102e-03 | -5.50 | response to lipoprotein particle | biological process | GO:0055094 | 37 | 2 | 18204 | 47 |
CD68,TREM2 |
4.113e-03 | -5.49 | negative regulation of locomotion | biological process | GO:0040013 | 413 | 5 | 18204 | 47 |
CXCL12,APOE,MEF2C,ADORA3,WNT5A |
4.290e-03 | -5.45 | MMP3 (matrix metallopeptidase 3) | protein interactions | 4314 | 38 | 2 | 19454 | 50 |
APOE,SPP1 |
4.299e-03 | -5.45 | negative regulation of neuron projection development | biological process | GO:0010977 | 127 | 3 | 18204 | 47 |
SPP1,APOE,WNT5A |
4.323e-03 | -5.44 | negative regulation of receptor-mediated endocytosis | biological process | GO:0048261 | 38 | 2 | 18204 | 47 |
APOC2,APOC1 |
4.362e-03 | -5.43 | regulation of growth | biological process | GO:0040008 | 603 | 6 | 18204 | 47 |
APOE,PPARD,WNT5A,SPP1,CXCL12,MEF2C |
4.394e-03 | -5.43 | regulation of interleukin-1 production | biological process | GO:0032652 | 128 | 3 | 18204 | 47 |
WNT5A,TREM2,HAVCR2 |
4.432e-03 | -5.42 | regulation of secretion | biological process | GO:0051046 | 605 | 6 | 18204 | 47 |
TREM2,APOE,MEF2C,ADORA3,CXCL12,SPP1 |
4.549e-03 | -5.39 | blood vessel remodeling | biological process | GO:0001974 | 39 | 2 | 18204 | 47 |
MEF2C,AXL |
4.549e-03 | -5.39 | olfactory lobe development | biological process | GO:0021988 | 39 | 2 | 18204 | 47 |
WNT5A,CSF1R |
4.549e-03 | -5.39 | regulation of natural killer cell activation | biological process | GO:0032814 | 39 | 2 | 18204 | 47 |
HAVCR2,AXL |
4.549e-03 | -5.39 | glial cell activation | biological process | GO:0061900 | 39 | 2 | 18204 | 47 |
C1QA,TREM2 |
4.549e-03 | -5.39 | animal organ formation | biological process | GO:0048645 | 39 | 2 | 18204 | 47 |
WNT5A,MEF2C |
4.592e-03 | -5.38 | C3ANPHYLTXNR | prints domains | PR01060 | 1 | 1 | 5227 | 24 |
C3AR1 |
4.592e-03 | -5.38 | PROXISOMPABR | prints domains | PR01290 | 1 | 1 | 5227 | 24 |
PPARD |
4.592e-03 | -5.38 | OSTEOPONTIN | prints domains | PR00216 | 1 | 1 | 5227 | 24 |
SPP1 |
4.592e-03 | -5.38 | ADENOSINEA3R | prints domains | PR00555 | 1 | 1 | 5227 | 24 |
ADORA3 |
4.687e-03 | -5.36 | response to calcium ion | biological process | GO:0051592 | 131 | 3 | 18204 | 47 |
KCNMB1,MEF2C,WNT5A |
4.744e-03 | -5.35 | SYT16 (synaptotagmin 16) | protein interactions | 83851 | 40 | 2 | 19454 | 50 |
APOC1,APOC2 |
4.781e-03 | -5.34 | cellular response to lipoprotein particle stimulus | biological process | GO:0071402 | 40 | 2 | 18204 | 47 |
CD68,TREM2 |
4.781e-03 | -5.34 | positive regulation of fatty acid metabolic process | biological process | GO:0045923 | 40 | 2 | 18204 | 47 |
PPARD,APOC2 |
4.788e-03 | -5.34 | negative regulation of neurogenesis | biological process | GO:0050768 | 132 | 3 | 18204 | 47 |
SPP1,TREM2,WNT5A |
4.805e-03 | -5.34 | peptide binding | molecular function | GO:0042277 | 258 | 4 | 18094 | 48 |
C1QA,APOE,ITM2B,TREM2 |
4.848e-03 | -5.33 | cell-cell signaling | biological process | GO:0007267 | 822 | 7 | 18204 | 47 |
MEF2C,C1QA,KCNMB1,RGS10,WNT5A,PDGFA,APOE |
4.876e-03 | -5.32 | positive regulation of defense response | biological process | GO:0031349 | 430 | 5 | 18204 | 47 |
WNT5A,TREM2,MEF2C,ALPK1,HAVCR2 |
4.951e-03 | -5.31 | positive regulation of cell motility | biological process | GO:2000147 | 619 | 6 | 18204 | 47 |
CSF1R,CXCL12,TREM2,PDGFA,WNT5A,C3AR1 |
4.977e-03 | -5.30 | Chylomicron-mediated lipid transport | REACTOME pathways | R-HSA-174800 | 28 | 2 | 10285 | 39 |
APOE,APOC2 |
4.980e-03 | -5.30 | TCAF2 (TRPM8 channel associated factor 2) | protein interactions | 285966 | 41 | 2 | 19454 | 50 |
C3AR1,HAVCR2 |
4.986e-03 | -5.30 | regulation of leukocyte proliferation | biological process | GO:0070663 | 268 | 4 | 18204 | 47 |
CSF2RA,CSF1R,MEF2C,HAVCR2 |
5.018e-03 | -5.29 | apoptotic cell clearance | biological process | GO:0043277 | 41 | 2 | 18204 | 47 |
TREM2,AXL |
5.051e-03 | -5.29 | negative regulation of cell development | biological process | GO:0010721 | 269 | 4 | 18204 | 47 |
WNT5A,TREM2,SPP1,C1QC |
5.060e-03 | -5.29 | positive regulation of cell communication | biological process | GO:0010647 | 1792 | 11 | 18204 | 47 |
HAVCR2,ALPK1,MEF2C,TREM2,PDGFA,WNT5A,APOE,PPARD,AXL,CSF1R,SPP1 |
5.067e-03 | -5.29 | transmembrane signaling receptor activity | molecular function | GO:0004888 | 1251 | 9 | 18094 | 48 |
AXL,ADORA3,P2RY13,CSF2RA,CSF1R,SIGLEC8,GPR34,TREM2,C3AR1 |
5.103e-03 | -5.28 | positive regulation of signaling | biological process | GO:0023056 | 1794 | 11 | 18204 | 47 |
PPARD,ALPK1,APOE,HAVCR2,PDGFA,WNT5A,TREM2,SPP1,CSF1R,AXL,MEF2C |
5.122e-03 | -5.27 | CSF1-CSF1R complex | cellular component | GO:1990682 | 2 | 1 | 19108 | 49 |
CSF1R |
5.122e-03 | -5.27 | platelet-derived growth factor complex | cellular component | GO:1990265 | 2 | 1 | 19108 | 49 |
PDGFA |
5.122e-03 | -5.27 | chylomicron remnant | cellular component | GO:0034360 | 2 | 1 | 19108 | 49 |
APOE |
5.122e-03 | -5.27 | discoidal high-density lipoprotein particle | cellular component | GO:0034365 | 2 | 1 | 19108 | 49 |
APOE |
5.134e-03 | -5.27 | ZNF736 (zinc finger protein 736) | protein interactions | 728927 | 2 | 1 | 19454 | 50 |
EPB41L2 |
5.134e-03 | -5.27 | DBX1 (developing brain homeobox 1) | protein interactions | 120237 | 2 | 1 | 19454 | 50 |
APOC1 |
5.134e-03 | -5.27 | FAM47E (family with sequence similarity 47 member E) | protein interactions | 100129583 | 2 | 1 | 19454 | 50 |
WDR77 |
5.134e-03 | -5.27 | VAPA (VAMP associated protein A) | protein interactions | 103222768 | 2 | 1 | 19454 | 50 |
OSBPL1A |
5.157e-03 | -5.27 | muscle cell fate determination | biological process | GO:0007521 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | positive regulation of antigen processing and presentation of peptide antigen | biological process | GO:0002585 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | cervix development | biological process | GO:0060067 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | cellular response to folic acid | biological process | GO:0071231 | 2 | 1 | 18204 | 47 |
FOLR2 |
5.157e-03 | -5.27 | response to ultrasound | biological process | GO:1990478 | 2 | 1 | 18204 | 47 |
CXCL12 |
5.157e-03 | -5.27 | negative regulation of macrophage colony-stimulating factor production | biological process | GO:1901257 | 2 | 1 | 18204 | 47 |
HAVCR2 |
5.157e-03 | -5.27 | positive regulation of timing of anagen | biological process | GO:0051885 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | platelet-derived growth factor receptor-alpha signaling pathway | biological process | GO:0035790 | 2 | 1 | 18204 | 47 |
PDGFA |
5.157e-03 | -5.27 | chemorepulsion of dopaminergic neuron axon | biological process | GO:0036518 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | positive regulation of alkaline phosphatase activity | biological process | GO:0010694 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | response to fenofibrate | biological process | GO:1901557 | 2 | 1 | 18204 | 47 |
ABCB4 |
5.157e-03 | -5.27 | sinoatrial valve development | biological process | GO:0003172 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | planar cell polarity pathway involved in gastrula mediolateral intercalation | biological process | GO:0060775 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | lateral sprouting involved in mammary gland duct morphogenesis | biological process | GO:0060599 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | mediolateral intercalation | biological process | GO:0060031 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | detection of peptidoglycan | biological process | GO:0032499 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | nephron tubule epithelial cell differentiation | biological process | GO:0072160 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | embryonic lung development | biological process | GO:1990401 | 2 | 1 | 18204 | 47 |
PDGFA |
5.157e-03 | -5.27 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | biological process | GO:0002582 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | hypophysis morphogenesis | biological process | GO:0048850 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | lipid transport involved in lipid storage | biological process | GO:0010877 | 2 | 1 | 18204 | 47 |
APOE |
5.157e-03 | -5.27 | positive regulation of engulfment of apoptotic cell | biological process | GO:1901076 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | response to trichostatin A | biological process | GO:0035983 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | negative regulation of phosphatidylcholine metabolic process | biological process | GO:0150174 | 2 | 1 | 18204 | 47 |
APOC1 |
5.157e-03 | -5.27 | cellular response to trichostatin A | biological process | GO:0035984 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | positive regulation of estradiol secretion | biological process | GO:2000866 | 2 | 1 | 18204 | 47 |
SPP1 |
5.157e-03 | -5.27 | NMDA selective glutamate receptor signaling pathway | biological process | GO:0098989 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | negative regulation of phosphatidylinositol biosynthetic process | biological process | GO:0010512 | 2 | 1 | 18204 | 47 |
PDGFA |
5.157e-03 | -5.27 | positive regulation of inward rectifier potassium channel activity | biological process | GO:1901980 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | optic cup formation involved in camera-type eye development | biological process | GO:0003408 | 2 | 1 | 18204 | 47 |
WNT5A |
5.157e-03 | -5.27 | negative regulation of immunological synapse formation | biological process | GO:2000521 | 2 | 1 | 18204 | 47 |
HAVCR2 |
5.157e-03 | -5.27 | positive regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010902 | 2 | 1 | 18204 | 47 |
APOC2 |
5.157e-03 | -5.27 | positive regulation of antigen processing and presentation of peptide antigen via MHC class II | biological process | GO:0002588 | 2 | 1 | 18204 | 47 |
TREM2 |
5.157e-03 | -5.27 | regulation of alkaline phosphatase activity | biological process | GO:0010692 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | AMPA selective glutamate receptor signaling pathway | biological process | GO:0098990 | 2 | 1 | 18204 | 47 |
MEF2C |
5.157e-03 | -5.27 | regulation of interleukin-3 production | biological process | GO:0032672 | 2 | 1 | 18204 | 47 |
HAVCR2 |
5.202e-03 | -5.26 | regulation of MAP kinase activity | biological process | GO:0043405 | 136 | 3 | 18204 | 47 |
APOE,PDGFA,WNT5A |
5.220e-03 | -5.26 | COL5A1 (collagen type V alpha 1 chain) | protein interactions | 1289 | 42 | 2 | 19454 | 50 |
PDGFA,C1QC |
5.244e-03 | -5.25 | P2YPURNOCPTR | prints domains | PR01157 | 24 | 2 | 5227 | 24 |
GPR34,P2RY13 |
5.260e-03 | -5.25 | regulation of cholesterol metabolic process | biological process | GO:0090181 | 42 | 2 | 18204 | 47 |
CH25H,APOE |
5.260e-03 | -5.25 | regulation of catecholamine secretion | biological process | GO:0050433 | 42 | 2 | 18204 | 47 |
ADORA3,CXCL12 |
5.260e-03 | -5.25 | triglyceride homeostasis | biological process | GO:0070328 | 42 | 2 | 18204 | 47 |
APOE,APOC2 |
5.260e-03 | -5.25 | positive regulation of lymphocyte migration | biological process | GO:2000403 | 42 | 2 | 18204 | 47 |
CXCL12,WNT5A |
5.299e-03 | -5.24 | macrophage colony-stimulating factor receptor activity | molecular function | GO:0005011 | 2 | 1 | 18094 | 48 |
CSF1R |
5.299e-03 | -5.24 | chemoattractant activity involved in axon guidance | molecular function | GO:1902379 | 2 | 1 | 18094 | 48 |
WNT5A |
5.299e-03 | -5.24 | folic acid receptor activity | molecular function | GO:0061714 | 2 | 1 | 18094 | 48 |
FOLR2 |
5.392e-03 | -5.22 | RNase_H1_N | interpro domains | IPR011320 | 2 | 1 | 18521 | 50 |
RNASEH1 |
5.392e-03 | -5.22 | RNase_H1_N_sf | interpro domains | IPR037056 | 2 | 1 | 18521 | 50 |
RNASEH1 |
5.392e-03 | -5.22 | PDGF_N | interpro domains | IPR006782 | 2 | 1 | 18521 | 50 |
PDGFA |
5.392e-03 | -5.22 | IL3Ra_N | interpro domains | IPR040907 | 2 | 1 | 18521 | 50 |
CSF2RA |
5.392e-03 | -5.22 | RNaseH_domain | interpro domains | IPR002156 | 2 | 1 | 18521 | 50 |
RNASEH1 |
5.392e-03 | -5.22 | PH2_ADAP | interpro domains | IPR037851 | 2 | 1 | 18521 | 50 |
ADAP2 |
5.392e-03 | -5.22 | P2Y13_rcpt | interpro domains | IPR008109 | 2 | 1 | 18521 | 50 |
P2RY13 |
5.392e-03 | -5.22 | PH1_ADAP | interpro domains | IPR037849 | 2 | 1 | 18521 | 50 |
ADAP2 |
5.392e-03 | -5.22 | XV/XVIII_trimerization_dom | interpro domains | IPR045463 | 2 | 1 | 18521 | 50 |
COL18A1 |
5.392e-03 | -5.22 | Collagenase_NC10/endostatin | interpro domains | IPR010515 | 2 | 1 | 18521 | 50 |
COL18A1 |
5.392e-03 | -5.22 | Ribosomal_bL9/RNase_H1_N | interpro domains | IPR009027 | 2 | 1 | 18521 | 50 |
RNASEH1 |
5.392e-03 | -5.22 | Aste_AspA | interpro domains | IPR007036 | 2 | 1 | 18521 | 50 |
ACY3 |
5.392e-03 | -5.22 | Aspartoacylase | interpro domains | IPR016708 | 2 | 1 | 18521 | 50 |
ACY3 |
5.418e-03 | -5.22 | regulation of axonogenesis | biological process | GO:0050770 | 138 | 3 | 18204 | 47 |
WNT5A,CXCL12,SPP1 |
5.418e-03 | -5.22 | negative regulation of nervous system development | biological process | GO:0051961 | 138 | 3 | 18204 | 47 |
WNT5A,TREM2,SPP1 |
5.466e-03 | -5.21 | SLC22A18 (solute carrier family 22 member 18) | protein interactions | 5002 | 43 | 2 | 19454 | 50 |
HAVCR2,C3AR1 |
5.466e-03 | -5.21 | FGF4 (fibroblast growth factor 4) | protein interactions | 2249 | 43 | 2 | 19454 | 50 |
COL18A1,HS3ST1 |
5.508e-03 | -5.20 | acylglycerol homeostasis | biological process | GO:0055090 | 43 | 2 | 18204 | 47 |
APOC2,APOE |
5.508e-03 | -5.20 | regulation of bone resorption | biological process | GO:0045124 | 43 | 2 | 18204 | 47 |
CSF1R,SPP1 |
5.514e-03 | -5.20 | positive regulation of locomotion | biological process | GO:0040017 | 633 | 6 | 18204 | 47 |
CSF1R,CXCL12,TREM2,PDGFA,WNT5A,C3AR1 |
5.527e-03 | -5.20 | cellular response to hypoxia | biological process | GO:0071456 | 139 | 3 | 18204 | 47 |
TREM2,KCNMB1,PPARD |
5.557e-03 | -5.19 | response to organic cyclic compound | biological process | GO:0014070 | 843 | 7 | 18204 | 47 |
PPARD,P2RY13,KCNMB1,SPP1,FOLR2,MEF2C,ABCB4 |
5.557e-03 | -5.19 | regulation of defense response | biological process | GO:0031347 | 843 | 7 | 18204 | 47 |
MEF2C,WNT5A,TREM2,PPARD,APOE,ALPK1,HAVCR2 |
5.585e-03 | -5.19 | TNFSF8 (TNF superfamily member 8) | protein interactions | 944 | 140 | 3 | 19454 | 50 |
ITM2B,HS3ST1,DCBLD1 |
5.612e-03 | -5.18 | Collagen_trimer | pfam domains | PF20010 | 2 | 1 | 17795 | 50 |
COL18A1 |
5.612e-03 | -5.18 | AstE_AspA | pfam domains | PF04952 | 2 | 1 | 17795 | 50 |
ACY3 |
5.612e-03 | -5.18 | Cauli_VI | pfam domains | PF01693 | 2 | 1 | 17795 | 50 |
RNASEH1 |
5.612e-03 | -5.18 | IL3Ra_N | pfam domains | PF18611 | 2 | 1 | 17795 | 50 |
CSF2RA |
5.612e-03 | -5.18 | Endostatin | pfam domains | PF06482 | 2 | 1 | 17795 | 50 |
COL18A1 |
5.612e-03 | -5.18 | PDGF_N | pfam domains | PF04692 | 2 | 1 | 17795 | 50 |
PDGFA |
5.717e-03 | -5.16 | LPCAT4 (lysophosphatidylcholine acyltransferase 4) | protein interactions | 254531 | 44 | 2 | 19454 | 50 |
TSPAN15,HAVCR2 |
5.717e-03 | -5.16 | COL4A1 (collagen type IV alpha 1 chain) | protein interactions | 1282 | 44 | 2 | 19454 | 50 |
COL18A1,PDGFA |
5.760e-03 | -5.16 | mammary gland morphogenesis | biological process | GO:0060443 | 44 | 2 | 18204 | 47 |
CSF1R,WNT5A |
5.760e-03 | -5.16 | negative regulation of type II interferon production | biological process | GO:0032689 | 44 | 2 | 18204 | 47 |
HAVCR2,AXL |
5.842e-03 | -5.14 | regulation of innate immune response | biological process | GO:0045088 | 449 | 5 | 18204 | 47 |
WNT5A,TREM2,ALPK1,APOE,HAVCR2 |
5.864e-03 | -5.14 | neuron migration | biological process | GO:0001764 | 142 | 3 | 18204 | 47 |
MEF2C,AXL,CXCL12 |
5.915e-03 | -5.13 | human chr1p13.2 | chromosome location | human chr1p13.2 | 60 | 2 | 26134 | 50 |
ADORA3,WDR77 |
5.976e-03 | -5.12 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 11 | 18204 | 47 |
PPARD,APOE,PDGFA,WNT5A,TREM2,CXCL12,AXL,CSF1R,HAVCR2,ALPK1,MEF2C |
5.979e-03 | -5.12 | regulation of cellular ketone metabolic process | biological process | GO:0010565 | 143 | 3 | 18204 | 47 |
APOC2,PPARD,APOC1 |
6.018e-03 | -5.11 | positive regulation of potassium ion transport | biological process | GO:0043268 | 45 | 2 | 18204 | 47 |
KCNMB1,TREM2 |
6.018e-03 | -5.11 | negative regulation of blood coagulation | biological process | GO:0030195 | 45 | 2 | 18204 | 47 |
APOE,PDGFA |
6.018e-03 | -5.11 | embryo implantation | biological process | GO:0007566 | 45 | 2 | 18204 | 47 |
PPARD,SPP1 |
6.033e-03 | -5.11 | regulation of transferase activity | biological process | GO:0051338 | 645 | 6 | 18204 | 47 |
APOE,WNT5A,PDGFA,TREM2,CSF1R,AXL |
6.064e-03 | -5.11 | RNASE_H_1 | prosite domains | PS50879 | 2 | 1 | 12186 | 37 |
RNASEH1 |
6.073e-03 | -5.10 | - | gene3d domains | 2.20.25.160 | 2 | 1 | 14470 | 44 |
ACY3 |
6.073e-03 | -5.10 | - | gene3d domains | 3.40.1620.70 | 2 | 1 | 14470 | 44 |
COL18A1 |
6.073e-03 | -5.10 | Ribonuclease H1, N-terminal domain | gene3d domains | 3.40.970.10 | 2 | 1 | 14470 | 44 |
RNASEH1 |
6.121e-03 | -5.10 | P4HA1 (prolyl 4-hydroxylase subunit alpha 1) | protein interactions | 5033 | 285 | 4 | 19454 | 50 |
COL18A1,APOE,AXL,WDR77 |
6.174e-03 | -5.09 | regulation of cellular catabolic process | biological process | GO:0031329 | 455 | 5 | 18204 | 47 |
TSPAN15,TREM2,APOC1,APOC2,APOE |
6.230e-03 | -5.08 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 47 |
TREM2,WNT5A,BHLHE41,SPP1,CXCL12 |
6.230e-03 | -5.08 | pattern specification process | biological process | GO:0007389 | 456 | 5 | 18204 | 47 |
WNT5A,MEF2C,C1QA,WDR77,BHLHE41 |
6.234e-03 | -5.08 | TM9SF1 (transmembrane 9 superfamily member 1) | protein interactions | 10548 | 46 | 2 | 19454 | 50 |
RNASEH1,TSPAN15 |
6.282e-03 | -5.07 | regulation of triglyceride metabolic process | biological process | GO:0090207 | 46 | 2 | 18204 | 47 |
APOC2,APOE |
6.282e-03 | -5.07 | negative regulation of hemostasis | biological process | GO:1900047 | 46 | 2 | 18204 | 47 |
APOE,PDGFA |
6.282e-03 | -5.07 | negative chemotaxis | biological process | GO:0050919 | 46 | 2 | 18204 | 47 |
WNT5A,PDGFA |
6.332e-03 | -5.06 | cellular response to decreased oxygen levels | biological process | GO:0036294 | 146 | 3 | 18204 | 47 |
TREM2,PPARD,KCNMB1 |
6.500e-03 | -5.04 | PTGER4 (prostaglandin E receptor 4) | protein interactions | 5734 | 47 | 2 | 19454 | 50 |
SPP1,ACY3 |
6.502e-03 | -5.04 | Visual phototransduction | REACTOME pathways | R-HSA-2187338 | 101 | 3 | 10285 | 39 |
DHRS9,APOE,APOC2 |
6.550e-03 | -5.03 | genitalia development | biological process | GO:0048806 | 47 | 2 | 18204 | 47 |
AXL,WNT5A |
6.550e-03 | -5.03 | negative regulation of lipid transport | biological process | GO:0032369 | 47 | 2 | 18204 | 47 |
APOC1,APOC2 |
6.587e-03 | -5.02 | positive regulation of signal transduction | biological process | GO:0009967 | 1593 | 10 | 18204 | 47 |
CSF1R,MEF2C,AXL,APOE,ALPK1,HAVCR2,PPARD,TREM2,WNT5A,PDGFA |
6.730e-03 | -5.00 | response to hypoxia | biological process | GO:0001666 | 292 | 4 | 18204 | 47 |
KCNMB1,CXCL12,PPARD,TREM2 |
6.772e-03 | -4.99 | NACC2 (NACC family member 2) | protein interactions | 138151 | 48 | 2 | 19454 | 50 |
OSBPL1A,PPARD |
6.772e-03 | -4.99 | NOCT (nocturnin) | protein interactions | 25819 | 48 | 2 | 19454 | 50 |
C1QB,HAVCR2 |
6.810e-03 | -4.99 | negative regulation of defense response | biological process | GO:0031348 | 293 | 4 | 18204 | 47 |
TREM2,PPARD,APOE,HAVCR2 |
6.824e-03 | -4.99 | negative regulation of axonogenesis | biological process | GO:0050771 | 48 | 2 | 18204 | 47 |
SPP1,WNT5A |
7.098e-03 | -4.95 | Chagas disease (American trypanosomiasis) | KEGG pathways | ko05142 | 102 | 3 | 7161 | 28 |
C1QA,C1QC,C1QB |
7.098e-03 | -4.95 | Chagas disease (American trypanosomiasis) | KEGG pathways | hsa05142 | 102 | 3 | 7161 | 28 |
C1QB,C1QA,C1QC |
7.103e-03 | -4.95 | negative regulation of coagulation | biological process | GO:0050819 | 49 | 2 | 18204 | 47 |
PDGFA,APOE |
7.103e-03 | -4.95 | regulation of T cell migration | biological process | GO:2000404 | 49 | 2 | 18204 | 47 |
WNT5A,CXCL12 |
7.138e-03 | -4.94 | carboxylic acid transport | biological process | GO:0046942 | 297 | 4 | 18204 | 47 |
ABCB4,FOLR2,APOE,PPARD |
7.203e-03 | -4.93 | leukocyte proliferation | biological process | GO:0070661 | 153 | 3 | 18204 | 47 |
CSF1R,TREM2,MEF2C |
7.222e-03 | -4.93 | organic acid transport | biological process | GO:0015849 | 298 | 4 | 18204 | 47 |
PPARD,FOLR2,APOE,ABCB4 |
7.272e-03 | -4.92 | Ig_3 | pfam domains | PF13927 | 141 | 3 | 17795 | 50 |
CSF1R,AXL,SIGLEC8 |
7.281e-03 | -4.92 | Synthesis of bile acids and bile salts | REACTOME pathways | R-HSA-192105 | 34 | 2 | 10285 | 39 |
OSBPL1A,CH25H |
7.304e-03 | -4.92 | Immune System | REACTOME pathways | R-HSA-168256 | 2101 | 15 | 10285 | 39 |
SIGLEC8,CSF1R,C1QA,CD68,C3AR1,PDGFA,MEF2C,C1QB,CSF2RA,RNASET2,OSBPL1A,KLHL5,TREM2,C1QC,HAVCR2 |
7.330e-03 | -4.92 | ZDHHC13 (zinc finger DHHC-type palmitoyltransferase 13) | protein interactions | 54503 | 50 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
7.333e-03 | -4.92 | monocarboxylic acid transport | biological process | GO:0015718 | 154 | 3 | 18204 | 47 |
PPARD,APOE,ABCB4 |
7.386e-03 | -4.91 | modulation by host of viral process | biological process | GO:0044788 | 50 | 2 | 18204 | 47 |
APOE,CSF1R |
7.386e-03 | -4.91 | vasodilation | biological process | GO:0042311 | 50 | 2 | 18204 | 47 |
APOE,KCNMB1 |
7.386e-03 | -4.91 | neuroinflammatory response | biological process | GO:0150076 | 50 | 2 | 18204 | 47 |
C1QA,TREM2 |
7.464e-03 | -4.90 | myeloid leukocyte activation | biological process | GO:0002274 | 155 | 3 | 18204 | 47 |
TREM2,C1QA,HAVCR2 |
7.472e-03 | -4.90 | primary lysosome | cellular component | GO:0005766 | 156 | 3 | 19108 | 49 |
RNASET2,C3AR1,CD68 |
7.472e-03 | -4.90 | azurophil granule | cellular component | GO:0042582 | 156 | 3 | 19108 | 49 |
C3AR1,RNASET2,CD68 |
7.477e-03 | -4.90 | lipid catabolic process | biological process | GO:0016042 | 301 | 4 | 18204 | 47 |
APOE,SPP1,PPARD,APOC2 |
7.485e-03 | -4.89 | fatty acid binding | molecular function | GO:0005504 | 49 | 2 | 18094 | 48 |
APOC1,PPARD |
7.563e-03 | -4.88 | immune response-activating signaling pathway | biological process | GO:0002757 | 302 | 4 | 18204 | 47 |
C3AR1,HAVCR2,ALPK1,MEF2C |
7.587e-03 | -4.88 | extracellular exosome | cellular component | GO:0070062 | 2175 | 12 | 19108 | 49 |
ITM2B,SPP1,OSBPL1A,COL18A1,ABCB4,WNT5A,APOE,EPB41L2,AXL,ACY3,CXCL12,RNASET2 |
7.602e-03 | -4.88 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 7 | 18204 | 47 |
C3AR1,WNT5A,PDGFA,SPP1,CXCL12,MEF2C,CSF1R |
7.675e-03 | -4.87 | regulation of granulocyte chemotaxis | biological process | GO:0071622 | 51 | 2 | 18204 | 47 |
C3AR1,CSF1R |
7.675e-03 | -4.87 | regulation of bone remodeling | biological process | GO:0046850 | 51 | 2 | 18204 | 47 |
SPP1,CSF1R |
7.691e-03 | -4.87 | ZNF534 (zinc finger protein 534) | protein interactions | 147658 | 3 | 1 | 19454 | 50 |
C1QC |
7.691e-03 | -4.87 | Pebp1 (phosphatidylethanolamine binding protein 1) | protein interactions | 23980 | 3 | 1 | 19454 | 50 |
PPARD |
7.691e-03 | -4.87 | NRN1L (neuritin 1 like) | protein interactions | 123904 | 3 | 1 | 19454 | 50 |
TREM2 |
7.721e-03 | -4.86 | regulation of cellular component organization | biological process | GO:0051128 | 2455 | 13 | 18204 | 47 |
WNT5A,PDGFA,TREM2,APOE,AXL,CSF1R,ABCB4,APOC2,CXCL12,SPP1,APOC1,CH25H,MEF2C |
7.726e-03 | -4.86 | positive regulation of phospholipid catabolic process | biological process | GO:0060697 | 3 | 1 | 18204 | 47 |
APOC2 |
7.726e-03 | -4.86 | positive regulation of low-density lipoprotein particle receptor catabolic process | biological process | GO:0032805 | 3 | 1 | 18204 | 47 |
APOE |
7.726e-03 | -4.86 | regulation of tolerance induction dependent upon immune response | biological process | GO:0002652 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | regulation of cell proliferation in midbrain | biological process | GO:1904933 | 3 | 1 | 18204 | 47 |
WNT5A |
7.726e-03 | -4.86 | cardiac right atrium morphogenesis | biological process | GO:0003213 | 3 | 1 | 18204 | 47 |
WNT5A |
7.726e-03 | -4.86 | mesodermal to mesenchymal transition involved in gastrulation | biological process | GO:0060809 | 3 | 1 | 18204 | 47 |
WNT5A |
7.726e-03 | -4.86 | regulation of phosphatidylcholine catabolic process | biological process | GO:0010899 | 3 | 1 | 18204 | 47 |
APOC1 |
7.726e-03 | -4.86 | positive regulation of chemokine-mediated signaling pathway | biological process | GO:0070101 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | biological process | GO:1900238 | 3 | 1 | 18204 | 47 |
PDGFA |
7.726e-03 | -4.86 | complement component C5a signaling pathway | biological process | GO:0038178 | 3 | 1 | 18204 | 47 |
C3AR1 |
7.726e-03 | -4.86 | positive regulation of low-density lipoprotein particle clearance | biological process | GO:1905581 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | positive regulation of metanephric mesenchymal cell migration | biological process | GO:2000591 | 3 | 1 | 18204 | 47 |
PDGFA |
7.726e-03 | -4.86 | vertebrate eye-specific patterning | biological process | GO:0150064 | 3 | 1 | 18204 | 47 |
C1QA |
7.726e-03 | -4.86 | diencephalon morphogenesis | biological process | GO:0048852 | 3 | 1 | 18204 | 47 |
WNT5A |
7.726e-03 | -4.86 | chemoattraction of axon | biological process | GO:0061642 | 3 | 1 | 18204 | 47 |
WNT5A |
7.726e-03 | -4.86 | regulation of estradiol secretion | biological process | GO:2000864 | 3 | 1 | 18204 | 47 |
SPP1 |
7.726e-03 | -4.86 | negative regulation of natural killer cell mediated immune response to tumor cell | biological process | GO:0002856 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | regulation of engulfment of apoptotic cell | biological process | GO:1901074 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | positive regulation of macrophage apoptotic process | biological process | GO:2000111 | 3 | 1 | 18204 | 47 |
MEF2C |
7.726e-03 | -4.86 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:2001189 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | regulation of synaptic activity | biological process | GO:0060025 | 3 | 1 | 18204 | 47 |
MEF2C |
7.726e-03 | -4.86 | outer hair cell apoptotic process | biological process | GO:1905584 | 3 | 1 | 18204 | 47 |
USP53 |
7.726e-03 | -4.86 | negative regulation of autophagic cell death | biological process | GO:1904093 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway | biological process | GO:0035793 | 3 | 1 | 18204 | 47 |
PDGFA |
7.726e-03 | -4.86 | negative regulation of myeloid dendritic cell activation | biological process | GO:0030886 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | biological process | GO:0002859 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | negative regulation of macrophage colony-stimulating factor signaling pathway | biological process | GO:1902227 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | ceramide translocation | biological process | GO:0099040 | 3 | 1 | 18204 | 47 |
ABCB4 |
7.726e-03 | -4.86 | chylomicron remodeling | biological process | GO:0034371 | 3 | 1 | 18204 | 47 |
APOC2 |
7.726e-03 | -4.86 | regulation of CAMKK-AMPK signaling cascade | biological process | GO:1905289 | 3 | 1 | 18204 | 47 |
TREM2 |
7.726e-03 | -4.86 | natural killer cell tolerance induction | biological process | GO:0002519 | 3 | 1 | 18204 | 47 |
HAVCR2 |
7.726e-03 | -4.86 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development | biological process | GO:0060528 | 3 | 1 | 18204 | 47 |
WDR77 |
7.736e-03 | -4.86 | 7tm_1 | pfam domains | PF00001 | 279 | 4 | 17795 | 50 |
GPR34,C3AR1,P2RY13,ADORA3 |
7.792e-03 | -4.85 | APOE (apolipoprotein E) | protein interactions | 348 | 158 | 3 | 19454 | 50 |
APOE,TREM2,APOC2 |
7.805e-03 | -4.85 | response to bacterium | biological process | GO:0009617 | 681 | 6 | 18204 | 47 |
WNT5A,TREM2,CD68,HAVCR2,AXL,MEF2C |
7.832e-03 | -4.85 | signal transduction | biological process | GO:0007165 | 4637 | 20 | 18204 | 47 |
PDGFA,WNT5A,CSF2RA,TREM2,PPARD,APOE,CSF1R,AXL,CXCL12,SPP1,RGS10,P2RY13,RGL3,C3AR1,ALPK1,HAVCR2,ADORA3,MEF2C,SIGLEC8,GPR34 |
7.914e-03 | -4.84 | response to decreased oxygen levels | biological process | GO:0036293 | 306 | 4 | 18204 | 47 |
TREM2,KCNMB1,CXCL12,PPARD |
7.928e-03 | -4.84 | TYRO3 (TYRO3 protein tyrosine kinase) | protein interactions | 7301 | 159 | 3 | 19454 | 50 |
AXL,APOE,ITM2B |
7.928e-03 | -4.84 | EPB41L1 (erythrocyte membrane protein band 4.1 like 1) | protein interactions | 2036 | 159 | 3 | 19454 | 50 |
AXL,WDR77,EPB41L2 |
7.938e-03 | -4.84 | complement component C5a receptor activity | molecular function | GO:0004878 | 3 | 1 | 18094 | 48 |
C3AR1 |
7.938e-03 | -4.84 | C-4 methylsterol oxidase activity | molecular function | GO:0000254 | 3 | 1 | 18094 | 48 |
CH25H |
7.938e-03 | -4.84 | ceramide floppase activity | molecular function | GO:0099038 | 3 | 1 | 18094 | 48 |
ABCB4 |
7.969e-03 | -4.83 | negative regulation of cellular process | biological process | GO:0048523 | 5320 | 22 | 18204 | 47 |
MEF2C,ADORA3,HAVCR2,RGS10,APOC2,CSF1R,TREM2,CH25H,BHLHE41,APOC1,COL18A1,SPP1,CXCL12,AXL,TSPAN15,C1QC,APOE,WDR77,PPARD,ITM2B,WNT5A,PDGFA |
8.023e-03 | -4.83 | tube morphogenesis | biological process | GO:0035239 | 685 | 6 | 18204 | 47 |
CSF1R,MEF2C,APOE,PDGFA,WNT5A,COL18A1 |
8.034e-03 | -4.82 | response to nutrient levels | biological process | GO:0031667 | 485 | 5 | 18204 | 47 |
SPP1,APOE,CD68,FOLR2,PPARD |
8.078e-03 | -4.82 | LAMP_CS | interpro domains | IPR018134 | 3 | 1 | 18521 | 50 |
CD68 |
8.078e-03 | -4.82 | RGS10/12/14-like | interpro domains | IPR046995 | 3 | 1 | 18521 | 50 |
RGS10 |
8.078e-03 | -4.82 | FLAP/GST2/LTC4S_CS | interpro domains | IPR018295 | 3 | 1 | 18521 | 50 |
LTC4S |
8.078e-03 | -4.82 | 1Cnucl_rcpt | interpro domains | IPR003074 | 3 | 1 | 18521 | 50 |
PPARD |
8.078e-03 | -4.82 | ITM2 | interpro domains | IPR040145 | 3 | 1 | 18521 | 50 |
ITM2B |
8.078e-03 | -4.82 | 5_LipOase_AP | interpro domains | IPR001446 | 3 | 1 | 18521 | 50 |
LTC4S |
8.078e-03 | -4.82 | Anphylx_rcpt_C3a/C5a1-2 | interpro domains | IPR002234 | 3 | 1 | 18521 | 50 |
C3AR1 |
8.206e-03 | -4.80 | NFU1 (NFU1 iron-sulfur cluster scaffold) | protein interactions | 27247 | 53 | 2 | 19454 | 50 |
APOC1,APOC2 |
8.268e-03 | -4.80 | regulation of platelet activation | biological process | GO:0010543 | 53 | 2 | 18204 | 47 |
APOE,PDGFA |
8.281e-03 | -4.79 | cellular response to oxygen levels | biological process | GO:0071453 | 161 | 3 | 18204 | 47 |
PPARD,KCNMB1,TREM2 |
8.295e-03 | -4.79 | late endosome | cellular component | GO:0005770 | 312 | 4 | 19108 | 49 |
TSPAN15,APOE,OSBPL1A,CD68 |
8.572e-03 | -4.76 | regulation of morphogenesis of a branching structure | biological process | GO:0060688 | 54 | 2 | 18204 | 47 |
WNT5A,PDGFA |
8.572e-03 | -4.76 | regulation of fatty acid biosynthetic process | biological process | GO:0042304 | 54 | 2 | 18204 | 47 |
APOC1,APOC2 |
8.572e-03 | -4.76 | regulation of cholesterol efflux | biological process | GO:0010874 | 54 | 2 | 18204 | 47 |
APOE,TREM2 |
8.572e-03 | -4.76 | regulation of lipid storage | biological process | GO:0010883 | 54 | 2 | 18204 | 47 |
TREM2,PPARD |
8.572e-03 | -4.76 | positive regulation of ossification | biological process | GO:0045778 | 54 | 2 | 18204 | 47 |
MEF2C,WNT5A |
8.772e-03 | -4.74 | V-set | pfam domains | PF07686 | 151 | 3 | 17795 | 50 |
TREM2,SIGLEC8,HAVCR2 |
8.814e-03 | -4.73 | ARV1 (ARV1 homolog, fatty acid homeostasis modulator) | protein interactions | 64801 | 55 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
8.854e-03 | -4.73 | monocarboxylic acid biosynthetic process | biological process | GO:0072330 | 165 | 3 | 18204 | 47 |
LTC4S,OSBPL1A,DHRS9 |
8.881e-03 | -4.72 | positive regulation of fibroblast proliferation | biological process | GO:0048146 | 55 | 2 | 18204 | 47 |
PDGFA,WNT5A |
8.881e-03 | -4.72 | response to axon injury | biological process | GO:0048678 | 55 | 2 | 18204 | 47 |
TREM2,AXL |
8.890e-03 | -4.72 | cell migration | biological process | GO:0016477 | 921 | 7 | 18204 | 47 |
MEF2C,AXL,CH25H,FOLR2,CXCL12,WNT5A,PPARD |
8.950e-03 | -4.72 | regulation of anatomical structure size | biological process | GO:0090066 | 498 | 5 | 18204 | 47 |
WNT5A,APOE,CXCL12,SPP1,KCNMB1 |
9.001e-03 | -4.71 | lymphocyte mediated immunity | biological process | GO:0002449 | 166 | 3 | 18204 | 47 |
C1QA,C1QC,C1QB |
9.001e-03 | -4.71 | organic hydroxy compound transport | biological process | GO:0015850 | 166 | 3 | 18204 | 47 |
APOC2,APOE,APOC1 |
9.082e-03 | -4.70 | LAMP_2 | prosite domains | PS00311 | 3 | 1 | 12186 | 37 |
CD68 |
9.082e-03 | -4.70 | FLAP_GST2_LTC4S | prosite domains | PS01297 | 3 | 1 | 12186 | 37 |
LTC4S |
9.097e-03 | -4.70 | positive regulation of cytokine production | biological process | GO:0001819 | 500 | 5 | 18204 | 47 |
HAVCR2,C3AR1,CSF1R,TREM2,WNT5A |
9.125e-03 | -4.70 | LRFN3 (leucine rich repeat and fibronectin type III domain containing 3) | protein interactions | 79414 | 56 | 2 | 19454 | 50 |
ITM2B,C1QB |
9.163e-03 | -4.69 | ANPHYLATOXNR | prints domains | PR01104 | 2 | 1 | 5227 | 24 |
C3AR1 |
9.163e-03 | -4.69 | BKCHANNELB | prints domains | PR01450 | 2 | 1 | 5227 | 24 |
KCNMB1 |
9.163e-03 | -4.69 | P2Y13PRNCPTR | prints domains | PR01735 | 2 | 1 | 5227 | 24 |
P2RY13 |
9.195e-03 | -4.69 | negative regulation of leukocyte apoptotic process | biological process | GO:2000107 | 56 | 2 | 18204 | 47 |
AXL,CXCL12 |
9.288e-03 | -4.68 | Lipid digestion, mobilization, and transport | REACTOME pathways | R-HSA-73923 | 115 | 3 | 10285 | 39 |
APOC1,APOC2,APOE |
9.299e-03 | -4.68 | positive regulation of developmental growth | biological process | GO:0048639 | 168 | 3 | 18204 | 47 |
MEF2C,PPARD,CXCL12 |
9.328e-03 | -4.67 | wound healing | biological process | GO:0042060 | 321 | 4 | 18204 | 47 |
PPARD,WNT5A,PDGFA,AXL |
9.378e-03 | -4.67 | negative regulation of biological process | biological process | GO:0048519 | 5737 | 23 | 18204 | 47 |
CH25H,COL18A1,APOC1,BHLHE41,TSPAN15,AXL,SPP1,CXCL12,PDGFA,WNT5A,ITM2B,PPARD,APOE,WDR77,C1QC,ADORA3,MEF2C,CD68,HAVCR2,CSF1R,APOC2,RGS10,TREM2 |
9.472e-03 | -4.66 | response to inorganic substance | biological process | GO:0010035 | 505 | 5 | 18204 | 47 |
KCNMB1,MEF2C,AXL,COL18A1,WNT5A |
9.514e-03 | -4.66 | osteoclast differentiation | biological process | GO:0030316 | 57 | 2 | 18204 | 47 |
TREM2,CSF1R |
9.541e-03 | -4.65 | Ig-like_dom_sf | interpro domains | IPR036179 | 483 | 5 | 18521 | 50 |
AXL,CSF1R,SIGLEC8,HAVCR2,TREM2 |
9.757e-03 | -4.63 | female pregnancy | biological process | GO:0007565 | 171 | 3 | 18204 | 47 |
PPARD,SPP1,HAVCR2 |
9.763e-03 | -4.63 | MFSD8 (major facilitator superfamily domain containing 8) | protein interactions | 256471 | 58 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
9.763e-03 | -4.63 | FZD2 (frizzled class receptor 2) | protein interactions | 2535 | 58 | 2 | 19454 | 50 |
WNT5A,TSPAN15 |
9.791e-03 | -4.63 | Nuclear Receptors in Lipid Metabolism and Toxicity | WikiPathways | WP299 | 35 | 2 | 5310 | 23 |
ABCB4,PPARD |
9.838e-03 | -4.62 | mammary gland epithelium development | biological process | GO:0061180 | 58 | 2 | 18204 | 47 |
WNT5A,CSF1R |
9.864e-03 | -4.62 | negative regulation of cell differentiation | biological process | GO:0045596 | 716 | 6 | 18204 | 47 |
WNT5A,TREM2,PPARD,C1QC,BHLHE41,SPP1 |
9.878e-03 | -4.62 | G protein-coupled receptor signaling pathway | biological process | GO:0007186 | 1178 | 8 | 18204 | 47 |
TREM2,P2RY13,C3AR1,APOE,ADORA3,GPR34,RGS10,CXCL12 |
9.999e-03 | -4.61 | cell adhesion | biological process | GO:0007155 | 942 | 7 | 18204 | 47 |
COL18A1,PPARD,SIGLEC8,AXL,CXCL12,SPP1,FOLR2 |
1.003e-02 | -4.60 | Metabolism of lipids and lipoproteins | REACTOME pathways | R-HSA-556833 | 813 | 8 | 10285 | 39 |
ABCB4,APOE,PPARD,OSBPL1A,LTC4S,CH25H,APOC2,APOC1 |
1.004e-02 | -4.60 | azurophil granule membrane | cellular component | GO:0035577 | 59 | 2 | 19108 | 49 |
CD68,C3AR1 |
1.009e-02 | -4.60 | CNNM4 (cyclin and CBS domain divalent metal cation transport mediator 4) | protein interactions | 26504 | 59 | 2 | 19454 | 50 |
WNT5A,TSPAN15 |
1.009e-02 | -4.60 | HRG (histidine rich glycoprotein) | protein interactions | 3273 | 59 | 2 | 19454 | 50 |
C1QB,C1QA |
1.017e-02 | -4.59 | regulation of dendritic spine development | biological process | GO:0060998 | 59 | 2 | 18204 | 47 |
MEF2C,APOE |
1.022e-02 | -4.58 | granulocyte macrophage colony-stimulating factor receptor complex | cellular component | GO:0030526 | 4 | 1 | 19108 | 49 |
CSF2RA |
1.024e-02 | -4.58 | VGLL2 (vestigial like family member 2) | protein interactions | 245806 | 4 | 1 | 19454 | 50 |
MEF2C |
1.024e-02 | -4.58 | CREG2 (cellular repressor of E1A stimulated genes 2) | protein interactions | 200407 | 4 | 1 | 19454 | 50 |
USP53 |
1.024e-02 | -4.58 | Nrip1 (nuclear receptor interacting protein 1) | protein interactions | 268903 | 4 | 1 | 19454 | 50 |
PPARD |
1.024e-02 | -4.58 | CLCA1 (chloride channel accessory 1) | protein interactions | 1179 | 4 | 1 | 19454 | 50 |
KCNMB1 |
1.024e-02 | -4.58 | WNT5B (Wnt family member 5B) | protein interactions | 81029 | 4 | 1 | 19454 | 50 |
WNT5A |
1.029e-02 | -4.58 | regulation of metanephric mesenchymal cell migration | biological process | GO:2000589 | 4 | 1 | 18204 | 47 |
PDGFA |
1.029e-02 | -4.58 | respiratory burst after phagocytosis | biological process | GO:0045728 | 4 | 1 | 18204 | 47 |
TREM2 |
1.029e-02 | -4.58 | positive regulation of phospholipid efflux | biological process | GO:1902995 | 4 | 1 | 18204 | 47 |
APOE |
1.029e-02 | -4.58 | regulation of branching involved in mammary gland duct morphogenesis | biological process | GO:0060762 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | positive regulation of fat cell proliferation | biological process | GO:0070346 | 4 | 1 | 18204 | 47 |
PPARD |
1.029e-02 | -4.58 | regulation of antigen processing and presentation of peptide antigen via MHC class II | biological process | GO:0002586 | 4 | 1 | 18204 | 47 |
TREM2 |
1.029e-02 | -4.58 | 9-cis-retinoic acid biosynthetic process | biological process | GO:0042904 | 4 | 1 | 18204 | 47 |
DHRS9 |
1.029e-02 | -4.58 | macrophage colony-stimulating factor signaling pathway | biological process | GO:0038145 | 4 | 1 | 18204 | 47 |
CSF1R |
1.029e-02 | -4.58 | epithelial cell proliferation involved in mammary gland duct elongation | biological process | GO:0060750 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | epithelial cell proliferation involved in renal tubule morphogenesis | biological process | GO:2001013 | 4 | 1 | 18204 | 47 |
MEF2C |
1.029e-02 | -4.58 | NMDA glutamate receptor clustering | biological process | GO:0097114 | 4 | 1 | 18204 | 47 |
APOE |
1.029e-02 | -4.58 | regulation of autophagic cell death | biological process | GO:1904092 | 4 | 1 | 18204 | 47 |
TREM2 |
1.029e-02 | -4.58 | positive regulation of thymocyte apoptotic process | biological process | GO:0070245 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | regulation of macrophage colony-stimulating factor signaling pathway | biological process | GO:1902226 | 4 | 1 | 18204 | 47 |
TREM2 |
1.029e-02 | -4.58 | urinary bladder development | biological process | GO:0060157 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | negative regulation of prostatic bud formation | biological process | GO:0060686 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | response to caloric restriction | biological process | GO:0061771 | 4 | 1 | 18204 | 47 |
APOE |
1.029e-02 | -4.58 | regulation of immunological synapse formation | biological process | GO:2000520 | 4 | 1 | 18204 | 47 |
HAVCR2 |
1.029e-02 | -4.58 | negative regulation of dendritic cell antigen processing and presentation | biological process | GO:0002605 | 4 | 1 | 18204 | 47 |
CD68 |
1.029e-02 | -4.58 | negative regulation of leukocyte tethering or rolling | biological process | GO:1903237 | 4 | 1 | 18204 | 47 |
CXCL12 |
1.029e-02 | -4.58 | DNA replication, removal of RNA primer | biological process | GO:0043137 | 4 | 1 | 18204 | 47 |
RNASEH1 |
1.029e-02 | -4.58 | 9-cis-retinoic acid metabolic process | biological process | GO:0042905 | 4 | 1 | 18204 | 47 |
DHRS9 |
1.029e-02 | -4.58 | Wnt signaling pathway, calcium modulating pathway | biological process | GO:0007223 | 4 | 1 | 18204 | 47 |
WNT5A |
1.029e-02 | -4.58 | granulocyte-macrophage colony-stimulating factor signaling pathway | biological process | GO:0038157 | 4 | 1 | 18204 | 47 |
CSF2RA |
1.029e-02 | -4.58 | regulation of phospholipid efflux | biological process | GO:1902994 | 4 | 1 | 18204 | 47 |
APOE |
1.029e-02 | -4.58 | GPC1 (glypican 1) | protein interactions | 2817 | 175 | 3 | 19454 | 50 |
PDGFA,WDR77,COL18A1 |
1.036e-02 | -4.57 | response to oxygen levels | biological process | GO:0070482 | 331 | 4 | 18204 | 47 |
TREM2,KCNMB1,CXCL12,PPARD |
1.039e-02 | -4.57 | regulation of interleukin-6 production | biological process | GO:0032675 | 175 | 3 | 18204 | 47 |
WNT5A,TREM2,HAVCR2 |
1.042e-02 | -4.56 | COX1 (cytochrome c oxidase subunit I) | protein interactions | 4512 | 60 | 2 | 19454 | 50 |
KCNMB1,TSPAN15 |
1.044e-02 | -4.56 | endomembrane system | cellular component | GO:0012505 | 4764 | 20 | 19108 | 49 |
WNT5A,DHRS9,CH25H,TSPAN15,RNASET2,C3AR1,LTC4S,APOE,PDGFA,WDR77,CD68,COL18A1,HAVCR2,APOC1,HS3ST1,ITM2B,OSBPL1A,SPP1,P2RY13,APOC2 |
1.045e-02 | -4.56 | cell activation | biological process | GO:0001775 | 725 | 6 | 18204 | 47 |
C1QA,MEF2C,AXL,PDGFA,TREM2,HAVCR2 |
1.052e-02 | -4.55 | cell population proliferation | biological process | GO:0008283 | 726 | 6 | 18204 | 47 |
PPARD,WDR77,WNT5A,MEF2C,TREM2,CSF1R |
1.054e-02 | -4.55 | S (surface glycoprotein) | protein interactions | 43740568 | 728 | 6 | 19454 | 50 |
USP53,C1QB,AXL,C1QA,APOE,C1QC |
1.057e-02 | -4.55 | very-low-density lipoprotein particle receptor binding | molecular function | GO:0070326 | 4 | 1 | 18094 | 48 |
APOE |
1.057e-02 | -4.55 | sphingolipid floppase activity | molecular function | GO:0046623 | 4 | 1 | 18094 | 48 |
ABCB4 |
1.057e-02 | -4.55 | very-low-density lipoprotein particle binding | molecular function | GO:0034189 | 4 | 1 | 18094 | 48 |
TREM2 |
1.057e-02 | -4.55 | lipoprotein lipase activator activity | molecular function | GO:0060230 | 4 | 1 | 18094 | 48 |
APOC2 |
1.069e-02 | -4.54 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 39 | 16828 | 50 |
HAVCR2,FILIP1L,SPP1,C3AR1,KLHL5,DCBLD1,EPB41L2,ABCB4,C1QA,ADORA3,ANKRD22,KCNMB1,MEF2C,PPARD,COL18A1,WNT5A,APOC1,GPR34,RNASEH1,C1QB,SIGLEC8,APOE,RGL3,LTC4S,WDR77,DHRS9,TREM2,HS3ST1,OSBPL1A,AXL,ALPK1,ITM2B,ADAP2,CSF1R,C1QC,CSF2RA,FOLR2,CH25H,P2RY13 |
1.069e-02 | -4.54 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 39 | 16828 | 50 |
C1QA,ABCB4,EPB41L2,KLHL5,DCBLD1,C3AR1,FILIP1L,HAVCR2,SPP1,GPR34,APOC1,RNASEH1,C1QB,WNT5A,COL18A1,MEF2C,PPARD,KCNMB1,ADORA3,ANKRD22,OSBPL1A,TREM2,HS3ST1,DHRS9,WDR77,LTC4S,APOE,RGL3,SIGLEC8,CH25H,P2RY13,FOLR2,C1QC,CSF2RA,CSF1R,ADAP2,ITM2B,AXL,ALPK1 |
1.073e-02 | -4.53 | regulation of response to stimulus | biological process | GO:0048583 | 4104 | 18 | 18204 | 47 |
SPP1,CXCL12,RGS10,CSF1R,AXL,TSPAN15,C1QC,APOE,PPARD,TREM2,PDGFA,WNT5A,C1QB,MEF2C,C1QA,ALPK1,HAVCR2,C3AR1 |
1.076e-02 | -4.53 | Cortactin-binding_p2_N | interpro domains | IPR019131 | 4 | 1 | 18521 | 50 |
FILIP1L |
1.076e-02 | -4.53 | MADS_MEF2-like | interpro domains | IPR033896 | 4 | 1 | 18521 | 50 |
MEF2C |
1.076e-02 | -4.53 | ApoA_E | interpro domains | IPR000074 | 4 | 1 | 18521 | 50 |
APOE |
1.076e-02 | -4.53 | K_chnl_Ca-activ_BK_bsu | interpro domains | IPR003930 | 4 | 1 | 18521 | 50 |
KCNMB1 |
1.076e-02 | -4.53 | SAB_dom | interpro domains | IPR007477 | 4 | 1 | 18521 | 50 |
EPB41L2 |
1.076e-02 | -4.53 | Band_4 | interpro domains | IPR008379 | 4 | 1 | 18521 | 50 |
EPB41L2 |
1.076e-02 | -4.53 | Adenosn_rcpt | interpro domains | IPR001634 | 4 | 1 | 18521 | 50 |
ADORA3 |
1.076e-02 | -4.53 | HJURP_C | interpro domains | IPR022102 | 4 | 1 | 18521 | 50 |
MEF2C |
1.076e-02 | -4.53 | PRKG1 (protein kinase cGMP-dependent 1) | protein interactions | 5592 | 61 | 2 | 19454 | 50 |
WDR77,SPP1 |
1.084e-02 | -4.52 | cellular component maintenance | biological process | GO:0043954 | 61 | 2 | 18204 | 47 |
CSF1R,TREM2 |
1.085e-02 | -4.52 | extracellular vesicle | cellular component | GO:1903561 | 2278 | 12 | 19108 | 49 |
COL18A1,OSBPL1A,SPP1,ITM2B,ABCB4,WNT5A,RNASET2,AXL,ACY3,EPB41L2,CXCL12,APOE |
1.089e-02 | -4.52 | extracellular organelle | cellular component | GO:0043230 | 2279 | 12 | 19108 | 49 |
APOE,EPB41L2,AXL,CXCL12,ACY3,RNASET2,WNT5A,ABCB4,SPP1,OSBPL1A,ITM2B,COL18A1 |
1.089e-02 | -4.52 | extracellular membrane-bounded organelle | cellular component | GO:0065010 | 2279 | 12 | 19108 | 49 |
SPP1,ITM2B,OSBPL1A,COL18A1,ABCB4,WNT5A,APOE,RNASET2,AXL,ACY3,CXCL12,EPB41L2 |
1.094e-02 | -4.52 | SCCPDH (saccharopine dehydrogenase (putative)) | protein interactions | 51097 | 179 | 3 | 19454 | 50 |
C3AR1,USP53,APOE |
1.104e-02 | -4.51 | regulation of response to wounding | biological process | GO:1903034 | 179 | 3 | 18204 | 47 |
APOE,SPP1,PDGFA |
1.106e-02 | -4.50 | cellular response to cytokine stimulus | biological process | GO:0071345 | 734 | 6 | 18204 | 47 |
WNT5A,CSF2RA,TREM2,CSF1R,AXL,CXCL12 |
1.110e-02 | -4.50 | IL1R2 (interleukin 1 receptor type 2) | protein interactions | 7850 | 62 | 2 | 19454 | 50 |
RGS10,ITM2B |
1.111e-02 | -4.50 | homeostatic process | biological process | GO:0042592 | 1456 | 9 | 18204 | 47 |
APOE,PPARD,TREM2,WNT5A,CXCL12,APOC2,ABCB4,MEF2C,AXL |
1.119e-02 | -4.49 | SAB | pfam domains | PF04382 | 4 | 1 | 17795 | 50 |
EPB41L2 |
1.119e-02 | -4.49 | CaKB | pfam domains | PF03185 | 4 | 1 | 17795 | 50 |
KCNMB1 |
1.119e-02 | -4.49 | 4_1_CTD | pfam domains | PF05902 | 4 | 1 | 17795 | 50 |
EPB41L2 |
1.119e-02 | -4.49 | Apolipoprotein | pfam domains | PF01442 | 4 | 1 | 17795 | 50 |
APOE |
1.119e-02 | -4.49 | HJURP_C | pfam domains | PF12347 | 4 | 1 | 17795 | 50 |
MEF2C |
1.119e-02 | -4.49 | CortBP2 | pfam domains | PF09727 | 4 | 1 | 17795 | 50 |
FILIP1L |
1.138e-02 | -4.48 | negative regulation of cell projection organization | biological process | GO:0031345 | 181 | 3 | 18204 | 47 |
APOE,SPP1,WNT5A |
1.138e-02 | -4.48 | Ig_V-set | interpro domains | IPR013106 | 173 | 3 | 18521 | 50 |
SIGLEC8,HAVCR2,TREM2 |
1.144e-02 | -4.47 | SPARC (secreted protein acidic and cysteine rich) | protein interactions | 6678 | 63 | 2 | 19454 | 50 |
PDGFA,COL18A1 |
1.144e-02 | -4.47 | TSC22D2 (TSC22 domain family member 2) | protein interactions | 9819 | 63 | 2 | 19454 | 50 |
OSBPL1A,WDR77 |
1.144e-02 | -4.47 | FITM2 (fat storage inducing transmembrane protein 2) | protein interactions | 128486 | 63 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.144e-02 | -4.47 | HSDL1 (hydroxysteroid dehydrogenase like 1) | protein interactions | 83693 | 63 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.146e-02 | -4.47 | vesicle | cellular component | GO:0031982 | 4141 | 18 | 19108 | 49 |
HAVCR2,COL18A1,OSBPL1A,SPP1,ITM2B,APOC2,ABCB4,WNT5A,RNASET2,EPB41L2,ACY3,CXCL12,TSPAN15,AXL,C3AR1,APOE,CD68,PDGFA |
1.147e-02 | -4.47 | Bile acid and bile salt metabolism | REACTOME pathways | R-HSA-194068 | 43 | 2 | 10285 | 39 |
OSBPL1A,CH25H |
1.147e-02 | -4.47 | Signaling by Retinoic Acid | REACTOME pathways | R-HSA-5362517 | 43 | 2 | 10285 | 39 |
PPARD,DHRS9 |
1.153e-02 | -4.46 | glandular epithelial cell differentiation | biological process | GO:0002067 | 63 | 2 | 18204 | 47 |
WDR77,WNT5A |
1.155e-02 | -4.46 | regulation of cytokine-mediated signaling pathway | biological process | GO:0001959 | 182 | 3 | 18204 | 47 |
WNT5A,TREM2,AXL |
1.160e-02 | -4.46 | synapse | cellular component | GO:0045202 | 1473 | 9 | 19108 | 49 |
APOE,MEF2C,RGS10,C1QC,WNT5A,ADORA3,C1QA,C1QB,KCNMB1 |
1.162e-02 | -4.46 | positive regulation of gene expression | biological process | GO:0010628 | 1212 | 8 | 18204 | 47 |
MEF2C,CSF1R,HAVCR2,WDR77,PPARD,C3AR1,TREM2,WNT5A |
1.178e-02 | -4.44 | transmembrane receptor protein tyrosine kinase activity | molecular function | GO:0004714 | 62 | 2 | 18094 | 48 |
CSF1R,AXL |
1.179e-02 | -4.44 | NAT14 (N-acetyltransferase 14 (putative)) | protein interactions | 57106 | 64 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
1.179e-02 | -4.44 | MICOS13 (mitochondrial contact site and cristae organizing system subunit 13) | protein interactions | 125988 | 64 | 2 | 19454 | 50 |
APOC2,APOC1 |
1.179e-02 | -4.44 | ND5 (NADH dehydrogenase subunit 5) | protein interactions | 4540 | 64 | 2 | 19454 | 50 |
TSPAN15,GPR34 |
1.179e-02 | -4.44 | SLC25A17 (solute carrier family 25 member 17) | protein interactions | 10478 | 64 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.186e-02 | -4.43 | regulation of response to biotic stimulus | biological process | GO:0002831 | 534 | 5 | 18204 | 47 |
HAVCR2,APOE,ALPK1,TREM2,WNT5A |
1.198e-02 | -4.42 | membrane | cellular component | GO:0016020 | 9220 | 32 | 19108 | 49 |
P2RY13,ABCB4,CSF2RA,HAVCR2,DCBLD1,CSF1R,EPB41L2,RGL3,FOLR2,APOE,ADAP2,CD68,CH25H,DHRS9,SIGLEC8,WNT5A,TREM2,RGS10,ADORA3,ITM2B,IFITM10,OSBPL1A,ACY3,CXCL12,AXL,TSPAN15,LTC4S,C3AR1,PDGFA,FILIP1L,KCNMB1,GPR34 |
1.199e-02 | -4.42 | Retinoid metabolism and transport | REACTOME pathways | R-HSA-975634 | 44 | 2 | 10285 | 39 |
APOC2,APOE |
1.209e-02 | -4.42 | LAMP_3 | prosite domains | PS51407 | 4 | 1 | 12186 | 37 |
CD68 |
1.214e-02 | -4.41 | CCR1 (C-C motif chemokine receptor 1) | protein interactions | 1230 | 348 | 4 | 19454 | 50 |
ANKRD22,C1QC,DHRS9,C1QB |
1.224e-02 | -4.40 | heart looping | biological process | GO:0001947 | 65 | 2 | 18204 | 47 |
MEF2C,WNT5A |
1.224e-02 | -4.40 | forebrain cell migration | biological process | GO:0021885 | 65 | 2 | 18204 | 47 |
AXL,CXCL12 |
1.242e-02 | -4.39 | cell maturation | biological process | GO:0048469 | 187 | 3 | 18204 | 47 |
AXL,C1QA,WDR77 |
1.250e-02 | -4.38 | MICB (MHC class I polypeptide-related sequence B) | protein interactions | 4277 | 66 | 2 | 19454 | 50 |
DHRS9,APOE |
1.250e-02 | -4.38 | AGPAT4 (1-acylglycerol-3-phosphate O-acyltransferase 4) | protein interactions | 56895 | 66 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.250e-02 | -4.38 | LCN6 (lipocalin 6) | protein interactions | 158062 | 66 | 2 | 19454 | 50 |
HS3ST1,WNT5A |
1.250e-02 | -4.38 | COL4A2 (collagen type IV alpha 2 chain) | protein interactions | 1284 | 66 | 2 | 19454 | 50 |
C1QC,C1QB |
1.260e-02 | -4.37 | intracellular receptor signaling pathway | biological process | GO:0030522 | 188 | 3 | 18204 | 47 |
HAVCR2,ALPK1,PPARD |
1.260e-02 | -4.37 | astrocyte differentiation | biological process | GO:0048708 | 66 | 2 | 18204 | 47 |
TREM2,C1QA |
1.260e-02 | -4.37 | positive regulation of non-canonical NF-kappaB signal transduction | biological process | GO:1901224 | 66 | 2 | 18204 | 47 |
TREM2,HAVCR2 |
1.260e-02 | -4.37 | regulation of lipid catabolic process | biological process | GO:0050994 | 66 | 2 | 18204 | 47 |
APOC1,APOC2 |
1.260e-02 | -4.37 | myeloid cell activation involved in immune response | biological process | GO:0002275 | 66 | 2 | 18204 | 47 |
HAVCR2,TREM2 |
1.260e-02 | -4.37 | animal organ regeneration | biological process | GO:0031100 | 66 | 2 | 18204 | 47 |
AXL,CXCL12 |
1.260e-02 | -4.37 | regulation of morphogenesis of an epithelium | biological process | GO:1905330 | 66 | 2 | 18204 | 47 |
WNT5A,PDGFA |
1.262e-02 | -4.37 | Ig-like_fold | interpro domains | IPR013783 | 721 | 6 | 18521 | 50 |
SIGLEC8,CSF2RA,AXL,CSF1R,HAVCR2,TREM2 |
1.275e-02 | -4.36 | regulation of cellular component size | biological process | GO:0032535 | 352 | 4 | 18204 | 47 |
WNT5A,APOE,CXCL12,SPP1 |
1.278e-02 | -4.36 | positive regulation of vasculature development | biological process | GO:1904018 | 189 | 3 | 18204 | 47 |
WNT5A,CXCL12,C3AR1 |
1.279e-02 | -4.36 | Cdkn2a (cyclin dependent kinase inhibitor 2A) | protein interactions | 12578 | 5 | 1 | 19454 | 50 |
PDGFA |
1.279e-02 | -4.36 | DSEL (dermatan sulfate epimerase like) | protein interactions | 92126 | 5 | 1 | 19454 | 50 |
SPP1 |
1.279e-02 | -4.36 | SLC25A47 (solute carrier family 25 member 47) | protein interactions | 283600 | 5 | 1 | 19454 | 50 |
C1QA |
1.284e-02 | -4.35 | negative regulation of fat cell proliferation | biological process | GO:0070345 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | positive regulation of dendritic spine maintenance | biological process | GO:1902952 | 5 | 1 | 18204 | 47 |
APOE |
1.284e-02 | -4.35 | toll-like receptor 7 signaling pathway | biological process | GO:0034154 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | mammary gland branching involved in thelarche | biological process | GO:0060744 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | negative regulation of response to tumor cell | biological process | GO:0002835 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | regulation of protein kinase C activity | biological process | GO:1900019 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | positive regulation of hair follicle maturation | biological process | GO:0048818 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | biological process | GO:0002580 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | positive regulation of macrophage fusion | biological process | GO:0034241 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | convergent extension involved in organogenesis | biological process | GO:0060029 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | epithelial-mesenchymal cell signaling | biological process | GO:0060684 | 5 | 1 | 18204 | 47 |
PDGFA |
1.284e-02 | -4.35 | AMPA glutamate receptor clustering | biological process | GO:0097113 | 5 | 1 | 18204 | 47 |
APOE |
1.284e-02 | -4.35 | convergent extension involved in axis elongation | biological process | GO:0060028 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | branch elongation involved in mammary gland duct branching | biological process | GO:0060751 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | microglial cell activation involved in immune response | biological process | GO:0002282 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | regulation of macrophage fusion | biological process | GO:0034239 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | regulation of hippocampal neuron apoptotic process | biological process | GO:0110089 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | androgen catabolic process | biological process | GO:0006710 | 5 | 1 | 18204 | 47 |
SPP1 |
1.284e-02 | -4.35 | regulation of myeloid dendritic cell activation | biological process | GO:0030885 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | regulation of phosphatidylinositol biosynthetic process | biological process | GO:0010511 | 5 | 1 | 18204 | 47 |
PDGFA |
1.284e-02 | -4.35 | negative regulation of melanin biosynthetic process | biological process | GO:0048022 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | negative regulation of secondary metabolite biosynthetic process | biological process | GO:1900377 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | glutamate receptor clustering | biological process | GO:0097688 | 5 | 1 | 18204 | 47 |
APOE |
1.284e-02 | -4.35 | regulation of timing of anagen | biological process | GO:0051884 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | positive regulation of amyloid fibril formation | biological process | GO:1905908 | 5 | 1 | 18204 | 47 |
APOE |
1.284e-02 | -4.35 | detection of lipopolysaccharide | biological process | GO:0032497 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | negative regulation of phospholipid biosynthetic process | biological process | GO:0071072 | 5 | 1 | 18204 | 47 |
PDGFA |
1.284e-02 | -4.35 | thelarche | biological process | GO:0042695 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | negative regulation of defense response to bacterium | biological process | GO:1900425 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | positive regulation of skeletal muscle tissue regeneration | biological process | GO:0043415 | 5 | 1 | 18204 | 47 |
PPARD |
1.284e-02 | -4.35 | sphingolipid translocation | biological process | GO:0099039 | 5 | 1 | 18204 | 47 |
ABCB4 |
1.284e-02 | -4.35 | positive regulation of protein kinase C activity | biological process | GO:1900020 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | serotonergic neuron axon guidance | biological process | GO:0036515 | 5 | 1 | 18204 | 47 |
WNT5A |
1.284e-02 | -4.35 | negative regulation of astrocyte activation | biological process | GO:0061889 | 5 | 1 | 18204 | 47 |
TREM2 |
1.284e-02 | -4.35 | positive regulation of phospholipid translocation | biological process | GO:0061092 | 5 | 1 | 18204 | 47 |
ABCB4 |
1.284e-02 | -4.35 | negative regulation of immune response to tumor cell | biological process | GO:0002838 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | regulation of granulocyte colony-stimulating factor production | biological process | GO:0071655 | 5 | 1 | 18204 | 47 |
HAVCR2 |
1.284e-02 | -4.35 | melanocyte proliferation | biological process | GO:0097325 | 5 | 1 | 18204 | 47 |
WNT5A |
1.294e-02 | -4.35 | negative regulation of response to stimulus | biological process | GO:0048585 | 1760 | 10 | 18204 | 47 |
PPARD,HAVCR2,APOE,WNT5A,PDGFA,TREM2,RGS10,SPP1,CXCL12,TSPAN15 |
1.320e-02 | -4.33 | apolipoprotein A-I binding | molecular function | GO:0034186 | 5 | 1 | 18094 | 48 |
TREM2 |
1.320e-02 | -4.33 | aminoacylase activity | molecular function | GO:0004046 | 5 | 1 | 18094 | 48 |
ACY3 |
1.320e-02 | -4.33 | inositol 1,3,4,5 tetrakisphosphate binding | molecular function | GO:0043533 | 5 | 1 | 18094 | 48 |
ADAP2 |
1.320e-02 | -4.33 | lipoteichoic acid binding | molecular function | GO:0070891 | 5 | 1 | 18094 | 48 |
TREM2 |
1.320e-02 | -4.33 | leukotriene-C4 synthase activity | molecular function | GO:0004464 | 5 | 1 | 18094 | 48 |
LTC4S |
1.320e-02 | -4.33 | G protein-coupled adenosine receptor activity | molecular function | GO:0001609 | 5 | 1 | 18094 | 48 |
ADORA3 |
1.320e-02 | -4.33 | MRF binding | molecular function | GO:0043426 | 5 | 1 | 18094 | 48 |
BHLHE41 |
1.320e-02 | -4.33 | opsonin receptor activity | molecular function | GO:0001847 | 5 | 1 | 18094 | 48 |
C3AR1 |
1.324e-02 | -4.32 | SLC19A2 (solute carrier family 19 member 2) | protein interactions | 10560 | 68 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.333e-02 | -4.32 | multi-organism reproductive process | biological process | GO:0044703 | 192 | 3 | 18204 | 47 |
PPARD,HAVCR2,SPP1 |
1.343e-02 | -4.31 | Short_hematopoietin_rcpt_2_CS | interpro domains | IPR003532 | 5 | 1 | 18521 | 50 |
CSF2RA |
1.343e-02 | -4.31 | TF_MADSbox | interpro domains | IPR002100 | 5 | 1 | 18521 | 50 |
MEF2C |
1.343e-02 | -4.31 | Lamp2-like_luminal | interpro domains | IPR048528 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | TF_MADSbox_sf | interpro domains | IPR036879 | 5 | 1 | 18521 | 50 |
MEF2C |
1.343e-02 | -4.31 | Lysosome-assoc_membr_glycop | interpro domains | IPR002000 | 5 | 1 | 18521 | 50 |
CD68 |
1.343e-02 | -4.31 | Folate_rcpt | interpro domains | IPR004269 | 5 | 1 | 18521 | 50 |
FOLR2 |
1.359e-02 | -4.30 | negative regulation of developmental process | biological process | GO:0051093 | 1000 | 7 | 18204 | 47 |
PPARD,WDR77,C1QC,BHLHE41,WNT5A,TREM2,SPP1 |
1.362e-02 | -4.30 | cellular component disassembly | biological process | GO:0022411 | 359 | 4 | 18204 | 47 |
C1QA,TREM2,C1QC,C1QB |
1.370e-02 | -4.29 | regulation of response to cytokine stimulus | biological process | GO:0060759 | 194 | 3 | 18204 | 47 |
WNT5A,TREM2,AXL |
1.370e-02 | -4.29 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | biological process | GO:0002822 | 194 | 3 | 18204 | 47 |
MEF2C,TREM2,HAVCR2 |
1.371e-02 | -4.29 | regulation of lymphocyte migration | biological process | GO:2000401 | 69 | 2 | 18204 | 47 |
WNT5A,CXCL12 |
1.371e-02 | -4.29 | regulation of blood coagulation | biological process | GO:0030193 | 69 | 2 | 18204 | 47 |
PDGFA,APOE |
1.371e-02 | -4.29 | regulation of lipase activity | biological process | GO:0060191 | 69 | 2 | 18204 | 47 |
APOC1,APOC2 |
1.371e-02 | -4.29 | triglyceride metabolic process | biological process | GO:0006641 | 69 | 2 | 18204 | 47 |
APOE,APOC1 |
1.371e-02 | -4.29 | cytoplasmic pattern recognition receptor signaling pathway | biological process | GO:0002753 | 69 | 2 | 18204 | 47 |
HAVCR2,ALPK1 |
1.371e-02 | -4.29 | PROXISOMEPAR | prints domains | PR01288 | 3 | 1 | 5227 | 24 |
PPARD |
1.371e-02 | -4.29 | 5LPOXGNASEAP | prints domains | PR00488 | 3 | 1 | 5227 | 24 |
LTC4S |
1.374e-02 | -4.29 | regulation of biological quality | biological process | GO:0065008 | 2936 | 14 | 18204 | 47 |
MEF2C,KCNMB1,USP53,DHRS9,C3AR1,ABCB4,CSF1R,AXL,SPP1,CXCL12,TREM2,PDGFA,WNT5A,APOE |
1.388e-02 | -4.28 | regulation of protein catabolic process | biological process | GO:0042176 | 361 | 4 | 18204 | 47 |
APOE,TREM2,TSPAN15,WNT5A |
1.397e-02 | -4.27 | SRF-TF | pfam domains | PF00319 | 5 | 1 | 17795 | 50 |
MEF2C |
1.397e-02 | -4.27 | Lamp | pfam domains | PF01299 | 5 | 1 | 17795 | 50 |
CD68 |
1.399e-02 | -4.27 | MANBA (mannosidase beta) | protein interactions | 4126 | 70 | 2 | 19454 | 50 |
C1QB,C1QA |
1.409e-02 | -4.26 | negative regulation of smooth muscle cell proliferation | biological process | GO:0048662 | 70 | 2 | 18204 | 47 |
APOE,MEF2C |
1.409e-02 | -4.26 | determination of heart left/right asymmetry | biological process | GO:0061371 | 70 | 2 | 18204 | 47 |
WNT5A,MEF2C |
1.433e-02 | -4.25 | Systemic lupus erythematosus | KEGG pathways | ko05322 | 132 | 3 | 7161 | 28 |
C1QA,C1QC,C1QB |
1.433e-02 | -4.25 | Systemic lupus erythematosus | KEGG pathways | hsa05322 | 132 | 3 | 7161 | 28 |
C1QC,C1QA,C1QB |
1.433e-02 | -4.25 | MADS | smart domains | SM00432 | 5 | 1 | 9717 | 28 |
MEF2C |
1.437e-02 | -4.24 | SLC35F2 (solute carrier family 35 member F2) | protein interactions | 54733 | 71 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.448e-02 | -4.24 | embryonic heart tube morphogenesis | biological process | GO:0003143 | 71 | 2 | 18204 | 47 |
MEF2C,WNT5A |
1.448e-02 | -4.24 | regulation of hemostasis | biological process | GO:1900046 | 71 | 2 | 18204 | 47 |
APOE,PDGFA |
1.479e-02 | -4.21 | immune response-regulating signaling pathway | biological process | GO:0002764 | 368 | 4 | 18204 | 47 |
MEF2C,ALPK1,HAVCR2,C3AR1 |
1.486e-02 | -4.21 | multi-multicellular organism process | biological process | GO:0044706 | 200 | 3 | 18204 | 47 |
PPARD,HAVCR2,SPP1 |
1.487e-02 | -4.21 | cellular response to calcium ion | biological process | GO:0071277 | 72 | 2 | 18204 | 47 |
WNT5A,MEF2C |
1.487e-02 | -4.21 | positive regulation of interleukin-1 production | biological process | GO:0032732 | 72 | 2 | 18204 | 47 |
WNT5A,HAVCR2 |
1.506e-02 | -4.20 | negative regulation of inflammatory response | biological process | GO:0050728 | 201 | 3 | 18204 | 47 |
APOE,PPARD,TREM2 |
1.508e-02 | -4.19 | Adenosine P1 receptors | REACTOME pathways | R-HSA-417973 | 4 | 1 | 10285 | 39 |
ADORA3 |
1.509e-02 | -4.19 | HEMATOPO_REC_S_F2 | prosite domains | PS01356 | 5 | 1 | 12186 | 37 |
CSF2RA |
1.509e-02 | -4.19 | MADS_BOX_2 | prosite domains | PS50066 | 5 | 1 | 12186 | 37 |
MEF2C |
1.509e-02 | -4.19 | MADS_BOX_1 | prosite domains | PS00350 | 5 | 1 | 12186 | 37 |
MEF2C |
1.511e-02 | -4.19 | Apolipoprotein | gene3d domains | 1.20.120.20 | 5 | 1 | 14470 | 44 |
APOE |
1.511e-02 | -4.19 | Transcription factor, MADS-box | gene3d domains | 3.40.1810.10 | 5 | 1 | 14470 | 44 |
MEF2C |
1.512e-02 | -4.19 | SGTB (small glutamine rich tetratricopeptide repeat co-chaperone beta) | protein interactions | 54557 | 202 | 3 | 19454 | 50 |
SPP1,C1QA,CD68 |
1.515e-02 | -4.19 | MMP2 (matrix metallopeptidase 2) | protein interactions | 4313 | 73 | 2 | 19454 | 50 |
CXCL12,COL18A1 |
1.521e-02 | -4.19 | human chr3q12.1 | chromosome location | human chr3q12.1 | 8 | 1 | 26134 | 50 |
FILIP1L |
1.524e-02 | -4.18 | phosphatidylserine binding | molecular function | GO:0001786 | 71 | 2 | 18094 | 48 |
AXL,TREM2 |
1.524e-02 | -4.18 | RNA endonuclease activity | molecular function | GO:0004521 | 71 | 2 | 18094 | 48 |
RNASET2,RNASEH1 |
1.526e-02 | -4.18 | intracellular calcium ion homeostasis | biological process | GO:0006874 | 202 | 3 | 18204 | 47 |
WNT5A,CXCL12,APOE |
1.526e-02 | -4.18 | regulation of myoblast differentiation | biological process | GO:0045661 | 73 | 2 | 18204 | 47 |
PPARD,MEF2C |
1.526e-02 | -4.18 | negative regulation of wound healing | biological process | GO:0061045 | 73 | 2 | 18204 | 47 |
PDGFA,APOE |
1.526e-02 | -4.18 | negative regulation of reproductive process | biological process | GO:2000242 | 73 | 2 | 18204 | 47 |
WDR77,WNT5A |
1.529e-02 | -4.18 | multivesicular body, internal vesicle | cellular component | GO:0097487 | 6 | 1 | 19108 | 49 |
APOE |
1.529e-02 | -4.18 | intercellular canaliculus | cellular component | GO:0046581 | 6 | 1 | 19108 | 49 |
ABCB4 |
1.529e-02 | -4.18 | Cul4B-RING E3 ubiquitin ligase complex | cellular component | GO:0031465 | 6 | 1 | 19108 | 49 |
WDR77 |
1.531e-02 | -4.18 | CERS2 (ceramide synthase 2) | protein interactions | 29956 | 203 | 3 | 19454 | 50 |
TSPAN15,EPB41L2,C3AR1 |
1.532e-02 | -4.18 | Ncoa2 (nuclear receptor coactivator 2) | protein interactions | 17978 | 6 | 1 | 19454 | 50 |
PPARD |
1.532e-02 | -4.18 | PIGY (phosphatidylinositol glycan anchor biosynthesis class Y) | protein interactions | 84992 | 6 | 1 | 19454 | 50 |
ABCB4 |
1.532e-02 | -4.18 | LCAT (lecithin-cholesterol acyltransferase) | protein interactions | 3931 | 6 | 1 | 19454 | 50 |
APOE |
1.532e-02 | -4.18 | STAG3L4 (STAG3 cohesin complex component like 4 (pseudogene)) | protein interactions | 64940 | 6 | 1 | 19454 | 50 |
TSPAN15 |
1.532e-02 | -4.18 | FOLR3 (folate receptor gamma) | protein interactions | 2352 | 6 | 1 | 19454 | 50 |
FOLR2 |
1.532e-02 | -4.18 | FXYD7 (FXYD domain containing ion transport regulator 7) | protein interactions | 53822 | 6 | 1 | 19454 | 50 |
APOE |
1.532e-02 | -4.18 | Dock11 (dedicator of cytokinesis 11) | protein interactions | 75974 | 6 | 1 | 19454 | 50 |
EPB41L2 |
1.532e-02 | -4.18 | ZNF804A (zinc finger protein 804A) | protein interactions | 91752 | 6 | 1 | 19454 | 50 |
SPP1 |
1.535e-02 | -4.18 | Immunoglobulin | interpro domains | IPR013151 | 70 | 2 | 18521 | 50 |
CSF1R,SIGLEC8 |
1.539e-02 | -4.17 | negative regulation of epithelial cell proliferation involved in prostate gland development | biological process | GO:0060770 | 6 | 1 | 18204 | 47 |
WDR77 |
1.539e-02 | -4.17 | neutrophil clearance | biological process | GO:0097350 | 6 | 1 | 18204 | 47 |
AXL |
1.539e-02 | -4.17 | regulation of CD40 signaling pathway | biological process | GO:2000348 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | negative regulation of interferon-alpha production | biological process | GO:0032687 | 6 | 1 | 18204 | 47 |
HAVCR2 |
1.539e-02 | -4.17 | regulation of macrophage inflammatory protein 1 alpha production | biological process | GO:0071640 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | regulation of response to macrophage colony-stimulating factor | biological process | GO:1903969 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | bile acid secretion | biological process | GO:0032782 | 6 | 1 | 18204 | 47 |
ABCB4 |
1.539e-02 | -4.17 | cellular response to peptidoglycan | biological process | GO:0071224 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | dopaminergic neuron axon guidance | biological process | GO:0036514 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | positive regulation of dopamine secretion | biological process | GO:0033603 | 6 | 1 | 18204 | 47 |
CXCL12 |
1.539e-02 | -4.17 | positive regulation of protein localization to synapse | biological process | GO:1902474 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | planar cell polarity pathway involved in axis elongation | biological process | GO:0003402 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | positive regulation of macrophage proliferation | biological process | GO:0120041 | 6 | 1 | 18204 | 47 |
CSF1R |
1.539e-02 | -4.17 | negative regulation of sequestering of triglyceride | biological process | GO:0010891 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | regulation of antigen processing and presentation of peptide antigen | biological process | GO:0002583 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | positive regulation of protein localization to cell cortex | biological process | GO:1904778 | 6 | 1 | 18204 | 47 |
EPB41L2 |
1.539e-02 | -4.17 | chemorepulsion of axon | biological process | GO:0061643 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell | biological process | GO:2001188 | 6 | 1 | 18204 | 47 |
HAVCR2 |
1.539e-02 | -4.17 | regulation of low-density lipoprotein particle receptor catabolic process | biological process | GO:0032803 | 6 | 1 | 18204 | 47 |
APOE |
1.539e-02 | -4.17 | regulation of phospholipid translocation | biological process | GO:0061091 | 6 | 1 | 18204 | 47 |
ABCB4 |
1.539e-02 | -4.17 | regulation of cellular response to macrophage colony-stimulating factor stimulus | biological process | GO:1903972 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | cell surface receptor signaling pathway involved in heart development | biological process | GO:0061311 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | regulation of synapse pruning | biological process | GO:1905806 | 6 | 1 | 18204 | 47 |
TREM2 |
1.539e-02 | -4.17 | keratinocyte migration | biological process | GO:0051546 | 6 | 1 | 18204 | 47 |
PPARD |
1.539e-02 | -4.17 | regulation of prostatic bud formation | biological process | GO:0060685 | 6 | 1 | 18204 | 47 |
WNT5A |
1.539e-02 | -4.17 | B cell chemotaxis | biological process | GO:0035754 | 6 | 1 | 18204 | 47 |
CH25H |
1.539e-02 | -4.17 | regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010901 | 6 | 1 | 18204 | 47 |
APOC2 |
1.552e-02 | -4.17 | LPAR1 (lysophosphatidic acid receptor 1) | protein interactions | 1902 | 204 | 3 | 19454 | 50 |
AXL,C3AR1,TSPAN15 |
1.554e-02 | -4.16 | LPCAT3 (lysophosphatidylcholine acyltransferase 3) | protein interactions | 10162 | 74 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.554e-02 | -4.16 | NDUFB1 (NADH:ubiquinone oxidoreductase subunit B1) | protein interactions | 4707 | 74 | 2 | 19454 | 50 |
C3AR1,GPR34 |
1.554e-02 | -4.16 | SYNGR2 (synaptogyrin 2) | protein interactions | 9144 | 74 | 2 | 19454 | 50 |
ANKRD22,TSPAN15 |
1.558e-02 | -4.16 | regulation of leukocyte activation | biological process | GO:0002694 | 572 | 5 | 18204 | 47 |
MEF2C,AXL,TREM2,WNT5A,HAVCR2 |
1.566e-02 | -4.16 | regulation of coagulation | biological process | GO:0050818 | 74 | 2 | 18204 | 47 |
PDGFA,APOE |
1.566e-02 | -4.16 | positive regulation of protein localization to cell periphery | biological process | GO:1904377 | 74 | 2 | 18204 | 47 |
EPB41L2,TREM2 |
1.566e-02 | -4.16 | positive regulation of protein catabolic process | biological process | GO:0045732 | 204 | 3 | 18204 | 47 |
APOE,WNT5A,TREM2 |
1.581e-02 | -4.15 | RNA-DNA hybrid ribonuclease activity | molecular function | GO:0004523 | 6 | 1 | 18094 | 48 |
RNASEH1 |
1.581e-02 | -4.15 | sulfatide binding | molecular function | GO:0120146 | 6 | 1 | 18094 | 48 |
TREM2 |
1.587e-02 | -4.14 | clathrin-coated endocytic vesicle membrane | cellular component | GO:0030669 | 75 | 2 | 19108 | 49 |
APOE,WNT5A |
1.594e-02 | -4.14 | NPTX1 (neuronal pentraxin 1) | protein interactions | 4884 | 75 | 2 | 19454 | 50 |
WNT5A,C1QA |
1.594e-02 | -4.14 | ATP9A (ATPase phospholipid transporting 9A (putative)) | protein interactions | 10079 | 75 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
1.600e-02 | -4.13 | PDGFRA (platelet derived growth factor receptor alpha) | protein interactions | 5156 | 378 | 4 | 19454 | 50 |
PDGFA,WNT5A,HS3ST1,COL18A1 |
1.606e-02 | -4.13 | regulation of behavior | biological process | GO:0050795 | 75 | 2 | 18204 | 47 |
MEF2C,APOE |
1.609e-02 | -4.13 | LCCL | interpro domains | IPR004043 | 6 | 1 | 18521 | 50 |
DCBLD1 |
1.609e-02 | -4.13 | MAPEG-like_dom_sf | interpro domains | IPR023352 | 6 | 1 | 18521 | 50 |
LTC4S |
1.609e-02 | -4.13 | LCCL_sf | interpro domains | IPR036609 | 6 | 1 | 18521 | 50 |
DCBLD1 |
1.609e-02 | -4.13 | a-kinase_dom | interpro domains | IPR004166 | 6 | 1 | 18521 | 50 |
ALPK1 |
1.609e-02 | -4.13 | Fatty_acid_hydroxylase | interpro domains | IPR006694 | 6 | 1 | 18521 | 50 |
CH25H |
1.609e-02 | -4.13 | Membr-assoc_MAPEG | interpro domains | IPR001129 | 6 | 1 | 18521 | 50 |
LTC4S |
1.635e-02 | -4.11 | LMBR1 (limb development membrane protein 1) | protein interactions | 64327 | 76 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.635e-02 | -4.11 | BCL2L2 (BCL2 like 2) | protein interactions | 599 | 76 | 2 | 19454 | 50 |
APOC2,APOC1 |
1.635e-02 | -4.11 | CD1B (CD1b molecule) | protein interactions | 910 | 76 | 2 | 19454 | 50 |
ALPK1,ITM2B |
1.647e-02 | -4.11 | positive regulation of type II interferon production | biological process | GO:0032729 | 76 | 2 | 18204 | 47 |
WNT5A,HAVCR2 |
1.655e-02 | -4.10 | ig | pfam domains | PF00047 | 70 | 2 | 17795 | 50 |
SIGLEC8,CSF1R |
1.656e-02 | -4.10 | leukotriene biosynthesis | BIOCYC pathways | META_PWY66-375 | 5 | 1 | 902 | 3 |
LTC4S |
1.656e-02 | -4.10 | leukotriene biosynthesis | BIOCYC pathways | HUMAN_PWY66-375 | 5 | 1 | 902 | 3 |
LTC4S |
1.660e-02 | -4.10 | negative regulation of cell migration | biological process | GO:0030336 | 381 | 4 | 18204 | 47 |
APOE,CXCL12,ADORA3,MEF2C |
1.670e-02 | -4.09 | regulation of adaptive immune response | biological process | GO:0002819 | 209 | 3 | 18204 | 47 |
MEF2C,TREM2,HAVCR2 |
1.672e-02 | -4.09 | multicellular organism development | biological process | GO:0007275 | 3957 | 17 | 18204 | 47 |
MEF2C,C1QA,ADAP2,COL18A1,BHLHE41,HAVCR2,CSF1R,AXL,SPP1,CXCL12,TREM2,PDGFA,WNT5A,ITM2B,WDR77,APOE,PPARD |
1.674e-02 | -4.09 | MAPEG | pfam domains | PF01124 | 6 | 1 | 17795 | 50 |
LTC4S |
1.674e-02 | -4.09 | Alpha_kinase | pfam domains | PF02816 | 6 | 1 | 17795 | 50 |
ALPK1 |
1.674e-02 | -4.09 | LCCL | pfam domains | PF03815 | 6 | 1 | 17795 | 50 |
DCBLD1 |
1.674e-02 | -4.09 | FA_hydroxylase | pfam domains | PF04116 | 6 | 1 | 17795 | 50 |
CH25H |
1.676e-02 | -4.09 | LRRC8A (leucine rich repeat containing 8 VRAC subunit A) | protein interactions | 56262 | 77 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.676e-02 | -4.09 | FKBP2 (FKBP prolyl isomerase 2) | protein interactions | 2286 | 77 | 2 | 19454 | 50 |
EPB41L2,C1QC |
1.688e-02 | -4.08 | negative regulation of endocytosis | biological process | GO:0045806 | 77 | 2 | 18204 | 47 |
APOC2,APOC1 |
1.692e-02 | -4.08 | Integrins in angiogenesis | Pathway Interaction DB | avb3_integrin_pathway | 46 | 2 | 2226 | 10 |
CSF1R,SPP1 |
1.704e-02 | -4.07 | cytokine-mediated signaling pathway | biological process | GO:0019221 | 384 | 4 | 18204 | 47 |
TREM2,CSF1R,CSF2RA,CXCL12 |
1.709e-02 | -4.07 | Metabolism of fat-soluble vitamins | REACTOME pathways | R-HSA-6806667 | 53 | 2 | 10285 | 39 |
APOE,APOC2 |
1.717e-02 | -4.06 | Nedd4 (NEDD4 E3 ubiquitin protein ligase) | protein interactions | 25489 | 78 | 2 | 19454 | 50 |
PPARD,ADAP2 |
1.717e-02 | -4.06 | Alpha_kinase | smart domains | SM00811 | 6 | 1 | 9717 | 28 |
ALPK1 |
1.717e-02 | -4.06 | LCCL | smart domains | SM00603 | 6 | 1 | 9717 | 28 |
DCBLD1 |
1.730e-02 | -4.06 | negative regulation of endothelial cell proliferation | biological process | GO:0001937 | 78 | 2 | 18204 | 47 |
APOE,MEF2C |
1.734e-02 | -4.05 | positive regulation of monoatomic ion transport | biological process | GO:0043270 | 212 | 3 | 18204 | 47 |
KCNMB1,CXCL12,TREM2 |
1.759e-02 | -4.04 | NUCB2 (nucleobindin 2) | protein interactions | 4925 | 79 | 2 | 19454 | 50 |
TREM2,AXL |
1.759e-02 | -4.04 | CIB2 (calcium and integrin binding family member 2) | protein interactions | 10518 | 79 | 2 | 19454 | 50 |
RGL3,AXL |
1.759e-02 | -4.04 | NCS1 (neuronal calcium sensor 1) | protein interactions | 23413 | 79 | 2 | 19454 | 50 |
SPP1,RNASEH1 |
1.772e-02 | -4.03 | energy homeostasis | biological process | GO:0097009 | 79 | 2 | 18204 | 47 |
PPARD,APOE |
1.786e-02 | -4.03 | MFSD9 (major facilitator superfamily domain containing 9) | protein interactions | 84804 | 7 | 1 | 19454 | 50 |
TSPAN15 |
1.786e-02 | -4.03 | SLC5A1 (solute carrier family 5 member 1) | protein interactions | 6523 | 7 | 1 | 19454 | 50 |
AXL |
1.786e-02 | -4.03 | SLC25A52 (solute carrier family 25 member 52) | protein interactions | 147407 | 7 | 1 | 19454 | 50 |
TSPAN15 |
1.786e-02 | -4.03 | CR1 (complement C3b/C4b receptor 1 (Knops blood group)) | protein interactions | 1378 | 7 | 1 | 19454 | 50 |
C1QA |
1.786e-02 | -4.03 | Rtf2 (replication termination factor 2) | protein interactions | 66404 | 7 | 1 | 19454 | 50 |
BHLHE41 |
1.786e-02 | -4.03 | ALG1L1P (ALG1 like 1, pseudogene) | protein interactions | 200810 | 7 | 1 | 19454 | 50 |
RGL3 |
1.786e-02 | -4.03 | RIMS4 (regulating synaptic membrane exocytosis 4) | protein interactions | 140730 | 7 | 1 | 19454 | 50 |
SPP1 |
1.786e-02 | -4.03 | CIMIP2A (ciliary microtubule inner protein 2A) | protein interactions | 401565 | 7 | 1 | 19454 | 50 |
ACY3 |
1.786e-02 | -4.03 | Gadd45b (growth arrest and DNA-damage-inducible 45 beta) | protein interactions | 17873 | 7 | 1 | 19454 | 50 |
PPARD |
1.786e-02 | -4.03 | SOX18 (SRY-box transcription factor 18) | protein interactions | 54345 | 7 | 1 | 19454 | 50 |
MEF2C |
1.793e-02 | -4.02 | regulation of immune effector process | biological process | GO:0002697 | 390 | 4 | 18204 | 47 |
HAVCR2,WNT5A,AXL,TREM2 |
1.794e-02 | -4.02 | development of secondary female sexual characteristics | biological process | GO:0046543 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | negative regulation of lipoprotein lipase activity | biological process | GO:0051005 | 7 | 1 | 18204 | 47 |
APOC1 |
1.794e-02 | -4.02 | platelet-derived growth factor receptor-beta signaling pathway | biological process | GO:0035791 | 7 | 1 | 18204 | 47 |
PDGFA |
1.794e-02 | -4.02 | retinoic acid biosynthetic process | biological process | GO:0002138 | 7 | 1 | 18204 | 47 |
DHRS9 |
1.794e-02 | -4.02 | positive regulation of complement activation | biological process | GO:0045917 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | positive regulation of microglial cell migration | biological process | GO:1904141 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | optic cup morphogenesis involved in camera-type eye development | biological process | GO:0002072 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | positive regulation of receptor catabolic process | biological process | GO:2000646 | 7 | 1 | 18204 | 47 |
APOE |
1.794e-02 | -4.02 | fat cell proliferation | biological process | GO:0070341 | 7 | 1 | 18204 | 47 |
PPARD |
1.794e-02 | -4.02 | positive regulation of lipoprotein lipase activity | biological process | GO:0051006 | 7 | 1 | 18204 | 47 |
APOC2 |
1.794e-02 | -4.02 | regulation of macrophage colony-stimulating factor production | biological process | GO:1901256 | 7 | 1 | 18204 | 47 |
HAVCR2 |
1.794e-02 | -4.02 | positive regulation of high-density lipoprotein particle clearance | biological process | GO:0010983 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | regulation of macrophage proliferation | biological process | GO:0120040 | 7 | 1 | 18204 | 47 |
CSF1R |
1.794e-02 | -4.02 | paraxial mesoderm formation | biological process | GO:0048341 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | positive regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002925 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | positive regulation of skeletal muscle cell differentiation | biological process | GO:2001016 | 7 | 1 | 18204 | 47 |
MEF2C |
1.794e-02 | -4.02 | positive regulation of pinocytosis | biological process | GO:0048549 | 7 | 1 | 18204 | 47 |
AXL |
1.794e-02 | -4.02 | convergent extension involved in gastrulation | biological process | GO:0060027 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | regulation of inward rectifier potassium channel activity | biological process | GO:1901979 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | positive regulation of axon extension involved in axon guidance | biological process | GO:0048842 | 7 | 1 | 18204 | 47 |
CXCL12 |
1.794e-02 | -4.02 | response to hydrostatic pressure | biological process | GO:0051599 | 7 | 1 | 18204 | 47 |
COL18A1 |
1.794e-02 | -4.02 | hindgut morphogenesis | biological process | GO:0007442 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | negative regulation of mesenchymal cell proliferation | biological process | GO:0072201 | 7 | 1 | 18204 | 47 |
WNT5A |
1.794e-02 | -4.02 | negative regulation of toll-like receptor 2 signaling pathway | biological process | GO:0034136 | 7 | 1 | 18204 | 47 |
TREM2 |
1.794e-02 | -4.02 | positive regulation of behavioral fear response | biological process | GO:2000987 | 7 | 1 | 18204 | 47 |
MEF2C |
1.801e-02 | -4.02 | COL6A2 (collagen type VI alpha 2 chain) | protein interactions | 1292 | 80 | 2 | 19454 | 50 |
C1QB,C1QC |
1.801e-02 | -4.02 | CEACAM21 (CEA cell adhesion molecule 21) | protein interactions | 90273 | 80 | 2 | 19454 | 50 |
ITM2B,HS3ST1 |
1.808e-02 | -4.01 | ALPHA_KINASE | prosite domains | PS51158 | 6 | 1 | 12186 | 37 |
ALPK1 |
1.808e-02 | -4.01 | LCCL | prosite domains | PS50820 | 6 | 1 | 12186 | 37 |
DCBLD1 |
1.811e-02 | -4.01 | MHCK/EF2 kinase | gene3d domains | 3.20.200.10 | 6 | 1 | 14470 | 44 |
ALPK1 |
1.811e-02 | -4.01 | LCCL-like domain | gene3d domains | 2.170.130.20 | 6 | 1 | 14470 | 44 |
DCBLD1 |
1.811e-02 | -4.01 | Membrane associated eicosanoid/glutathione metabolism-like domain | gene3d domains | 1.20.120.550 | 6 | 1 | 14470 | 44 |
LTC4S |
1.811e-02 | -4.01 | - | gene3d domains | 2.40.160.110 | 6 | 1 | 14470 | 44 |
CD68 |
1.814e-02 | -4.01 | negative regulation of NF-kappaB transcription factor activity | biological process | GO:0032088 | 80 | 2 | 18204 | 47 |
HAVCR2,ADORA3 |
1.821e-02 | -4.01 | cell chemotaxis | biological process | GO:0060326 | 216 | 3 | 18204 | 47 |
CH25H,FOLR2,CXCL12 |
1.821e-02 | -4.01 | regulation of myeloid cell differentiation | biological process | GO:0045637 | 216 | 3 | 18204 | 47 |
TREM2,MEF2C,C1QC |
1.825e-02 | -4.00 | LYSASSOCTDMP | prints domains | PR00336 | 4 | 1 | 5227 | 24 |
CD68 |
1.825e-02 | -4.00 | ADENOSINER | prints domains | PR00424 | 4 | 1 | 5227 | 24 |
ADORA3 |
1.833e-02 | -4.00 | endosome | cellular component | GO:0005768 | 1067 | 7 | 19108 | 49 |
ITM2B,OSBPL1A,HAVCR2,APOC2,APOE,CD68,TSPAN15 |
1.835e-02 | -4.00 | PIK3R1 (phosphoinositide-3-kinase regulatory subunit 1) | protein interactions | 5295 | 394 | 4 | 19454 | 50 |
HAVCR2,CSF1R,CSF2RA,AXL |
1.843e-02 | -3.99 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | molecular function | GO:0008467 | 7 | 1 | 18094 | 48 |
HS3ST1 |
1.843e-02 | -3.99 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen | molecular function | GO:0016716 | 7 | 1 | 18094 | 48 |
CH25H |
1.843e-02 | -3.99 | SLC30A7 (solute carrier family 30 member 7) | protein interactions | 148867 | 81 | 2 | 19454 | 50 |
WNT5A,TSPAN15 |
1.857e-02 | -3.99 | outflow tract morphogenesis | biological process | GO:0003151 | 81 | 2 | 18204 | 47 |
MEF2C,WNT5A |
1.865e-02 | -3.98 | leukocyte activation | biological process | GO:0045321 | 599 | 5 | 18204 | 47 |
TREM2,MEF2C,AXL,C1QA,HAVCR2 |
1.875e-02 | -3.98 | PD_growth_factor_CS | interpro domains | IPR023581 | 7 | 1 | 18521 | 50 |
PDGFA |
1.881e-02 | -3.97 | clathrin-coated vesicle | cellular component | GO:0030136 | 220 | 3 | 19108 | 49 |
ABCB4,APOE,WNT5A |
1.882e-02 | -3.97 | VLDL biosynthesis | REACTOME pathways | R-HSA-8866423 | 5 | 1 | 10285 | 39 |
APOC1 |
1.885e-02 | -3.97 | negative regulation of cell motility | biological process | GO:2000146 | 396 | 4 | 18204 | 47 |
ADORA3,MEF2C,APOE,CXCL12 |
1.886e-02 | -3.97 | Innate Immune System | REACTOME pathways | R-HSA-168249 | 1285 | 10 | 10285 | 39 |
PDGFA,C3AR1,C1QA,RNASET2,CD68,C1QC,CSF2RA,C1QB,MEF2C,TREM2 |
1.886e-02 | -3.97 | MSMO1 (methylsterol monooxygenase 1) | protein interactions | 6307 | 82 | 2 | 19454 | 50 |
TSPAN15,C3AR1 |
1.901e-02 | -3.96 | response to vitamin | biological process | GO:0033273 | 82 | 2 | 18204 | 47 |
SPP1,FOLR2 |
1.901e-02 | -3.96 | negative regulation of blood vessel endothelial cell migration | biological process | GO:0043537 | 82 | 2 | 18204 | 47 |
MEF2C,APOE |
1.911e-02 | -3.96 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 3 | 18204 | 47 |
PDGFA,CSF1R,TREM2 |
1.916e-02 | -3.95 | SCGB2A2 (secretoglobin family 2A member 2) | protein interactions | 4250 | 221 | 3 | 19454 | 50 |
COL18A1,TREM2,WNT5A |
1.917e-02 | -3.95 | organic anion transport | biological process | GO:0015711 | 398 | 4 | 18204 | 47 |
ABCB4,PPARD,APOE,FOLR2 |
1.934e-02 | -3.95 | leukocyte mediated immunity | biological process | GO:0002443 | 221 | 3 | 18204 | 47 |
C1QA,C1QC,C1QB |
1.944e-02 | -3.94 | regulation of amine transport | biological process | GO:0051952 | 83 | 2 | 18204 | 47 |
CXCL12,ADORA3 |
1.944e-02 | -3.94 | positive regulation of MAP kinase activity | biological process | GO:0043406 | 83 | 2 | 18204 | 47 |
PDGFA,WNT5A |
1.954e-02 | -3.94 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 48 |
AXL,CSF1R |
1.964e-02 | -3.93 | regulation of cell growth | biological process | GO:0001558 | 401 | 4 | 18204 | 47 |
SPP1,APOE,CXCL12,WNT5A |
1.974e-02 | -3.93 | IQSEC1 (IQ motif and Sec7 domain ArfGEF 1) | protein interactions | 9922 | 84 | 2 | 19454 | 50 |
HAVCR2,APOE |
1.974e-02 | -3.93 | P3H3 (prolyl 3-hydroxylase 3) | protein interactions | 10536 | 84 | 2 | 19454 | 50 |
C1QB,C1QA |
1.974e-02 | -3.93 | Tyr_kinase_cat_dom | interpro domains | IPR020635 | 80 | 2 | 18521 | 50 |
CSF1R,AXL |
1.976e-02 | -3.92 | neurogenesis | biological process | GO:0022008 | 1334 | 8 | 18204 | 47 |
CSF1R,MEF2C,AXL,C1QA,CXCL12,WNT5A,TREM2,APOE |
1.983e-02 | -3.92 | Cytokine-cytokine receptor interaction | KEGG pathways | hsa04060 | 270 | 4 | 7161 | 28 |
CXCL12,PDGFA,CSF2RA,CSF1R |
1.983e-02 | -3.92 | Cytokine-cytokine receptor interaction | KEGG pathways | ko04060 | 270 | 4 | 7161 | 28 |
CSF2RA,PDGFA,CXCL12,CSF1R |
1.989e-02 | -3.92 | chemokine-mediated signaling pathway | biological process | GO:0070098 | 84 | 2 | 18204 | 47 |
TREM2,CXCL12 |
1.999e-02 | -3.91 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 6 | 18204 | 47 |
WNT5A,MEF2C,RGL3,PPARD,C3AR1,APOE |
2.004e-02 | -3.91 | neuron projection guidance | biological process | GO:0097485 | 224 | 3 | 18204 | 47 |
CSF1R,WNT5A,CXCL12 |
2.004e-02 | -3.91 | axon guidance | biological process | GO:0007411 | 224 | 3 | 18204 | 47 |
CXCL12,CSF1R,WNT5A |
2.032e-02 | -3.90 | ECSIT (ECSIT signaling integrator) | protein interactions | 51295 | 226 | 3 | 19454 | 50 |
APOE,TSPAN15,C3AR1 |
2.032e-02 | -3.90 | PIK3R2 (phosphoinositide-3-kinase regulatory subunit 2) | protein interactions | 5296 | 226 | 3 | 19454 | 50 |
HAVCR2,CSF1R,AXL |
2.033e-02 | -3.90 | embryonic heart tube development | biological process | GO:0035050 | 85 | 2 | 18204 | 47 |
MEF2C,WNT5A |
2.034e-02 | -3.90 | growth factor complex | cellular component | GO:0036454 | 8 | 1 | 19108 | 49 |
PDGFA |
2.034e-02 | -3.90 | spherical high-density lipoprotein particle | cellular component | GO:0034366 | 8 | 1 | 19108 | 49 |
APOC2 |
2.038e-02 | -3.89 | SLC38A3 (solute carrier family 38 member 3) | protein interactions | 10991 | 8 | 1 | 19454 | 50 |
TSPAN15 |
2.038e-02 | -3.89 | SFTPA1 (surfactant protein A1) | protein interactions | 653509 | 8 | 1 | 19454 | 50 |
C1QA |
2.038e-02 | -3.89 | ASPA (aspartoacylase) | protein interactions | 443 | 8 | 1 | 19454 | 50 |
ACY3 |
2.042e-02 | -3.89 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 8 | 18094 | 48 |
RGS10,LTC4S,TREM2,RGL3,APOC1,ADAP2,APOE,APOC2 |
2.047e-02 | -3.89 | negative regulation of macrophage differentiation | biological process | GO:0045650 | 8 | 1 | 18204 | 47 |
C1QC |
2.047e-02 | -3.89 | positive regulation of triglyceride catabolic process | biological process | GO:0010898 | 8 | 1 | 18204 | 47 |
APOC2 |
2.047e-02 | -3.89 | positive regulation of natural killer cell differentiation | biological process | GO:0032825 | 8 | 1 | 18204 | 47 |
AXL |
2.047e-02 | -3.89 | positive regulation of CoA-transferase activity | biological process | GO:1905920 | 8 | 1 | 18204 | 47 |
APOE |
2.047e-02 | -3.89 | pericardium morphogenesis | biological process | GO:0003344 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | cellular response to interferon-alpha | biological process | GO:0035457 | 8 | 1 | 18204 | 47 |
AXL |
2.047e-02 | -3.89 | positive regulation of neuron projection arborization | biological process | GO:0150012 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | positive regulation of triglyceride lipase activity | biological process | GO:0061365 | 8 | 1 | 18204 | 47 |
APOC2 |
2.047e-02 | -3.89 | positive regulation of apoptotic cell clearance | biological process | GO:2000427 | 8 | 1 | 18204 | 47 |
TREM2 |
2.047e-02 | -3.89 | cellular response to macrophage colony-stimulating factor stimulus | biological process | GO:0036006 | 8 | 1 | 18204 | 47 |
CSF1R |
2.047e-02 | -3.89 | macrophage derived foam cell differentiation | biological process | GO:0010742 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | G protein-coupled adenosine receptor signaling pathway | biological process | GO:0001973 | 8 | 1 | 18204 | 47 |
ADORA3 |
2.047e-02 | -3.89 | diterpenoid biosynthetic process | biological process | GO:0016102 | 8 | 1 | 18204 | 47 |
DHRS9 |
2.047e-02 | -3.89 | amyloid-beta clearance by cellular catabolic process | biological process | GO:0150094 | 8 | 1 | 18204 | 47 |
TREM2 |
2.047e-02 | -3.89 | regulation of microglial cell migration | biological process | GO:1904139 | 8 | 1 | 18204 | 47 |
TREM2 |
2.047e-02 | -3.89 | protein import | biological process | GO:0017038 | 8 | 1 | 18204 | 47 |
APOE |
2.047e-02 | -3.89 | hindgut development | biological process | GO:0061525 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | positive regulation of fear response | biological process | GO:1903367 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | regulation of skeletal muscle tissue regeneration | biological process | GO:0043416 | 8 | 1 | 18204 | 47 |
PPARD |
2.047e-02 | -3.89 | regulation of Cdc42 protein signal transduction | biological process | GO:0032489 | 8 | 1 | 18204 | 47 |
APOE |
2.047e-02 | -3.89 | negative regulation of synapse assembly | biological process | GO:0051964 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | oocyte axis specification | biological process | GO:0007309 | 8 | 1 | 18204 | 47 |
WDR77 |
2.047e-02 | -3.89 | regulation of astrocyte activation | biological process | GO:0061888 | 8 | 1 | 18204 | 47 |
TREM2 |
2.047e-02 | -3.89 | lateral sprouting from an epithelium | biological process | GO:0060601 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | negative regulation of T-helper 1 type immune response | biological process | GO:0002826 | 8 | 1 | 18204 | 47 |
HAVCR2 |
2.047e-02 | -3.89 | regulation of germinal center formation | biological process | GO:0002634 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | olfactory bulb interneuron development | biological process | GO:0021891 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | negative regulation of p38MAPK cascade | biological process | GO:1903753 | 8 | 1 | 18204 | 47 |
TREM2 |
2.047e-02 | -3.89 | negative regulation of granulocyte differentiation | biological process | GO:0030853 | 8 | 1 | 18204 | 47 |
C1QC |
2.047e-02 | -3.89 | oocyte construction | biological process | GO:0007308 | 8 | 1 | 18204 | 47 |
WDR77 |
2.047e-02 | -3.89 | negative regulation of morphogenesis of an epithelium | biological process | GO:1905331 | 8 | 1 | 18204 | 47 |
WNT5A |
2.047e-02 | -3.89 | G protein-coupled purinergic receptor signaling pathway | biological process | GO:0035588 | 8 | 1 | 18204 | 47 |
ADORA3 |
2.047e-02 | -3.89 | cardiac ventricle formation | biological process | GO:0003211 | 8 | 1 | 18204 | 47 |
MEF2C |
2.047e-02 | -3.89 | notochord morphogenesis | biological process | GO:0048570 | 8 | 1 | 18204 | 47 |
WNT5A |
2.063e-02 | -3.88 | COL14A1 (collagen type XIV alpha 1 chain) | protein interactions | 7373 | 86 | 2 | 19454 | 50 |
C1QC,PDGFA |
2.078e-02 | -3.87 | regulation of potassium ion transmembrane transport | biological process | GO:1901379 | 86 | 2 | 18204 | 47 |
KCNMB1,TREM2 |
2.078e-02 | -3.87 | forebrain development | biological process | GO:0030900 | 408 | 4 | 18204 | 47 |
CXCL12,CSF1R,AXL,WNT5A |
2.087e-02 | -3.87 | biological regulation | biological process | GO:0065007 | 12501 | 39 | 18204 | 47 |
COL18A1,RGL3,APOC1,C3AR1,BHLHE41,CH25H,C1QA,SIGLEC8,C1QB,KCNMB1,ITM2B,CSF2RA,PDGFA,WNT5A,PPARD,C1QC,APOE,WDR77,TSPAN15,AXL,SPP1,CXCL12,DHRS9,USP53,P2RY13,HAVCR2,CD68,ALPK1,ADAP2,ADORA3,MEF2C,GPR34,TREM2,CSF1R,ABCB4,APOC2,EPB41L2,RGS10,FOLR2 |
2.095e-02 | -3.87 | regionalization | biological process | GO:0003002 | 409 | 4 | 18204 | 47 |
BHLHE41,C1QA,MEF2C,WNT5A |
2.103e-02 | -3.86 | phosphatidylcholine floppase activity | molecular function | GO:0090554 | 8 | 1 | 18094 | 48 |
ABCB4 |
2.103e-02 | -3.86 | PH domain binding | molecular function | GO:0042731 | 8 | 1 | 18094 | 48 |
EPB41L2 |
2.103e-02 | -3.86 | androsterone dehydrogenase activity | molecular function | GO:0047023 | 8 | 1 | 18094 | 48 |
DHRS9 |
2.103e-02 | -3.86 | testosterone dehydrogenase (NAD+) activity | molecular function | GO:0047035 | 8 | 1 | 18094 | 48 |
DHRS9 |
2.106e-02 | -3.86 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 6 | 14470 | 44 |
HAVCR2,AXL,CSF1R,SIGLEC8,CSF2RA,TREM2 |
2.107e-02 | -3.86 | PDGF_1 | prosite domains | PS00249 | 7 | 1 | 12186 | 37 |
PDGFA |
2.108e-02 | -3.86 | MICA (MHC class I polypeptide-related sequence A) | protein interactions | 100507436 | 87 | 2 | 19454 | 50 |
ITM2B,ADAP2 |
2.117e-02 | -3.86 | positive regulation of phosphorylation | biological process | GO:0042327 | 619 | 5 | 18204 | 47 |
PDGFA,WNT5A,CSF1R,TREM2,AXL |
2.124e-02 | -3.85 | modulation by host of symbiont process | biological process | GO:0051851 | 87 | 2 | 18204 | 47 |
CSF1R,APOE |
2.127e-02 | -3.85 | epithelium development | biological process | GO:0060429 | 1094 | 7 | 18204 | 47 |
MEF2C,CSF1R,WDR77,COL18A1,DHRS9,WNT5A,PDGFA |
2.130e-02 | -3.85 | regulation of cell differentiation | biological process | GO:0045595 | 1622 | 9 | 18204 | 47 |
WNT5A,TREM2,PPARD,C1QC,BHLHE41,MEF2C,AXL,CXCL12,SPP1 |
2.139e-02 | -3.84 | antioxidant activity | molecular function | GO:0016209 | 85 | 2 | 18094 | 48 |
APOE,LTC4S |
2.140e-02 | -3.84 | Folate_rcpt-like | interpro domains | IPR018143 | 8 | 1 | 18521 | 50 |
FOLR2 |
2.140e-02 | -3.84 | Tyr_kinase_rcpt_3_CS | interpro domains | IPR001824 | 8 | 1 | 18521 | 50 |
CSF1R |
2.140e-02 | -3.84 | TypeI_recpt_CBD | interpro domains | IPR015321 | 8 | 1 | 18521 | 50 |
CSF2RA |
2.153e-02 | -3.84 | Ig_sub | interpro domains | IPR003599 | 394 | 4 | 18521 | 50 |
CSF1R,AXL,HAVCR2,SIGLEC8 |
2.169e-02 | -3.83 | regulation of tissue remodeling | biological process | GO:0034103 | 88 | 2 | 18204 | 47 |
CSF1R,SPP1 |
2.171e-02 | -3.83 | cellular response to nutrient levels | biological process | GO:0031669 | 231 | 3 | 18204 | 47 |
PPARD,FOLR2,CD68 |
2.171e-02 | -3.83 | calcium ion homeostasis | biological process | GO:0055074 | 231 | 3 | 18204 | 47 |
CXCL12,APOE,WNT5A |
2.194e-02 | -3.82 | cell motility | biological process | GO:0048870 | 1101 | 7 | 18204 | 47 |
CH25H,AXL,MEF2C,FOLR2,CXCL12,WNT5A,PPARD |
2.196e-02 | -3.82 | connective tissue development | biological process | GO:0061448 | 232 | 3 | 18204 | 47 |
PPARD,WNT5A,MEF2C |
2.203e-02 | -3.82 | TyrKc | smart domains | SM00219 | 80 | 2 | 9717 | 28 |
AXL,CSF1R |
2.216e-02 | -3.81 | positive regulation of lipid biosynthetic process | biological process | GO:0046889 | 89 | 2 | 18204 | 47 |
APOE,APOC2 |
2.226e-02 | -3.80 | IL6Ra-bind | pfam domains | PF09240 | 8 | 1 | 17795 | 50 |
CSF2RA |
2.226e-02 | -3.80 | Folate_rec | pfam domains | PF03024 | 8 | 1 | 17795 | 50 |
FOLR2 |
2.240e-02 | -3.80 | neuron development | biological process | GO:0048666 | 859 | 6 | 18204 | 47 |
APOE,WNT5A,CXCL12,MEF2C,C1QA,CSF1R |
2.248e-02 | -3.79 | blood circulation | biological process | GO:0008015 | 418 | 4 | 18204 | 47 |
C3AR1,CXCL12,APOE,KCNMB1 |
2.254e-02 | -3.79 | Synthesis of Lipoxins (LX) | REACTOME pathways | R-HSA-2142700 | 6 | 1 | 10285 | 39 |
LTC4S |
2.262e-02 | -3.79 | regulation of animal organ morphogenesis | biological process | GO:2000027 | 90 | 2 | 18204 | 47 |
WNT5A,PDGFA |
2.272e-02 | -3.78 | human chr4p15.33 | chromosome location | human chr4p15.33 | 12 | 1 | 26134 | 50 |
HS3ST1 |
2.276e-02 | -3.78 | MADSDOMAIN | prints domains | PR00404 | 5 | 1 | 5227 | 24 |
MEF2C |
2.282e-02 | -3.78 | monocarboxylic acid binding | molecular function | GO:0033293 | 88 | 2 | 18094 | 48 |
PPARD,APOC1 |
2.283e-02 | -3.78 | PDGF | smart domains | SM00141 | 8 | 1 | 9717 | 28 |
PDGFA |
2.285e-02 | -3.78 | spectrin | cellular component | GO:0008091 | 9 | 1 | 19108 | 49 |
EPB41L2 |
2.285e-02 | -3.78 | regulation of cytokine production | biological process | GO:0001817 | 863 | 6 | 18204 | 47 |
C3AR1,HAVCR2,WNT5A,CSF1R,TREM2,AXL |
2.290e-02 | -3.78 | GNRHR (gonadotropin releasing hormone receptor) | protein interactions | 2798 | 9 | 1 | 19454 | 50 |
RGS10 |
2.290e-02 | -3.78 | Prmt5 (protein arginine N-methyltransferase 5) | protein interactions | 27374 | 9 | 1 | 19454 | 50 |
WDR77 |
2.290e-02 | -3.78 | Hnrnph1 (heterogeneous nuclear ribonucleoprotein H1) | protein interactions | 59013 | 9 | 1 | 19454 | 50 |
WDR77 |
2.290e-02 | -3.78 | ALPK1 (alpha kinase 1) | protein interactions | 80216 | 9 | 1 | 19454 | 50 |
ALPK1 |
2.290e-02 | -3.78 | IFI27 (interferon alpha inducible protein 27) | protein interactions | 3429 | 9 | 1 | 19454 | 50 |
APOC2 |
2.290e-02 | -3.78 | LINC02582 (long intergenic non-protein coding RNA 2582) | protein interactions | 100505817 | 9 | 1 | 19454 | 50 |
APOE |
2.290e-02 | -3.78 | CACNA2D3 (calcium voltage-gated channel auxiliary subunit alpha2delta 3) | protein interactions | 55799 | 9 | 1 | 19454 | 50 |
APOE |
2.290e-02 | -3.78 | RDH8 (retinol dehydrogenase 8) | protein interactions | 50700 | 9 | 1 | 19454 | 50 |
PDGFA |
2.293e-02 | -3.78 | cytoplasmic vesicle | cellular component | GO:0031410 | 2521 | 12 | 19108 | 49 |
TSPAN15,RNASET2,C3AR1,APOE,PDGFA,CD68,WNT5A,ABCB4,APOC2,HAVCR2,OSBPL1A,ITM2B |
2.295e-02 | -3.77 | regulation of endothelial cell migration | biological process | GO:0010594 | 236 | 3 | 18204 | 47 |
WNT5A,MEF2C,APOE |
2.300e-02 | -3.77 | foam cell differentiation | biological process | GO:0090077 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | regulation of hair follicle maturation | biological process | GO:0048819 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | negative regulation of axon extension involved in axon guidance | biological process | GO:0048843 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | sterol catabolic process | biological process | GO:0016127 | 9 | 1 | 18204 | 47 |
APOE |
2.300e-02 | -3.77 | negative regulation of cellular extravasation | biological process | GO:0002692 | 9 | 1 | 18204 | 47 |
CXCL12 |
2.300e-02 | -3.77 | regulation of complement activation, classical pathway | biological process | GO:0030450 | 9 | 1 | 18204 | 47 |
TREM2 |
2.300e-02 | -3.77 | regulation of protein localization to cell cortex | biological process | GO:1904776 | 9 | 1 | 18204 | 47 |
EPB41L2 |
2.300e-02 | -3.77 | epithelial cell proliferation involved in prostate gland development | biological process | GO:0060767 | 9 | 1 | 18204 | 47 |
WDR77 |
2.300e-02 | -3.77 | positive regulation of antigen processing and presentation | biological process | GO:0002579 | 9 | 1 | 18204 | 47 |
TREM2 |
2.300e-02 | -3.77 | positive regulation of protein kinase C signaling | biological process | GO:0090037 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | negative regulation of antigen processing and presentation | biological process | GO:0002578 | 9 | 1 | 18204 | 47 |
CD68 |
2.300e-02 | -3.77 | regulation of branching involved in salivary gland morphogenesis | biological process | GO:0060693 | 9 | 1 | 18204 | 47 |
PDGFA |
2.300e-02 | -3.77 | cholesterol catabolic process | biological process | GO:0006707 | 9 | 1 | 18204 | 47 |
APOE |
2.300e-02 | -3.77 | positive regulation of myeloid cell apoptotic process | biological process | GO:0033034 | 9 | 1 | 18204 | 47 |
MEF2C |
2.300e-02 | -3.77 | toll-like receptor 9 signaling pathway | biological process | GO:0034162 | 9 | 1 | 18204 | 47 |
HAVCR2 |
2.300e-02 | -3.77 | mesenchymal-epithelial cell signaling | biological process | GO:0060638 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | glomerulus morphogenesis | biological process | GO:0072102 | 9 | 1 | 18204 | 47 |
MEF2C |
2.300e-02 | -3.77 | positive regulation of hematopoietic stem cell proliferation | biological process | GO:1902035 | 9 | 1 | 18204 | 47 |
WNT5A |
2.300e-02 | -3.77 | respiratory burst involved in defense response | biological process | GO:0002679 | 9 | 1 | 18204 | 47 |
TREM2 |
2.300e-02 | -3.77 | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | biological process | GO:0002858 | 9 | 1 | 18204 | 47 |
HAVCR2 |
2.309e-02 | -3.77 | regulation of fibroblast proliferation | biological process | GO:0048145 | 91 | 2 | 18204 | 47 |
WNT5A,PDGFA |
2.309e-02 | -3.77 | cellular oxidant detoxification | biological process | GO:0098869 | 91 | 2 | 18204 | 47 |
LTC4S,APOE |
2.309e-02 | -3.77 | regulation of smooth muscle cell migration | biological process | GO:0014910 | 91 | 2 | 18204 | 47 |
MEF2C,PDGFA |
2.320e-02 | -3.76 | epithelial cell differentiation | biological process | GO:0030855 | 634 | 5 | 18204 | 47 |
WDR77,COL18A1,DHRS9,WNT5A,MEF2C |
2.320e-02 | -3.76 | anatomical structure maturation | biological process | GO:0071695 | 237 | 3 | 18204 | 47 |
WDR77,AXL,C1QA |
2.332e-02 | -3.76 | intracellular vesicle | cellular component | GO:0097708 | 2527 | 12 | 19108 | 49 |
C3AR1,TSPAN15,RNASET2,CD68,PDGFA,APOE,WNT5A,APOC2,ABCB4,HAVCR2,ITM2B,OSBPL1A |
2.339e-02 | -3.76 | COL18A1 (collagen type XVIII alpha 1 chain) | protein interactions | 80781 | 92 | 2 | 19454 | 50 |
C1QB,C1QC |
2.348e-02 | -3.75 | RANBP9 (RAN binding protein 9) | protein interactions | 10048 | 425 | 4 | 19454 | 50 |
AXL,PPARD,SPP1,ADAP2 |
2.353e-02 | -3.75 | haematopoietic_and_lymphoid_tissue-other-normal | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-other-normal | 8 | 1 | 16828 | 50 |
CSF1R |
2.353e-02 | -3.75 | GPCRs, Class A Rhodopsin-like | WikiPathways | WP455 | 259 | 4 | 5310 | 23 |
ADORA3,P2RY13,C3AR1,GPR34 |
2.357e-02 | -3.75 | cellular response to chemokine | biological process | GO:1990869 | 92 | 2 | 18204 | 47 |
TREM2,CXCL12 |
2.357e-02 | -3.75 | response to chemokine | biological process | GO:1990868 | 92 | 2 | 18204 | 47 |
CXCL12,TREM2 |
2.363e-02 | -3.75 | androstan-3-alpha,17-beta-diol dehydrogenase activity | molecular function | GO:0047044 | 9 | 1 | 18094 | 48 |
DHRS9 |
2.372e-02 | -3.74 | regulation of hemopoiesis | biological process | GO:1903706 | 425 | 4 | 18204 | 47 |
TREM2,MEF2C,AXL,C1QC |
2.376e-02 | -3.74 | clathrin-coated endocytic vesicle | cellular component | GO:0045334 | 93 | 2 | 19108 | 49 |
APOE,WNT5A |
2.376e-02 | -3.74 | Schaffer collateral - CA1 synapse | cellular component | GO:0098685 | 93 | 2 | 19108 | 49 |
ADORA3,WNT5A |
2.380e-02 | -3.74 | alcohol binding | molecular function | GO:0043178 | 90 | 2 | 18094 | 48 |
ADAP2,OSBPL1A |
2.387e-02 | -3.74 | MAIP1 (matrix AAA peptidase interacting protein 1) | protein interactions | 79568 | 93 | 2 | 19454 | 50 |
APOC2,APOC1 |
2.387e-02 | -3.74 | ADAM10 (ADAM metallopeptidase domain 10) | protein interactions | 102 | 93 | 2 | 19454 | 50 |
AXL,TSPAN15 |
2.404e-02 | -3.73 | RECEPTOR_TYR_KIN_III | prosite domains | PS00240 | 8 | 1 | 12186 | 37 |
CSF1R |
2.404e-02 | -3.73 | PDGF/VEGF_dom | interpro domains | IPR000072 | 9 | 1 | 18521 | 50 |
PDGFA |
2.404e-02 | -3.73 | BRICHOS_dom | interpro domains | IPR007084 | 9 | 1 | 18521 | 50 |
ITM2B |
2.405e-02 | -3.73 | fatty acid transport | biological process | GO:0015908 | 93 | 2 | 18204 | 47 |
PPARD,APOE |
2.405e-02 | -3.73 | positive regulation of cellular component organization | biological process | GO:0051130 | 1122 | 7 | 18204 | 47 |
TREM2,WNT5A,APOE,AXL,ABCB4,CXCL12,APOC2 |
2.417e-02 | -3.72 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 8 | 18204 | 47 |
MEF2C,AXL,CXCL12,WNT5A,TREM2,PPARD,C3AR1,APOE |
2.427e-02 | -3.72 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 47 |
CSF1R,AXL,PDGFA,WNT5A |
2.427e-02 | -3.72 | regulation of inflammatory response | biological process | GO:0050727 | 428 | 4 | 18204 | 47 |
TREM2,WNT5A,APOE,PPARD |
2.435e-02 | -3.72 | NDUFB3 (NADH:ubiquinone oxidoreductase subunit B3) | protein interactions | 4709 | 94 | 2 | 19454 | 50 |
GPR34,C3AR1 |
2.438e-02 | -3.71 | postsynapse | cellular component | GO:0098794 | 646 | 5 | 19108 | 49 |
C1QC,C1QB,MEF2C,WNT5A,C1QA |
2.438e-02 | -3.71 | BAG6 (BAG cochaperone 6) | protein interactions | 7917 | 430 | 4 | 19454 | 50 |
HAVCR2,AXL,SPP1,C1QA |
2.453e-02 | -3.71 | positive regulation of neuron differentiation | biological process | GO:0045666 | 94 | 2 | 18204 | 47 |
MEF2C,CXCL12 |
2.456e-02 | -3.71 | TUBB3 (tubulin beta 3 class III) | protein interactions | 10381 | 431 | 4 | 19454 | 50 |
PPARD,C1QA,WDR77,EPB41L2 |
2.500e-02 | -3.69 | cGMP-PKG signaling pathway | KEGG pathways | hsa04022 | 163 | 3 | 7161 | 28 |
MEF2C,ADORA3,KCNMB1 |
2.500e-02 | -3.69 | cGMP-PKG signaling pathway | KEGG pathways | ko04022 | 163 | 3 | 7161 | 28 |
MEF2C,KCNMB1,ADORA3 |
2.501e-02 | -3.69 | BRICHOS | pfam domains | PF04089 | 9 | 1 | 17795 | 50 |
ITM2B |
2.501e-02 | -3.69 | PDGF | pfam domains | PF00341 | 9 | 1 | 17795 | 50 |
PDGFA |
2.502e-02 | -3.69 | regulation of neuron apoptotic process | biological process | GO:0043523 | 244 | 3 | 18204 | 47 |
TREM2,MEF2C,AXL |
2.518e-02 | -3.68 | cytokine activity | molecular function | GO:0005125 | 238 | 3 | 18094 | 48 |
SPP1,CXCL12,WNT5A |
2.523e-02 | -3.68 | IG | smart domains | SM00409 | 394 | 4 | 9717 | 28 |
AXL,HAVCR2,SIGLEC8,CSF1R |
2.536e-02 | -3.67 | tetraspanin-enriched microdomain | cellular component | GO:0097197 | 10 | 1 | 19108 | 49 |
TSPAN15 |
2.541e-02 | -3.67 | ST8SIA2 (ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2) | protein interactions | 8128 | 10 | 1 | 19454 | 50 |
HS3ST1 |
2.541e-02 | -3.67 | C1RL (complement C1r subcomponent like) | protein interactions | 51279 | 10 | 1 | 19454 | 50 |
SPP1 |
2.541e-02 | -3.67 | TMEM204 (transmembrane protein 204) | protein interactions | 79652 | 10 | 1 | 19454 | 50 |
AXL |
2.541e-02 | -3.67 | TNP1 (transition protein 1) | protein interactions | 7141 | 10 | 1 | 19454 | 50 |
PPARD |
2.541e-02 | -3.67 | C1S (complement C1s) | protein interactions | 716 | 10 | 1 | 19454 | 50 |
C1QA |
2.541e-02 | -3.67 | HMCN1 (hemicentin 1) | protein interactions | 83872 | 10 | 1 | 19454 | 50 |
WDR77 |
2.541e-02 | -3.67 | DSCR4 (Down syndrome critical region 4) | protein interactions | 10281 | 10 | 1 | 19454 | 50 |
APOC2 |
2.551e-02 | -3.67 | negative regulation of developmental growth | biological process | GO:0048640 | 96 | 2 | 18204 | 47 |
WNT5A,SPP1 |
2.553e-02 | -3.67 | nitric oxide-cGMP-mediated signaling | biological process | GO:0038060 | 10 | 1 | 18204 | 47 |
APOE |
2.553e-02 | -3.67 | germinal center formation | biological process | GO:0002467 | 10 | 1 | 18204 | 47 |
MEF2C |
2.553e-02 | -3.67 | prostate glandular acinus development | biological process | GO:0060525 | 10 | 1 | 18204 | 47 |
WDR77 |
2.553e-02 | -3.67 | regulation of natural killer cell mediated immune response to tumor cell | biological process | GO:0002855 | 10 | 1 | 18204 | 47 |
HAVCR2 |
2.553e-02 | -3.67 | negative regulation of cholesterol biosynthetic process | biological process | GO:0045541 | 10 | 1 | 18204 | 47 |
APOE |
2.553e-02 | -3.67 | regulation of apoptotic cell clearance | biological process | GO:2000425 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | regulation of phosphatidylcholine metabolic process | biological process | GO:0150172 | 10 | 1 | 18204 | 47 |
APOC1 |
2.553e-02 | -3.67 | positive regulation of microglial cell activation | biological process | GO:1903980 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | planar cell polarity pathway involved in neural tube closure | biological process | GO:0090179 | 10 | 1 | 18204 | 47 |
WNT5A |
2.553e-02 | -3.67 | cellular response to lipoteichoic acid | biological process | GO:0071223 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | regulation of resting membrane potential | biological process | GO:0060075 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | negative regulation of sterol biosynthetic process | biological process | GO:0106119 | 10 | 1 | 18204 | 47 |
APOE |
2.553e-02 | -3.67 | negative regulation of natural killer cell activation | biological process | GO:0032815 | 10 | 1 | 18204 | 47 |
HAVCR2 |
2.553e-02 | -3.67 | high-density lipoprotein particle assembly | biological process | GO:0034380 | 10 | 1 | 18204 | 47 |
APOE |
2.553e-02 | -3.67 | paraxial mesoderm morphogenesis | biological process | GO:0048340 | 10 | 1 | 18204 | 47 |
WNT5A |
2.553e-02 | -3.67 | response to folic acid | biological process | GO:0051593 | 10 | 1 | 18204 | 47 |
FOLR2 |
2.553e-02 | -3.67 | integrin activation | biological process | GO:0033622 | 10 | 1 | 18204 | 47 |
CXCL12 |
2.553e-02 | -3.67 | positive regulation of ATP biosynthetic process | biological process | GO:2001171 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | development of secondary sexual characteristics | biological process | GO:0045136 | 10 | 1 | 18204 | 47 |
WNT5A |
2.553e-02 | -3.67 | cellular response to testosterone stimulus | biological process | GO:0071394 | 10 | 1 | 18204 | 47 |
SPP1 |
2.553e-02 | -3.67 | negative regulation of glial cell apoptotic process | biological process | GO:0034351 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | regulation of CoA-transferase activity | biological process | GO:1905918 | 10 | 1 | 18204 | 47 |
APOE |
2.553e-02 | -3.67 | regulation of postsynaptic cytosolic calcium ion concentration | biological process | GO:0099566 | 10 | 1 | 18204 | 47 |
WNT5A |
2.553e-02 | -3.67 | folic acid transport | biological process | GO:0015884 | 10 | 1 | 18204 | 47 |
FOLR2 |
2.553e-02 | -3.67 | endothelial cell morphogenesis | biological process | GO:0001886 | 10 | 1 | 18204 | 47 |
COL18A1 |
2.553e-02 | -3.67 | cellular response to parathyroid hormone stimulus | biological process | GO:0071374 | 10 | 1 | 18204 | 47 |
MEF2C |
2.553e-02 | -3.67 | response to lipoteichoic acid | biological process | GO:0070391 | 10 | 1 | 18204 | 47 |
TREM2 |
2.553e-02 | -3.67 | regulation of epithelial cell proliferation involved in prostate gland development | biological process | GO:0060768 | 10 | 1 | 18204 | 47 |
WDR77 |
2.565e-02 | -3.66 | BRICHOS | smart domains | SM01039 | 9 | 1 | 9717 | 28 |
ITM2B |
2.565e-02 | -3.66 | ORANGE | smart domains | SM00511 | 9 | 1 | 9717 | 28 |
BHLHE41 |
2.579e-02 | -3.66 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 8 | 18204 | 47 |
WNT5A,TREM2,PPARD,CD68,MEF2C,SPP1,FOLR2,CXCL12 |
2.581e-02 | -3.66 | GSDMA (gasdermin A) | protein interactions | 284110 | 97 | 2 | 19454 | 50 |
APOC2,APOC1 |
2.581e-02 | -3.66 | ATP13A2 (ATPase cation transporting 13A2) | protein interactions | 23400 | 97 | 2 | 19454 | 50 |
HAVCR2,TSPAN15 |
2.600e-02 | -3.65 | leukocyte homeostasis | biological process | GO:0001776 | 97 | 2 | 18204 | 47 |
AXL,MEF2C |
2.600e-02 | -3.65 | acylglycerol metabolic process | biological process | GO:0006639 | 97 | 2 | 18204 | 47 |
APOE,APOC1 |
2.622e-02 | -3.64 | minor groove of adenine-thymine-rich DNA binding | molecular function | GO:0003680 | 10 | 1 | 18094 | 48 |
MEF2C |
2.646e-02 | -3.63 | human chr7q21.12 | chromosome location | human chr7q21.12 | 14 | 1 | 26134 | 50 |
ABCB4 |
2.650e-02 | -3.63 | regulation of striated muscle cell differentiation | biological process | GO:0051153 | 98 | 2 | 18204 | 47 |
MEF2C,BHLHE41 |
2.650e-02 | -3.63 | neutral lipid metabolic process | biological process | GO:0006638 | 98 | 2 | 18204 | 47 |
APOC1,APOE |
2.671e-02 | -3.62 | organic cyclic compound catabolic process | biological process | GO:1901361 | 441 | 4 | 18204 | 47 |
RNASET2,RNASEH1,APOE,SPP1 |
2.680e-02 | -3.62 | TLCD4 (TLC domain containing 4) | protein interactions | 148534 | 99 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
2.701e-02 | -3.61 | axis specification | biological process | GO:0009798 | 99 | 2 | 18204 | 47 |
WNT5A,WDR77 |
2.701e-02 | -3.61 | BRICHOS | prosite domains | PS50869 | 9 | 1 | 12186 | 37 |
ITM2B |
2.701e-02 | -3.61 | PDGF_2 | prosite domains | PS50278 | 9 | 1 | 12186 | 37 |
PDGFA |
2.704e-02 | -3.61 | - | gene3d domains | 6.10.250.980 | 9 | 1 | 14470 | 44 |
BHLHE41 |
2.710e-02 | -3.61 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 4 | 18204 | 47 |
WNT5A,CXCL12,SPP1,APOE |
2.710e-02 | -3.61 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 4 | 18204 | 47 |
WNT5A,CSF1R,MEF2C,CXCL12 |
2.718e-02 | -3.61 | GPCR ligand binding | REACTOME pathways | R-HSA-500792 | 453 | 5 | 10285 | 39 |
P2RY13,CXCL12,C3AR1,WNT5A,ADORA3 |
2.719e-02 | -3.60 | Tyr_kinase_AS | interpro domains | IPR008266 | 95 | 2 | 18521 | 50 |
AXL,CSF1R |
2.727e-02 | -3.60 | Integrin cell surface interactions | REACTOME pathways | R-HSA-216083 | 68 | 2 | 10285 | 39 |
SPP1,COL18A1 |
2.731e-02 | -3.60 | SYNE4 (spectrin repeat containing nuclear envelope family member 4) | protein interactions | 163183 | 100 | 2 | 19454 | 50 |
ITM2B,TSPAN15 |
2.779e-02 | -3.58 | tube development | biological process | GO:0035295 | 903 | 6 | 18204 | 47 |
APOE,CSF1R,MEF2C,PDGFA,WNT5A,COL18A1 |
2.781e-02 | -3.58 | FAM241A (family with sequence similarity 241 member A) | protein interactions | 132720 | 101 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
2.781e-02 | -3.58 | TMEM11 (transmembrane protein 11) | protein interactions | 8834 | 101 | 2 | 19454 | 50 |
RNASEH1,ADORA3 |
2.786e-02 | -3.58 | Metabolism of vitamins and cofactors | REACTOME pathways | R-HSA-196854 | 174 | 3 | 10285 | 39 |
APOE,APOC2,FOLR2 |
2.792e-02 | -3.58 | NUDT2 (nudix hydrolase 2) | protein interactions | 318 | 11 | 1 | 19454 | 50 |
ANKRD22 |
2.792e-02 | -3.58 | TMEM168 (transmembrane protein 168) | protein interactions | 64418 | 11 | 1 | 19454 | 50 |
SPP1 |
2.792e-02 | -3.58 | MEF2B (myocyte enhancer factor 2B) | protein interactions | 100271849 | 11 | 1 | 19454 | 50 |
MEF2C |
2.792e-02 | -3.58 | FAM200A (family with sequence similarity 200 member A) | protein interactions | 221786 | 11 | 1 | 19454 | 50 |
RGL3 |
2.792e-02 | -3.58 | ALOX5AP (arachidonate 5-lipoxygenase activating protein) | protein interactions | 241 | 11 | 1 | 19454 | 50 |
LTC4S |
2.792e-02 | -3.58 | C2orf50 (chromosome 2 open reading frame 50) | protein interactions | 130813 | 11 | 1 | 19454 | 50 |
SPP1 |
2.794e-02 | -3.58 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 47 |
TREM2,WNT5A,APOE,CXCL12,SPP1 |
2.799e-02 | -3.58 | generation of neurons | biological process | GO:0048699 | 1158 | 7 | 18204 | 47 |
WNT5A,APOE,MEF2C,C1QA,AXL,CSF1R,CXCL12 |
2.802e-02 | -3.57 | negative regulation of endothelial cell migration | biological process | GO:0010596 | 101 | 2 | 18204 | 47 |
APOE,MEF2C |
2.802e-02 | -3.57 | cholesterol homeostasis | biological process | GO:0042632 | 101 | 2 | 18204 | 47 |
APOE,APOC2 |
2.802e-02 | -3.57 | regulation of potassium ion transport | biological process | GO:0043266 | 101 | 2 | 18204 | 47 |
TREM2,KCNMB1 |
2.804e-02 | -3.57 | neuron projection extension involved in neuron projection guidance | biological process | GO:1902284 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | thymocyte apoptotic process | biological process | GO:0070242 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | positive regulation of voltage-gated potassium channel activity | biological process | GO:1903818 | 11 | 1 | 18204 | 47 |
TREM2 |
2.804e-02 | -3.57 | positive regulation of cardiac muscle cell differentiation | biological process | GO:2000727 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | primitive streak formation | biological process | GO:0090009 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | regulation of macrophage apoptotic process | biological process | GO:2000109 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | negative regulation of collateral sprouting | biological process | GO:0048671 | 11 | 1 | 18204 | 47 |
SPP1 |
2.804e-02 | -3.57 | embryonic camera-type eye formation | biological process | GO:0060900 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | regulation of dendritic cell antigen processing and presentation | biological process | GO:0002604 | 11 | 1 | 18204 | 47 |
CD68 |
2.804e-02 | -3.57 | positive regulation of steroid hormone secretion | biological process | GO:2000833 | 11 | 1 | 18204 | 47 |
SPP1 |
2.804e-02 | -3.57 | negative regulation of synapse organization | biological process | GO:1905809 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | regulation of establishment of planar polarity involved in neural tube closure | biological process | GO:0090178 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | positive regulation of lipoprotein particle clearance | biological process | GO:0010986 | 11 | 1 | 18204 | 47 |
TREM2 |
2.804e-02 | -3.57 | regulation of high-density lipoprotein particle clearance | biological process | GO:0010982 | 11 | 1 | 18204 | 47 |
TREM2 |
2.804e-02 | -3.57 | regulation of receptor catabolic process | biological process | GO:2000644 | 11 | 1 | 18204 | 47 |
APOE |
2.804e-02 | -3.57 | cardiac chamber formation | biological process | GO:0003207 | 11 | 1 | 18204 | 47 |
MEF2C |
2.804e-02 | -3.57 | dendritic spine maintenance | biological process | GO:0097062 | 11 | 1 | 18204 | 47 |
TREM2 |
2.804e-02 | -3.57 | positive regulation of cell-cell adhesion mediated by cadherin | biological process | GO:2000049 | 11 | 1 | 18204 | 47 |
WNT5A |
2.804e-02 | -3.57 | epithelial cell differentiation involved in prostate gland development | biological process | GO:0060742 | 11 | 1 | 18204 | 47 |
WDR77 |
2.804e-02 | -3.57 | axon extension involved in axon guidance | biological process | GO:0048846 | 11 | 1 | 18204 | 47 |
WNT5A |
2.830e-02 | -3.56 | positive regulation of growth | biological process | GO:0045927 | 256 | 3 | 18204 | 47 |
MEF2C,CXCL12,PPARD |
2.830e-02 | -3.56 | positive regulation of protein kinase activity | biological process | GO:0045860 | 256 | 3 | 18204 | 47 |
CSF1R,PDGFA,WNT5A |
2.854e-02 | -3.56 | sterol homeostasis | biological process | GO:0055092 | 102 | 2 | 18204 | 47 |
APOC2,APOE |
2.855e-02 | -3.56 | system development | biological process | GO:0048731 | 3533 | 15 | 18204 | 47 |
ITM2B,WNT5A,PDGFA,TREM2,PPARD,APOE,WDR77,AXL,CSF1R,CXCL12,COL18A1,HAVCR2,ADAP2,MEF2C,C1QA |
2.860e-02 | -3.55 | PLCG1 (phospholipase C gamma 1) | protein interactions | 5335 | 258 | 3 | 19454 | 50 |
PDGFA,EPB41L2,AXL |
2.861e-02 | -3.55 | regulation of signaling | biological process | GO:0023051 | 3534 | 15 | 18204 | 47 |
HAVCR2,ALPK1,ADORA3,MEF2C,PDGFA,WNT5A,TREM2,PPARD,APOE,TSPAN15,AXL,CSF1R,RGS10,SPP1,CXCL12 |
2.880e-02 | -3.55 | complement receptor activity | molecular function | GO:0004875 | 11 | 1 | 18094 | 48 |
C3AR1 |
2.880e-02 | -3.55 | platelet-derived growth factor binding | molecular function | GO:0048407 | 11 | 1 | 18094 | 48 |
PDGFA |
2.880e-02 | -3.55 | testosterone dehydrogenase [NAD(P)] activity | molecular function | GO:0030283 | 11 | 1 | 18094 | 48 |
DHRS9 |
2.884e-02 | -3.55 | KLRG2 (killer cell lectin like receptor G2) | protein interactions | 346689 | 103 | 2 | 19454 | 50 |
WNT5A,HS3ST1 |
2.884e-02 | -3.55 | CERS6 (ceramide synthase 6) | protein interactions | 253782 | 103 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
2.884e-02 | -3.55 | ZDHHC5 (zinc finger DHHC-type palmitoyltransferase 5) | protein interactions | 25921 | 103 | 2 | 19454 | 50 |
AXL,HAVCR2 |
2.894e-02 | -3.54 | Ig-like_dom | interpro domains | IPR007110 | 432 | 4 | 18521 | 50 |
HAVCR2,SIGLEC8,AXL,CSF1R |
2.908e-02 | -3.54 | regulation of cell communication | biological process | GO:0010646 | 3541 | 15 | 18204 | 47 |
ADORA3,MEF2C,ALPK1,HAVCR2,TSPAN15,CSF1R,AXL,CXCL12,SPP1,RGS10,WNT5A,PDGFA,TREM2,PPARD,APOE |
2.926e-02 | -3.53 | negative regulation of apoptotic process | biological process | GO:0043066 | 914 | 6 | 18204 | 47 |
WNT5A,TREM2,CXCL12,CSF1R,MEF2C,AXL |
2.926e-02 | -3.53 | chemical homeostasis | biological process | GO:0048878 | 914 | 6 | 18204 | 47 |
APOC2,CXCL12,APOE,WNT5A,TREM2,ABCB4 |
2.930e-02 | -3.53 | embryonic organ development | biological process | GO:0048568 | 454 | 4 | 18204 | 47 |
COL18A1,PDGFA,WNT5A,MEF2C |
2.931e-02 | -3.53 | NST/OST | interpro domains | IPR037359 | 11 | 1 | 18521 | 50 |
HS3ST1 |
2.931e-02 | -3.53 | Type_1_exporter | interpro domains | IPR039421 | 11 | 1 | 18521 | 50 |
ABCB4 |
2.936e-02 | -3.53 | KLHL12 (kelch like family member 12) | protein interactions | 59349 | 104 | 2 | 19454 | 50 |
KLHL5,RGL3 |
2.946e-02 | -3.52 | LGR4 (leucine rich repeat containing G protein-coupled receptor 4) | protein interactions | 55366 | 261 | 3 | 19454 | 50 |
HS3ST1,HAVCR2,TSPAN15 |
2.954e-02 | -3.52 | Circadian Clock | REACTOME pathways | R-HSA-400253 | 71 | 2 | 10285 | 39 |
MEF2C,BHLHE41 |
2.958e-02 | -3.52 | regulation of steroid metabolic process | biological process | GO:0019218 | 104 | 2 | 18204 | 47 |
CH25H,APOE |
2.958e-02 | -3.52 | epithelial cell migration | biological process | GO:0010631 | 104 | 2 | 18204 | 47 |
PPARD,WNT5A |
2.987e-02 | -3.51 | Lung fibrosis | WikiPathways | WP3624 | 63 | 2 | 5310 | 23 |
PDGFA,SPP1 |
2.995e-02 | -3.51 | Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4) | REACTOME pathways | R-HSA-5688890 | 8 | 1 | 10285 | 39 |
CSF2RA |
2.995e-02 | -3.51 | Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5) | REACTOME pathways | R-HSA-5688849 | 8 | 1 | 10285 | 39 |
CSF2RA |
3.000e-02 | -3.51 | - | gene3d domains | 3.30.70.3490 | 10 | 1 | 14470 | 44 |
OSBPL1A |
3.002e-02 | -3.51 | biological process involved in symbiotic interaction | biological process | GO:0044403 | 262 | 3 | 18204 | 47 |
APOE,CSF1R,AXL |
3.010e-02 | -3.50 | gland morphogenesis | biological process | GO:0022612 | 105 | 2 | 18204 | 47 |
CSF1R,WNT5A |
3.010e-02 | -3.50 | regulation of postsynapse organization | biological process | GO:0099175 | 105 | 2 | 18204 | 47 |
WNT5A,APOE |
3.033e-02 | -3.50 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 47 |
MEF2C,APOE,RGS10,KCNMB1 |
3.036e-02 | -3.49 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 5 | 19454 | 50 |
DCBLD1,RGL3,ITM2B,WDR77,EPB41L2 |
3.042e-02 | -3.49 | SIRPB1 (signal regulatory protein beta 1) | protein interactions | 10326 | 12 | 1 | 19454 | 50 |
APOC1 |
3.042e-02 | -3.49 | RSC1A1 (regulator of solute carriers 1) | protein interactions | 6248 | 12 | 1 | 19454 | 50 |
SPP1 |
3.042e-02 | -3.49 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 50 |
APOE |
3.042e-02 | -3.49 | PORCN (porcupine O-acyltransferase) | protein interactions | 64840 | 12 | 1 | 19454 | 50 |
APOC2 |
3.042e-02 | -3.49 | TM7SF2 (transmembrane 7 superfamily member 2) | protein interactions | 7108 | 12 | 1 | 19454 | 50 |
TSPAN15 |
3.049e-02 | -3.49 | Hairy_orange | pfam domains | PF07527 | 11 | 1 | 17795 | 50 |
BHLHE41 |
3.056e-02 | -3.49 | cellular response to antibiotic | biological process | GO:0071236 | 12 | 1 | 18204 | 47 |
MEF2C |
3.056e-02 | -3.49 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | biological process | GO:0015015 | 12 | 1 | 18204 | 47 |
HS3ST1 |
3.056e-02 | -3.49 | hormone catabolic process | biological process | GO:0042447 | 12 | 1 | 18204 | 47 |
SPP1 |
3.056e-02 | -3.49 | regulation of skeletal muscle satellite cell proliferation | biological process | GO:0014842 | 12 | 1 | 18204 | 47 |
PPARD |
3.056e-02 | -3.49 | negative regulation of transcription by competitive promoter binding | biological process | GO:0010944 | 12 | 1 | 18204 | 47 |
BHLHE41 |
3.056e-02 | -3.49 | regulation of glomerular mesangial cell proliferation | biological process | GO:0072124 | 12 | 1 | 18204 | 47 |
PDGFA |
3.056e-02 | -3.49 | positive regulation of hair follicle development | biological process | GO:0051798 | 12 | 1 | 18204 | 47 |
WNT5A |
3.056e-02 | -3.49 | negative regulation of macrophage cytokine production | biological process | GO:0010936 | 12 | 1 | 18204 | 47 |
AXL |
3.056e-02 | -3.49 | very-low-density lipoprotein particle assembly | biological process | GO:0034379 | 12 | 1 | 18204 | 47 |
APOC1 |
3.056e-02 | -3.49 | regulation of pinocytosis | biological process | GO:0048548 | 12 | 1 | 18204 | 47 |
AXL |
3.056e-02 | -3.49 | regulation of chemokine-mediated signaling pathway | biological process | GO:0070099 | 12 | 1 | 18204 | 47 |
TREM2 |
3.056e-02 | -3.49 | regulation of glial cell apoptotic process | biological process | GO:0034350 | 12 | 1 | 18204 | 47 |
TREM2 |
3.056e-02 | -3.49 | regulation of toll-like receptor 2 signaling pathway | biological process | GO:0034135 | 12 | 1 | 18204 | 47 |
TREM2 |
3.056e-02 | -3.49 | neurotransmitter-gated ion channel clustering | biological process | GO:0072578 | 12 | 1 | 18204 | 47 |
APOE |
3.056e-02 | -3.49 | midgut development | biological process | GO:0007494 | 12 | 1 | 18204 | 47 |
WNT5A |
3.056e-02 | -3.49 | positive regulation of catecholamine secretion | biological process | GO:0033605 | 12 | 1 | 18204 | 47 |
CXCL12 |
3.063e-02 | -3.49 | pigmentation | biological process | GO:0043473 | 106 | 2 | 18204 | 47 |
MEF2C,APOE |
3.070e-02 | -3.48 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 47 |
SPP1,APOE,CXCL12,TREM2,WNT5A |
3.116e-02 | -3.47 | neuron apoptotic process | biological process | GO:0051402 | 107 | 2 | 18204 | 47 |
USP53,AXL |
3.116e-02 | -3.47 | columnar/cuboidal epithelial cell differentiation | biological process | GO:0002065 | 107 | 2 | 18204 | 47 |
WDR77,WNT5A |
3.116e-02 | -3.47 | epithelium migration | biological process | GO:0090132 | 107 | 2 | 18204 | 47 |
PPARD,WNT5A |
3.129e-02 | -3.46 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 23 | 18204 | 47 |
ALPK1,HAVCR2,MEF2C,TREM2,FOLR2,EPB41L2,APOC2,ABCB4,CSF1R,C3AR1,KCNMB1,C1QB,C1QA,APOE,WDR77,C1QC,PPARD,WNT5A,PDGFA,CSF2RA,CXCL12,SPP1,AXL |
3.137e-02 | -3.46 | cell morphogenesis | biological process | GO:0000902 | 687 | 5 | 18204 | 47 |
CXCL12,COL18A1,WNT5A,MEF2C,CSF1R |
3.138e-02 | -3.46 | phospholipase inhibitor activity | molecular function | GO:0004859 | 12 | 1 | 18094 | 48 |
APOC1 |
3.147e-02 | -3.46 | CAMKV (CaM kinase like vesicle associated) | protein interactions | 79012 | 108 | 2 | 19454 | 50 |
COL18A1,EPB41L2 |
3.150e-02 | -3.46 | regulation of protein serine/threonine kinase activity | biological process | GO:0071900 | 267 | 3 | 18204 | 47 |
APOE,WNT5A,PDGFA |
3.154e-02 | -3.46 | hemopoiesis | biological process | GO:0030097 | 688 | 5 | 18204 | 47 |
WNT5A,MEF2C,AXL,TREM2,CSF1R |
3.164e-02 | -3.45 | Endochondral Ossification | WikiPathways | WP474 | 65 | 2 | 5310 | 23 |
MEF2C,SPP1 |
3.170e-02 | -3.45 | tissue remodeling | biological process | GO:0048771 | 108 | 2 | 18204 | 47 |
AXL,MEF2C |
3.182e-02 | -3.45 | Transcriptional misregulation in cancer | KEGG pathways | hsa05202 | 179 | 3 | 7161 | 28 |
CSF1R,PDGFA,MEF2C |
3.182e-02 | -3.45 | Transcriptional misregulation in cancer | KEGG pathways | ko05202 | 179 | 3 | 7161 | 28 |
MEF2C,PDGFA,CSF1R |
3.193e-02 | -3.44 | circulatory system development | biological process | GO:0072359 | 933 | 6 | 18204 | 47 |
MEF2C,PDGFA,WNT5A,ADAP2,COL18A1,APOE |
3.193e-02 | -3.44 | Formyl_rcpt-rel | interpro domains | IPR000826 | 12 | 1 | 18521 | 50 |
C3AR1 |
3.193e-02 | -3.44 | OSBP_sf | interpro domains | IPR037239 | 12 | 1 | 18521 | 50 |
OSBPL1A |
3.193e-02 | -3.44 | Oxysterol-bd | interpro domains | IPR000648 | 12 | 1 | 18521 | 50 |
OSBPL1A |
3.193e-02 | -3.44 | Orange_dom | interpro domains | IPR003650 | 12 | 1 | 18521 | 50 |
BHLHE41 |
3.193e-02 | -3.44 | Oxysterol-bd_CS | interpro domains | IPR018494 | 12 | 1 | 18521 | 50 |
OSBPL1A |
3.221e-02 | -3.44 | bone-calcaneus-chondrosarcoma | COSMIC cancer mutations | bone-calcaneus-chondrosarcoma | 11 | 1 | 16828 | 50 |
ALPK1 |
3.224e-02 | -3.43 | positive regulation of tumor necrosis factor production | biological process | GO:0032760 | 109 | 2 | 18204 | 47 |
HAVCR2,WNT5A |
3.224e-02 | -3.43 | regulation of non-canonical NF-kappaB signal transduction | biological process | GO:1901222 | 109 | 2 | 18204 | 47 |
TREM2,HAVCR2 |
3.247e-02 | -3.43 | regulation of protein kinase activity | biological process | GO:0045859 | 469 | 4 | 18204 | 47 |
APOE,WNT5A,PDGFA,CSF1R |
3.249e-02 | -3.43 | HIF-1-alpha transcription factor network | Pathway Interaction DB | hif1_tfpathway | 65 | 2 | 2226 | 10 |
CXCL12,BHLHE41 |
3.254e-02 | -3.43 | BBS1 (Bardet-Biedl syndrome 1) | protein interactions | 582 | 110 | 2 | 19454 | 50 |
RGS10,HAVCR2 |
3.254e-02 | -3.43 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 2 | 19454 | 50 |
CSF1R,CSF2RA |
3.254e-02 | -3.43 | SPACA1 (sperm acrosome associated 1) | protein interactions | 81833 | 110 | 2 | 19454 | 50 |
ITM2B,TSPAN15 |
3.254e-02 | -3.43 | DKKL1 (dickkopf like acrosomal protein 1) | protein interactions | 27120 | 110 | 2 | 19454 | 50 |
ITM2B,HS3ST1 |
3.271e-02 | -3.42 | carboxylic acid biosynthetic process | biological process | GO:0046394 | 271 | 3 | 18204 | 47 |
OSBPL1A,LTC4S,DHRS9 |
3.278e-02 | -3.42 | positive regulation of endothelial cell proliferation | biological process | GO:0001938 | 110 | 2 | 18204 | 47 |
CXCL12,WNT5A |
3.278e-02 | -3.42 | regulation of interleukin-1 beta production | biological process | GO:0032651 | 110 | 2 | 18204 | 47 |
WNT5A,TREM2 |
3.280e-02 | -3.42 | Class A/1 (Rhodopsin-like receptors) | REACTOME pathways | R-HSA-373076 | 322 | 4 | 10285 | 39 |
P2RY13,CXCL12,C3AR1,ADORA3 |
3.284e-02 | -3.42 | methylosome | cellular component | GO:0034709 | 13 | 1 | 19108 | 49 |
WDR77 |
3.291e-02 | -3.41 | Nfya (nuclear transcription factor-Y alpha) | protein interactions | 18044 | 13 | 1 | 19454 | 50 |
OSBPL1A |
3.291e-02 | -3.41 | TECPR1 (tectonin beta-propeller repeat containing 1) | protein interactions | 25851 | 13 | 1 | 19454 | 50 |
COL18A1 |
3.291e-02 | -3.41 | KCNQ4 (potassium voltage-gated channel subfamily Q member 4) | protein interactions | 9132 | 13 | 1 | 19454 | 50 |
CSF1R |
3.291e-02 | -3.41 | TEX44 (testis expressed 44) | protein interactions | 165100 | 13 | 1 | 19454 | 50 |
APOC1 |
3.291e-02 | -3.41 | CCL20 (C-C motif chemokine ligand 20) | protein interactions | 6364 | 13 | 1 | 19454 | 50 |
CXCL12 |
3.291e-02 | -3.41 | CSF2RA (colony stimulating factor 2 receptor subunit alpha) | protein interactions | 1438 | 13 | 1 | 19454 | 50 |
CSF2RA |
3.291e-02 | -3.41 | ANKH (ANKH inorganic pyrophosphate transport regulator) | protein interactions | 56172 | 13 | 1 | 19454 | 50 |
APOE |
3.291e-02 | -3.41 | PRKG2 (protein kinase cGMP-dependent 2) | protein interactions | 5593 | 13 | 1 | 19454 | 50 |
WDR77 |
3.292e-02 | -3.41 | PROTEIN_KINASE_TYR | prosite domains | PS00109 | 94 | 2 | 12186 | 37 |
AXL,CSF1R |
3.306e-02 | -3.41 | response to peptidoglycan | biological process | GO:0032494 | 13 | 1 | 18204 | 47 |
TREM2 |
3.306e-02 | -3.41 | detection of calcium ion | biological process | GO:0005513 | 13 | 1 | 18204 | 47 |
KCNMB1 |
3.306e-02 | -3.41 | regulation of dendritic spine maintenance | biological process | GO:1902950 | 13 | 1 | 18204 | 47 |
APOE |
3.306e-02 | -3.41 | response to water | biological process | GO:0009415 | 13 | 1 | 18204 | 47 |
COL18A1 |
3.306e-02 | -3.41 | positive regulation of T cell apoptotic process | biological process | GO:0070234 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | positive regulation of phagocytosis, engulfment | biological process | GO:0060100 | 13 | 1 | 18204 | 47 |
TREM2 |
3.306e-02 | -3.41 | regulation of triglyceride catabolic process | biological process | GO:0010896 | 13 | 1 | 18204 | 47 |
APOC2 |
3.306e-02 | -3.41 | olfactory bulb interneuron differentiation | biological process | GO:0021889 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | negative regulation of leukocyte adhesion to vascular endothelial cell | biological process | GO:1904995 | 13 | 1 | 18204 | 47 |
CXCL12 |
3.306e-02 | -3.41 | forebrain morphogenesis | biological process | GO:0048853 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | regulation of natural killer cell differentiation | biological process | GO:0032823 | 13 | 1 | 18204 | 47 |
AXL |
3.306e-02 | -3.41 | positive regulation of glial cell migration | biological process | GO:1903977 | 13 | 1 | 18204 | 47 |
TREM2 |
3.306e-02 | -3.41 | progesterone metabolic process | biological process | GO:0042448 | 13 | 1 | 18204 | 47 |
DHRS9 |
3.306e-02 | -3.41 | regulation of thymocyte apoptotic process | biological process | GO:0070243 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | response to parathyroid hormone | biological process | GO:0071107 | 13 | 1 | 18204 | 47 |
MEF2C |
3.306e-02 | -3.41 | detection of molecule of bacterial origin | biological process | GO:0032490 | 13 | 1 | 18204 | 47 |
TREM2 |
3.306e-02 | -3.41 | regulation of norepinephrine secretion | biological process | GO:0014061 | 13 | 1 | 18204 | 47 |
ADORA3 |
3.306e-02 | -3.41 | midbrain dopaminergic neuron differentiation | biological process | GO:1904948 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | convergent extension | biological process | GO:0060026 | 13 | 1 | 18204 | 47 |
WNT5A |
3.306e-02 | -3.41 | positive regulation of membrane invagination | biological process | GO:1905155 | 13 | 1 | 18204 | 47 |
TREM2 |
3.309e-02 | -3.41 | KIAA2013 (KIAA2013) | protein interactions | 90231 | 111 | 2 | 19454 | 50 |
TSPAN15,GPR34 |
3.309e-02 | -3.41 | TMEM120B (transmembrane protein 120B) | protein interactions | 144404 | 111 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
3.313e-02 | -3.41 | cell projection organization | biological process | GO:0030030 | 1200 | 7 | 18204 | 47 |
APOE,ALPK1,WNT5A,PDGFA,TREM2,CXCL12,CSF1R |
3.321e-02 | -3.40 | Oxysterol_BP | pfam domains | PF01237 | 12 | 1 | 17795 | 50 |
OSBPL1A |
3.363e-02 | -3.39 | Ca2+ activated K+ channels | REACTOME pathways | R-HSA-1296052 | 9 | 1 | 10285 | 39 |
KCNMB1 |
3.363e-02 | -3.39 | Synthesis of 5-eicosatetraenoic acids | REACTOME pathways | R-HSA-2142688 | 9 | 1 | 10285 | 39 |
LTC4S |
3.363e-02 | -3.39 | COPS8 (COP9 signalosome subunit 8) | protein interactions | 10920 | 112 | 2 | 19454 | 50 |
WDR77,EPB41L2 |
3.363e-02 | -3.39 | EDA (ectodysplasin A) | protein interactions | 1896 | 112 | 2 | 19454 | 50 |
C3AR1,AXL |
3.363e-02 | -3.39 | SGTA (small glutamine rich tetratricopeptide repeat co-chaperone alpha) | protein interactions | 6449 | 275 | 3 | 19454 | 50 |
C1QA,SPP1,AXL |
3.364e-02 | -3.39 | organic acid biosynthetic process | biological process | GO:0016053 | 274 | 3 | 18204 | 47 |
DHRS9,LTC4S,OSBPL1A |
3.364e-02 | -3.39 | tissue development | biological process | GO:0009888 | 1757 | 9 | 18204 | 47 |
PPARD,WDR77,PDGFA,WNT5A,DHRS9,COL18A1,SPP1,CSF1R,MEF2C |
3.384e-02 | -3.39 | negative regulation of programmed cell death | biological process | GO:0043069 | 946 | 6 | 18204 | 47 |
WNT5A,TREM2,AXL,MEF2C,CSF1R,CXCL12 |
3.388e-02 | -3.38 | mononuclear cell migration | biological process | GO:0071674 | 112 | 2 | 18204 | 47 |
FOLR2,CH25H |
3.388e-02 | -3.38 | female sex differentiation | biological process | GO:0046660 | 112 | 2 | 18204 | 47 |
AXL,WNT5A |
3.394e-02 | -3.38 | HMOX2 (heme oxygenase 2) | protein interactions | 3163 | 276 | 3 | 19454 | 50 |
C3AR1,TSPAN15,APOE |
3.395e-02 | -3.38 | gliogenesis | biological process | GO:0042063 | 275 | 3 | 18204 | 47 |
C1QA,CSF1R,TREM2 |
3.395e-02 | -3.38 | myosin heavy chain binding | molecular function | GO:0032036 | 13 | 1 | 18094 | 48 |
AXL |
3.395e-02 | -3.38 | folic acid binding | molecular function | GO:0005542 | 13 | 1 | 18094 | 48 |
FOLR2 |
3.395e-02 | -3.38 | calcium-activated potassium channel activity | molecular function | GO:0015269 | 13 | 1 | 18094 | 48 |
KCNMB1 |
3.395e-02 | -3.38 | high-density lipoprotein particle binding | molecular function | GO:0008035 | 13 | 1 | 18094 | 48 |
TREM2 |
3.426e-02 | -3.37 | telencephalon development | biological process | GO:0021537 | 276 | 3 | 18204 | 47 |
CXCL12,WNT5A,CSF1R |
3.426e-02 | -3.37 | learning or memory | biological process | GO:0007611 | 276 | 3 | 18204 | 47 |
TREM2,MEF2C,APOE |
3.444e-02 | -3.37 | tissue migration | biological process | GO:0090130 | 113 | 2 | 18204 | 47 |
PPARD,WNT5A |
3.444e-02 | -3.37 | positive regulation of tumor necrosis factor superfamily cytokine production | biological process | GO:1903557 | 113 | 2 | 18204 | 47 |
WNT5A,HAVCR2 |
3.454e-02 | -3.37 | CD225/Dispanin_fam | interpro domains | IPR007593 | 13 | 1 | 18521 | 50 |
IFITM10 |
3.454e-02 | -3.37 | FA | interpro domains | IPR014847 | 13 | 1 | 18521 | 50 |
EPB41L2 |
3.457e-02 | -3.36 | BASP1 (brain abundant membrane attached signal protein 1) | protein interactions | 10409 | 278 | 3 | 19454 | 50 |
EPB41L2,WDR77,AXL |
3.474e-02 | -3.36 | COL1A1 (collagen type I alpha 1 chain) | protein interactions | 1277 | 114 | 2 | 19454 | 50 |
COL18A1,PDGFA |
3.500e-02 | -3.35 | steroid biosynthetic process | biological process | GO:0006694 | 114 | 2 | 18204 | 47 |
CH25H,OSBPL1A |
3.509e-02 | -3.35 | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymph_node-lymphoid_neoplasm-angioimmunoblastic_T_cell_lymphoma | 12 | 1 | 16828 | 50 |
CSF1R |
3.530e-02 | -3.34 | PPARD (peroxisome proliferator activated receptor delta) | protein interactions | 5467 | 115 | 2 | 19454 | 50 |
PPARD,RGL3 |
3.530e-02 | -3.34 | CNTNAP3 (contactin associated protein family member 3) | protein interactions | 79937 | 115 | 2 | 19454 | 50 |
C1QB,C1QA |
3.530e-02 | -3.34 | NDUFB5 (NADH:ubiquinone oxidoreductase subunit B5) | protein interactions | 4711 | 115 | 2 | 19454 | 50 |
C3AR1,GPR34 |
3.539e-02 | -3.34 | HRAS (HRas proto-oncogene, GTPase) | protein interactions | 3265 | 712 | 5 | 19454 | 50 |
WDR77,ITM2B,USP53,EPB41L2,DCBLD1 |
3.540e-02 | -3.34 | CCL25 (C-C motif chemokine ligand 25) | protein interactions | 6370 | 14 | 1 | 19454 | 50 |
CXCL12 |
3.540e-02 | -3.34 | IFNA8 (interferon alpha 8) | protein interactions | 3445 | 14 | 1 | 19454 | 50 |
APOE |
3.540e-02 | -3.34 | PLA2G12A (phospholipase A2 group XIIA) | protein interactions | 81579 | 14 | 1 | 19454 | 50 |
MEF2C |
3.540e-02 | -3.34 | CROCCP2 (CROCC pseudogene 2) | protein interactions | 84809 | 14 | 1 | 19454 | 50 |
APOC2 |
3.540e-02 | -3.34 | FFAR3 (free fatty acid receptor 3) | protein interactions | 2865 | 14 | 1 | 19454 | 50 |
LTC4S |
3.540e-02 | -3.34 | C9 (complement C9) | protein interactions | 735 | 14 | 1 | 19454 | 50 |
APOE |
3.540e-02 | -3.34 | BAALC (BAALC binder of MAP3K1 and KLF4) | protein interactions | 79870 | 14 | 1 | 19454 | 50 |
OSBPL1A |
3.540e-02 | -3.34 | Pten (phosphatase and tensin homolog) | protein interactions | 19211 | 14 | 1 | 19454 | 50 |
PDGFA |
3.540e-02 | -3.34 | CES3 (carboxylesterase 3) | protein interactions | 23491 | 14 | 1 | 19454 | 50 |
C1QA |
3.540e-02 | -3.34 | ADAP2 (ArfGAP with dual PH domains 2) | protein interactions | 55803 | 14 | 1 | 19454 | 50 |
ADAP2 |
3.540e-02 | -3.34 | BORCS8-MEF2B (BORCS8-MEF2B readthrough) | protein interactions | 4207 | 14 | 1 | 19454 | 50 |
MEF2C |
3.551e-02 | -3.34 | EPHA7 (EPH receptor A7) | protein interactions | 2045 | 281 | 3 | 19454 | 50 |
COL18A1,WNT5A,CSF1R |
3.556e-02 | -3.34 | positive regulation of T cell chemotaxis | biological process | GO:0010820 | 14 | 1 | 18204 | 47 |
WNT5A |
3.556e-02 | -3.34 | mammary gland epithelial cell proliferation | biological process | GO:0033598 | 14 | 1 | 18204 | 47 |
WNT5A |
3.556e-02 | -3.34 | positive regulation of myoblast proliferation | biological process | GO:2000288 | 14 | 1 | 18204 | 47 |
PPARD |
3.556e-02 | -3.34 | positive regulation of purine nucleotide biosynthetic process | biological process | GO:1900373 | 14 | 1 | 18204 | 47 |
TREM2 |
3.556e-02 | -3.34 | neuron remodeling | biological process | GO:0016322 | 14 | 1 | 18204 | 47 |
C1QA |
3.556e-02 | -3.34 | complement receptor mediated signaling pathway | biological process | GO:0002430 | 14 | 1 | 18204 | 47 |
C3AR1 |
3.556e-02 | -3.34 | cellular response to ethanol | biological process | GO:0071361 | 14 | 1 | 18204 | 47 |
KCNMB1 |
3.556e-02 | -3.34 | toll-like receptor 3 signaling pathway | biological process | GO:0034138 | 14 | 1 | 18204 | 47 |
HAVCR2 |
3.556e-02 | -3.34 | negative regulation of long-term synaptic potentiation | biological process | GO:1900272 | 14 | 1 | 18204 | 47 |
APOE |
3.556e-02 | -3.34 | positive regulation of defense response to bacterium | biological process | GO:1900426 | 14 | 1 | 18204 | 47 |
HAVCR2 |
3.556e-02 | -3.34 | regulation of establishment of planar polarity | biological process | GO:0090175 | 14 | 1 | 18204 | 47 |
WNT5A |
3.556e-02 | -3.34 | ventricular cardiac muscle cell differentiation | biological process | GO:0055012 | 14 | 1 | 18204 | 47 |
MEF2C |
3.556e-02 | -3.34 | positive regulation of nucleotide biosynthetic process | biological process | GO:0030810 | 14 | 1 | 18204 | 47 |
TREM2 |
3.556e-02 | -3.34 | terpenoid biosynthetic process | biological process | GO:0016114 | 14 | 1 | 18204 | 47 |
DHRS9 |
3.556e-02 | -3.34 | positive regulation of phospholipid metabolic process | biological process | GO:1903727 | 14 | 1 | 18204 | 47 |
APOC2 |
3.556e-02 | -3.34 | induction of positive chemotaxis | biological process | GO:0050930 | 14 | 1 | 18204 | 47 |
CXCL12 |
3.583e-02 | -3.33 | multicellular organismal reproductive process | biological process | GO:0048609 | 959 | 6 | 18204 | 47 |
PPARD,HAVCR2,WDR77,FOLR2,SPP1,AXL |
3.585e-02 | -3.33 | ORANGE | prosite domains | PS51054 | 12 | 1 | 12186 | 37 |
BHLHE41 |
3.585e-02 | -3.33 | OSBP | prosite domains | PS01013 | 12 | 1 | 12186 | 37 |
OSBPL1A |
3.586e-02 | -3.33 | GPR89A (G protein-coupled receptor 89A) | protein interactions | 653519 | 116 | 2 | 19454 | 50 |
C3AR1,TSPAN15 |
3.590e-02 | -3.33 | - | gene3d domains | 2.40.160.120 | 12 | 1 | 14470 | 44 |
OSBPL1A |
3.593e-02 | -3.33 | CD225 | pfam domains | PF04505 | 13 | 1 | 17795 | 50 |
IFITM10 |
3.593e-02 | -3.33 | FA | pfam domains | PF08736 | 13 | 1 | 17795 | 50 |
EPB41L2 |
3.642e-02 | -3.31 | ABCF3 (ATP binding cassette subfamily F member 3) | protein interactions | 55324 | 117 | 2 | 19454 | 50 |
PPARD,SPP1 |
3.652e-02 | -3.31 | platelet-derived growth factor receptor binding | molecular function | GO:0005161 | 14 | 1 | 18094 | 48 |
PDGFA |
3.669e-02 | -3.31 | cellular detoxification | biological process | GO:1990748 | 117 | 2 | 18204 | 47 |
LTC4S,APOE |
3.669e-02 | -3.31 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 47 |
MEF2C,WNT5A |
3.684e-02 | -3.30 | FA | smart domains | SM01195 | 13 | 1 | 9717 | 28 |
EPB41L2 |
3.699e-02 | -3.30 | NDUFB8 (NADH:ubiquinone oxidoreductase subunit B8) | protein interactions | 4714 | 118 | 2 | 19454 | 50 |
GPR34,APOE |
3.699e-02 | -3.30 | CEACAM8 (CEA cell adhesion molecule 8) | protein interactions | 1088 | 118 | 2 | 19454 | 50 |
HS3ST1,APOE |
3.699e-02 | -3.30 | DNM1 (dynamin 1) | protein interactions | 1759 | 118 | 2 | 19454 | 50 |
ANKRD22,USP53 |
3.715e-02 | -3.29 | CXC_Chemokine_domain | interpro domains | IPR033899 | 14 | 1 | 18521 | 50 |
CXCL12 |
3.715e-02 | -3.29 | Ras_G-nucl-exch_fac_CS | interpro domains | IPR019804 | 14 | 1 | 18521 | 50 |
RGL3 |
3.726e-02 | -3.29 | negative regulation of epithelial cell migration | biological process | GO:0010633 | 118 | 2 | 18204 | 47 |
MEF2C,APOE |
3.726e-02 | -3.29 | regulation of receptor-mediated endocytosis | biological process | GO:0048259 | 118 | 2 | 18204 | 47 |
APOC1,APOC2 |
3.726e-02 | -3.29 | biological process involved in interaction with symbiont | biological process | GO:0051702 | 118 | 2 | 18204 | 47 |
CSF1R,APOE |
3.729e-02 | -3.29 | Diseases associated with surfactant metabolism | REACTOME pathways | R-HSA-5687613 | 10 | 1 | 10285 | 39 |
CSF2RA |
3.746e-02 | -3.28 | developmental maturation | biological process | GO:0021700 | 286 | 3 | 18204 | 47 |
AXL,C1QA,WDR77 |
3.756e-02 | -3.28 | HLA-DPA1 (major histocompatibility complex, class II, DP alpha 1) | protein interactions | 3113 | 119 | 2 | 19454 | 50 |
APOE,DCBLD1 |
3.775e-02 | -3.28 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | ko01521 | 79 | 2 | 7161 | 28 |
PDGFA,AXL |
3.775e-02 | -3.28 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | hsa01521 | 79 | 2 | 7161 | 28 |
PDGFA,AXL |
3.779e-02 | -3.28 | regulation of canonical NF-kappaB signal transduction | biological process | GO:0043122 | 287 | 3 | 18204 | 47 |
ALPK1,TREM2,WNT5A |
3.784e-02 | -3.27 | negative regulation of cellular catabolic process | biological process | GO:0031330 | 119 | 2 | 18204 | 47 |
TREM2,APOC1 |
3.788e-02 | -3.27 | TMEM181 (transmembrane protein 181) | protein interactions | 57583 | 15 | 1 | 19454 | 50 |
TSPAN15 |
3.788e-02 | -3.27 | GH1 (growth hormone 1) | protein interactions | 2688 | 15 | 1 | 19454 | 50 |
TREM2 |
3.788e-02 | -3.27 | Cenpf (centromere protein F) | protein interactions | 108000 | 15 | 1 | 19454 | 50 |
OSBPL1A |
3.788e-02 | -3.27 | FZD1 (frizzled class receptor 1) | protein interactions | 8321 | 15 | 1 | 19454 | 50 |
WNT5A |
3.788e-02 | -3.27 | FN3K (fructosamine 3 kinase) | protein interactions | 64122 | 15 | 1 | 19454 | 50 |
AXL |
3.805e-02 | -3.27 | cell migration involved in gastrulation | biological process | GO:0042074 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | regulation of secondary metabolic process | biological process | GO:0043455 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | phagocytosis, recognition | biological process | GO:0006910 | 15 | 1 | 18204 | 47 |
TREM2 |
3.805e-02 | -3.27 | regulation of membrane invagination | biological process | GO:1905153 | 15 | 1 | 18204 | 47 |
TREM2 |
3.805e-02 | -3.27 | positive regulation of cholesterol metabolic process | biological process | GO:0090205 | 15 | 1 | 18204 | 47 |
APOE |
3.805e-02 | -3.27 | regulation of neuron projection arborization | biological process | GO:0150011 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | negative regulation of NLRP3 inflammasome complex assembly | biological process | GO:1900226 | 15 | 1 | 18204 | 47 |
TREM2 |
3.805e-02 | -3.27 | lipoprotein catabolic process | biological process | GO:0042159 | 15 | 1 | 18204 | 47 |
APOE |
3.805e-02 | -3.27 | regulation of melanin biosynthetic process | biological process | GO:0048021 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | regulation of sequestering of triglyceride | biological process | GO:0010889 | 15 | 1 | 18204 | 47 |
TREM2 |
3.805e-02 | -3.27 | regulation of phagocytosis, engulfment | biological process | GO:0060099 | 15 | 1 | 18204 | 47 |
TREM2 |
3.805e-02 | -3.27 | regulation of T cell chemotaxis | biological process | GO:0010819 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | regulation of secondary metabolite biosynthetic process | biological process | GO:1900376 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | positive regulation of non-canonical Wnt signaling pathway | biological process | GO:2000052 | 15 | 1 | 18204 | 47 |
WNT5A |
3.805e-02 | -3.27 | negative regulation of lipase activity | biological process | GO:0060192 | 15 | 1 | 18204 | 47 |
APOC1 |
3.805e-02 | -3.27 | detection of mechanical stimulus involved in sensory perception of pain | biological process | GO:0050966 | 15 | 1 | 18204 | 47 |
CXCL12 |
3.805e-02 | -3.27 | negative regulation of axon regeneration | biological process | GO:0048681 | 15 | 1 | 18204 | 47 |
SPP1 |
3.812e-02 | -3.27 | positive regulation of innate immune response | biological process | GO:0045089 | 288 | 3 | 18204 | 47 |
ALPK1,HAVCR2,WNT5A |
3.814e-02 | -3.27 | ITGA5 (integrin subunit alpha 5) | protein interactions | 3678 | 120 | 2 | 19454 | 50 |
SPP1,COL18A1 |
3.818e-02 | -3.27 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 4 | 18204 | 47 |
MEF2C,ADORA3,WNT5A,APOE |
3.834e-02 | -3.26 | EV release from cardiac cells and their functional effects | WikiPathways | WP3297 | 9 | 1 | 5310 | 23 |
CXCL12 |
3.842e-02 | -3.26 | regulation of cytokine production involved in immune response | biological process | GO:0002718 | 120 | 2 | 18204 | 47 |
WNT5A,AXL |
3.842e-02 | -3.26 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 4 | 18204 | 47 |
ADORA3,WNT5A,MEF2C,APOE |
3.843e-02 | -3.26 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 5 | 18204 | 47 |
APOC2,RGS10,ADAP2,APOC1,MEF2C |
3.846e-02 | -3.26 | positive regulation of secretion by cell | biological process | GO:1903532 | 289 | 3 | 18204 | 47 |
TREM2,SPP1,CXCL12 |
3.883e-02 | -3.25 | - | gene3d domains | 1.20.5.1700 | 13 | 1 | 14470 | 44 |
FILIP1L |
3.900e-02 | -3.24 | negative regulation of immune effector process | biological process | GO:0002698 | 121 | 2 | 18204 | 47 |
AXL,HAVCR2 |
3.908e-02 | -3.24 | heparan sulfate sulfotransferase activity | molecular function | GO:0034483 | 15 | 1 | 18094 | 48 |
HS3ST1 |
3.908e-02 | -3.24 | carbon-sulfur lyase activity | molecular function | GO:0016846 | 15 | 1 | 18094 | 48 |
LTC4S |
3.930e-02 | -3.24 | CYB5R1 (cytochrome b5 reductase 1) | protein interactions | 51706 | 122 | 2 | 19454 | 50 |
APOE,TSPAN15 |
3.943e-02 | -3.23 | retinol biosynthesis | BIOCYC pathways | META_PWY-6857 | 12 | 1 | 902 | 3 |
DHRS9 |
3.943e-02 | -3.23 | human chrX;Y | chromosome location | human chrX;Y | 21 | 1 | 26134 | 50 |
CSF2RA |
3.943e-02 | -3.23 | human chr10q26.11 | chromosome location | human chr10q26.11 | 21 | 1 | 26134 | 50 |
RGS10 |
3.959e-02 | -3.23 | lipoprotein metabolic process | biological process | GO:0042157 | 122 | 2 | 18204 | 47 |
APOC1,APOE |
3.961e-02 | -3.23 | skin-sole-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-sole-malignant_melanoma-acral_lentiginous | 254 | 3 | 16828 | 50 |
ALPK1,USP53,DCBLD1 |
3.988e-02 | -3.22 | TMEM132A (transmembrane protein 132A) | protein interactions | 54972 | 123 | 2 | 19454 | 50 |
C1QA,C1QB |
3.988e-02 | -3.22 | NAMPT (nicotinamide phosphoribosyltransferase) | protein interactions | 10135 | 123 | 2 | 19454 | 50 |
WDR77,AXL |
4.034e-02 | -3.21 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 15 | 10285 | 39 |
DHRS9,AXL,APOE,SPP1,WNT5A,C3AR1,PDGFA,ADORA3,PPARD,CXCL12,CSF2RA,RGS10,P2RY13,APOC2,MEF2C |
4.034e-02 | -3.21 | IG_LIKE | prosite domains | PS50835 | 430 | 4 | 12186 | 37 |
AXL,HAVCR2,SIGLEC8,CSF1R |
4.035e-02 | -3.21 | CXCL17 (C-X-C motif chemokine ligand 17) | protein interactions | 284340 | 16 | 1 | 19454 | 50 |
CXCL12 |
4.035e-02 | -3.21 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 50 |
MEF2C |
4.035e-02 | -3.21 | ENTPD4 (ectonucleoside triphosphate diphosphohydrolase 4) | protein interactions | 9583 | 16 | 1 | 19454 | 50 |
TSPAN15 |
4.035e-02 | -3.21 | IL20 (interleukin 20) | protein interactions | 50604 | 16 | 1 | 19454 | 50 |
HS3ST1 |
4.035e-02 | -3.21 | CYP2C8 (cytochrome P450 family 2 subfamily C member 8) | protein interactions | 1558 | 16 | 1 | 19454 | 50 |
APOE |
4.035e-02 | -3.21 | DGKQ (diacylglycerol kinase theta) | protein interactions | 1609 | 16 | 1 | 19454 | 50 |
HAVCR2 |
4.035e-02 | -3.21 | Rab5b (RAB5B, member RAS oncogene family) | protein interactions | 19344 | 16 | 1 | 19454 | 50 |
OSBPL1A |
4.035e-02 | -3.21 | FZD4 (frizzled class receptor 4) | protein interactions | 8322 | 16 | 1 | 19454 | 50 |
TSPAN15 |
4.047e-02 | -3.21 | IL5RA (interleukin 5 receptor subunit alpha) | protein interactions | 3568 | 124 | 2 | 19454 | 50 |
COL18A1,HS3ST1 |
4.047e-02 | -3.21 | ACACB (acetyl-CoA carboxylase beta) | protein interactions | 32 | 124 | 2 | 19454 | 50 |
PPARD,USP53 |
4.048e-02 | -3.21 | myeloid cell differentiation | biological process | GO:0030099 | 295 | 3 | 18204 | 47 |
TREM2,CSF1R,MEF2C |
4.054e-02 | -3.21 | regulation of granulocyte differentiation | biological process | GO:0030852 | 16 | 1 | 18204 | 47 |
C1QC |
4.054e-02 | -3.21 | response to ether | biological process | GO:0045472 | 16 | 1 | 18204 | 47 |
ABCB4 |
4.054e-02 | -3.21 | low-density lipoprotein particle remodeling | biological process | GO:0034374 | 16 | 1 | 18204 | 47 |
APOE |
4.054e-02 | -3.21 | heparan sulfate proteoglycan metabolic process | biological process | GO:0030201 | 16 | 1 | 18204 | 47 |
HS3ST1 |
4.054e-02 | -3.21 | regulation of ATP biosynthetic process | biological process | GO:2001169 | 16 | 1 | 18204 | 47 |
TREM2 |
4.054e-02 | -3.21 | regulation of cell proliferation involved in kidney development | biological process | GO:1901722 | 16 | 1 | 18204 | 47 |
PDGFA |
4.054e-02 | -3.21 | locomotory exploration behavior | biological process | GO:0035641 | 16 | 1 | 18204 | 47 |
APOE |
4.054e-02 | -3.21 | positive regulation of lymphocyte apoptotic process | biological process | GO:0070230 | 16 | 1 | 18204 | 47 |
WNT5A |
4.054e-02 | -3.21 | neutrophil homeostasis | biological process | GO:0001780 | 16 | 1 | 18204 | 47 |
AXL |
4.054e-02 | -3.21 | positive regulation of membrane protein ectodomain proteolysis | biological process | GO:0051044 | 16 | 1 | 18204 | 47 |
APOE |
4.054e-02 | -3.21 | natural killer cell differentiation | biological process | GO:0001779 | 16 | 1 | 18204 | 47 |
AXL |
4.054e-02 | -3.21 | negative regulation of astrocyte differentiation | biological process | GO:0048712 | 16 | 1 | 18204 | 47 |
TREM2 |
4.054e-02 | -3.21 | regulation of skeletal muscle cell proliferation | biological process | GO:0014857 | 16 | 1 | 18204 | 47 |
PPARD |
4.054e-02 | -3.21 | negative regulation of neuron projection regeneration | biological process | GO:0070571 | 16 | 1 | 18204 | 47 |
SPP1 |
4.054e-02 | -3.21 | negative regulation of inflammasome-mediated signaling pathway | biological process | GO:0141086 | 16 | 1 | 18204 | 47 |
TREM2 |
4.054e-02 | -3.21 | regulation of phospholipid biosynthetic process | biological process | GO:0071071 | 16 | 1 | 18204 | 47 |
PDGFA |
4.077e-02 | -3.20 | regulation of ossification | biological process | GO:0030278 | 124 | 2 | 18204 | 47 |
MEF2C,WNT5A |
4.082e-02 | -3.20 | reproductive structure development | biological process | GO:0048608 | 296 | 3 | 18204 | 47 |
WDR77,WNT5A,AXL |
4.095e-02 | -3.20 | Import of palmitoyl-CoA into the mitochondrial matrix | REACTOME pathways | R-HSA-200425 | 11 | 1 | 10285 | 39 |
PPARD |
4.106e-02 | -3.19 | UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats) | protein interactions | 55075 | 125 | 2 | 19454 | 50 |
RNASEH1,WDR77 |
4.137e-02 | -3.19 | pattern recognition receptor signaling pathway | biological process | GO:0002221 | 125 | 2 | 18204 | 47 |
ALPK1,HAVCR2 |
4.137e-02 | -3.19 | memory | biological process | GO:0007613 | 125 | 2 | 18204 | 47 |
APOE,TREM2 |
4.137e-02 | -3.19 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 47 |
WNT5A,CSF1R |
4.155e-02 | -3.18 | regulation of phosphorylation | biological process | GO:0042325 | 994 | 6 | 18204 | 47 |
TREM2,PDGFA,WNT5A,APOE,CSF1R,AXL |
4.162e-02 | -3.18 | circulatory system process | biological process | GO:0003013 | 508 | 4 | 18204 | 47 |
C3AR1,CXCL12,APOE,KCNMB1 |
4.163e-02 | -3.18 | floppase activity | molecular function | GO:0140328 | 16 | 1 | 18094 | 48 |
ABCB4 |
4.170e-02 | -3.18 | RASGEF | prosite domains | PS00720 | 14 | 1 | 12186 | 37 |
RGL3 |
4.173e-02 | -3.18 | central nervous system development | biological process | GO:0007417 | 995 | 6 | 18204 | 47 |
WNT5A,TREM2,CSF1R,AXL,C1QA,CXCL12 |
4.220e-02 | -3.17 | reproductive system development | biological process | GO:0061458 | 300 | 3 | 18204 | 47 |
AXL,WNT5A,WDR77 |
4.220e-02 | -3.17 | regulation of epithelial cell migration | biological process | GO:0010632 | 300 | 3 | 18204 | 47 |
APOE,WNT5A,MEF2C |
4.235e-02 | -3.16 | Ez/rad/moesin-like | interpro domains | IPR000798 | 16 | 1 | 18521 | 50 |
EPB41L2 |
4.251e-02 | -3.16 | SDF2L1 (stromal cell derived factor 2 like 1) | protein interactions | 23753 | 302 | 3 | 19454 | 50 |
WNT5A,COL18A1,AXL |
4.252e-02 | -3.16 | Composition of Lipid Particles | WikiPathways | WP3601 | 10 | 1 | 5310 | 23 |
APOE |
4.257e-02 | -3.16 | cellular response to toxic substance | biological process | GO:0097237 | 127 | 2 | 18204 | 47 |
APOE,LTC4S |
4.257e-02 | -3.16 | cardiac ventricle development | biological process | GO:0003231 | 127 | 2 | 18204 | 47 |
WNT5A,MEF2C |
4.257e-02 | -3.16 | regulation of myeloid leukocyte differentiation | biological process | GO:0002761 | 127 | 2 | 18204 | 47 |
C1QC,TREM2 |
4.257e-02 | -3.16 | cardiac chamber morphogenesis | biological process | GO:0003206 | 127 | 2 | 18204 | 47 |
WNT5A,MEF2C |
4.257e-02 | -3.16 | positive regulation of protein serine/threonine kinase activity | biological process | GO:0071902 | 127 | 2 | 18204 | 47 |
WNT5A,PDGFA |
4.266e-02 | -3.15 | the visual cycle I (vertebrates) | BIOCYC pathways | META_PWY-6861 | 13 | 1 | 902 | 3 |
DHRS9 |
4.282e-02 | -3.15 | endonuclease activity | molecular function | GO:0004519 | 124 | 2 | 18094 | 48 |
RNASEH1,RNASET2 |
4.282e-02 | -3.15 | TMEM45A (transmembrane protein 45A) | protein interactions | 55076 | 17 | 1 | 19454 | 50 |
WNT5A |
4.282e-02 | -3.15 | KCNG4 (potassium voltage-gated channel modifier subfamily G member 4) | protein interactions | 93107 | 17 | 1 | 19454 | 50 |
AXL |
4.282e-02 | -3.15 | C16orf92 (chromosome 16 open reading frame 92) | protein interactions | 146378 | 17 | 1 | 19454 | 50 |
APOE |
4.282e-02 | -3.15 | Aurkb (aurora kinase B) | protein interactions | 20877 | 17 | 1 | 19454 | 50 |
OSBPL1A |
4.282e-02 | -3.15 | AFD1 (acrofacial dysostosis 1, Nager type) | protein interactions | 171 | 17 | 1 | 19454 | 50 |
AXL |
4.282e-02 | -3.15 | BMP8A (bone morphogenetic protein 8a) | protein interactions | 353500 | 17 | 1 | 19454 | 50 |
C1QB |
4.282e-02 | -3.15 | FOXD4L3 (forkhead box D4 like 3) | protein interactions | 286380 | 17 | 1 | 19454 | 50 |
APOC1 |
4.282e-02 | -3.15 | GYPC (glycophorin C (Gerbich blood group)) | protein interactions | 2995 | 17 | 1 | 19454 | 50 |
TSPAN15 |
4.282e-02 | -3.15 | HIGD1C (HIG1 hypoxia inducible domain family member 1C) | protein interactions | 613227 | 17 | 1 | 19454 | 50 |
APOC1 |
4.286e-02 | -3.15 | TIMELESS (timeless circadian regulator) | protein interactions | 8914 | 128 | 2 | 19454 | 50 |
WDR77,EPB41L2 |
4.301e-02 | -3.15 | positive regulation of vascular permeability | biological process | GO:0043117 | 17 | 1 | 18204 | 47 |
APOE |
4.301e-02 | -3.15 | type B pancreatic cell development | biological process | GO:0003323 | 17 | 1 | 18204 | 47 |
WNT5A |
4.301e-02 | -3.15 | fatty acid homeostasis | biological process | GO:0055089 | 17 | 1 | 18204 | 47 |
APOE |
4.301e-02 | -3.15 | positive regulation of meiotic nuclear division | biological process | GO:0045836 | 17 | 1 | 18204 | 47 |
WNT5A |
4.301e-02 | -3.15 | regulation of hematopoietic stem cell proliferation | biological process | GO:1902033 | 17 | 1 | 18204 | 47 |
WNT5A |
4.301e-02 | -3.15 | negative regulation of neuroinflammatory response | biological process | GO:0150079 | 17 | 1 | 18204 | 47 |
TREM2 |
4.301e-02 | -3.15 | muscle cell fate commitment | biological process | GO:0042693 | 17 | 1 | 18204 | 47 |
MEF2C |
4.301e-02 | -3.15 | negative regulation of triglyceride metabolic process | biological process | GO:0090209 | 17 | 1 | 18204 | 47 |
APOE |
4.301e-02 | -3.15 | monocyte differentiation | biological process | GO:0030224 | 17 | 1 | 18204 | 47 |
CSF1R |
4.301e-02 | -3.15 | branch elongation of an epithelium | biological process | GO:0060602 | 17 | 1 | 18204 | 47 |
WNT5A |
4.311e-02 | -3.14 | human chr2p25.3 | chromosome location | human chr2p25.3 | 23 | 1 | 26134 | 50 |
RNASEH1 |
4.317e-02 | -3.14 | glial cell development | biological process | GO:0021782 | 128 | 2 | 18204 | 47 |
C1QA,TREM2 |
4.367e-02 | -3.13 | calcaneus | COSMIC cancer mutations | calcaneus | 15 | 1 | 16828 | 50 |
ALPK1 |
4.417e-02 | -3.12 | phospholipase activator activity | molecular function | GO:0016004 | 17 | 1 | 18094 | 48 |
APOC2 |
4.417e-02 | -3.12 | long-chain fatty acid binding | molecular function | GO:0036041 | 17 | 1 | 18094 | 48 |
PPARD |
4.417e-02 | -3.12 | apolipoprotein binding | molecular function | GO:0034185 | 17 | 1 | 18094 | 48 |
TREM2 |
4.417e-02 | -3.12 | low-density lipoprotein particle binding | molecular function | GO:0030169 | 17 | 1 | 18094 | 48 |
TREM2 |
4.417e-02 | -3.12 | phosphatidylethanolamine binding | molecular function | GO:0008429 | 17 | 1 | 18094 | 48 |
TREM2 |
4.418e-02 | -3.12 | monocarboxylic acid metabolic process | biological process | GO:0032787 | 518 | 4 | 18204 | 47 |
DHRS9,OSBPL1A,PPARD,LTC4S |
4.459e-02 | -3.11 | P2Y receptors | REACTOME pathways | R-HSA-417957 | 12 | 1 | 10285 | 39 |
P2RY13 |
4.468e-02 | -3.11 | NCOA2 (nuclear receptor coactivator 2) | protein interactions | 10499 | 131 | 2 | 19454 | 50 |
MEF2C,PPARD |
4.473e-02 | -3.11 | receptor ligand activity | molecular function | GO:0048018 | 506 | 4 | 18094 | 48 |
WNT5A,PDGFA,SPP1,CXCL12 |
4.493e-02 | -3.10 | RGS_subdom1/3 | interpro domains | IPR024066 | 17 | 1 | 18521 | 50 |
RGS10 |
4.494e-02 | -3.10 | human chr6q22.1 | chromosome location | human chr6q22.1 | 24 | 1 | 26134 | 50 |
DCBLD1 |
4.502e-02 | -3.10 | KELCHREPEAT | prints domains | PR00501 | 10 | 1 | 5227 | 24 |
KLHL5 |
4.529e-02 | -3.09 | LRRC4 (leucine rich repeat containing 4) | protein interactions | 64101 | 18 | 1 | 19454 | 50 |
SPP1 |
4.529e-02 | -3.09 | NAALADL2 (N-acetylated alpha-linked acidic dipeptidase like 2) | protein interactions | 254827 | 18 | 1 | 19454 | 50 |
ITM2B |
4.529e-02 | -3.09 | Lck (lymphocyte protein tyrosine kinase) | protein interactions | 16818 | 18 | 1 | 19454 | 50 |
APOE |
4.529e-02 | -3.09 | SNX25 (sorting nexin 25) | protein interactions | 83891 | 18 | 1 | 19454 | 50 |
TSPAN15 |
4.529e-02 | -3.09 | CSF2 (colony stimulating factor 2) | protein interactions | 1437 | 18 | 1 | 19454 | 50 |
CSF2RA |
4.529e-02 | -3.09 | KLHL1 (kelch like family member 1) | protein interactions | 57626 | 18 | 1 | 19454 | 50 |
KLHL5 |
4.534e-02 | -3.09 | histone deacetylase binding | molecular function | GO:0042826 | 128 | 2 | 18094 | 48 |
MEF2C,BHLHE41 |
4.534e-02 | -3.09 | RNA nuclease activity | molecular function | GO:0004540 | 128 | 2 | 18094 | 48 |
RNASEH1,RNASET2 |
4.549e-02 | -3.09 | regulation of protein kinase C signaling | biological process | GO:0090036 | 18 | 1 | 18204 | 47 |
WNT5A |
4.549e-02 | -3.09 | cell-cell junction maintenance | biological process | GO:0045217 | 18 | 1 | 18204 | 47 |
CSF1R |
4.549e-02 | -3.09 | response to interferon-alpha | biological process | GO:0035455 | 18 | 1 | 18204 | 47 |
AXL |
4.549e-02 | -3.09 | positive regulation of neuroinflammatory response | biological process | GO:0150078 | 18 | 1 | 18204 | 47 |
TREM2 |
4.549e-02 | -3.09 | regulation of leukocyte tethering or rolling | biological process | GO:1903236 | 18 | 1 | 18204 | 47 |
CXCL12 |
4.549e-02 | -3.09 | negative regulation of myotube differentiation | biological process | GO:0010832 | 18 | 1 | 18204 | 47 |
BHLHE41 |
4.549e-02 | -3.09 | positive regulation of cardiocyte differentiation | biological process | GO:1905209 | 18 | 1 | 18204 | 47 |
MEF2C |
4.549e-02 | -3.09 | regulation of humoral immune response mediated by circulating immunoglobulin | biological process | GO:0002923 | 18 | 1 | 18204 | 47 |
TREM2 |
4.549e-02 | -3.09 | ceramide transport | biological process | GO:0035627 | 18 | 1 | 18204 | 47 |
ABCB4 |
4.567e-02 | -3.09 | multicellular organismal process | biological process | GO:0032501 | 6177 | 22 | 18204 | 47 |
C1QA,MEF2C,ADAP2,KCNMB1,USP53,APOC1,COL18A1,HAVCR2,BHLHE41,C3AR1,AXL,CSF1R,SPP1,CXCL12,APOC2,TREM2,ITM2B,PDGFA,WNT5A,WDR77,APOE,PPARD |
4.567e-02 | -3.09 | sole | COSMIC cancer mutations | sole | 269 | 3 | 16828 | 50 |
ALPK1,USP53,DCBLD1 |
4.613e-02 | -3.08 | positive regulation of secretion | biological process | GO:0051047 | 311 | 3 | 18204 | 47 |
SPP1,CXCL12,TREM2 |
4.635e-02 | -3.07 | response to nitrogen compound | biological process | GO:1901698 | 1021 | 6 | 18204 | 47 |
RGS10,FOLR2,CXCL12,CD68,MEF2C,TREM2 |
4.636e-02 | -3.07 | signaling receptor activator activity | molecular function | GO:0030546 | 512 | 4 | 18094 | 48 |
WNT5A,PDGFA,CXCL12,SPP1 |
4.652e-02 | -3.07 | normal | COSMIC cancer mutations | normal | 16 | 1 | 16828 | 50 |
CSF1R |
4.654e-02 | -3.07 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 10 | 16828 | 50 |
RNASEH1,HS3ST1,C1QA,EPB41L2,USP53,CSF2RA,C1QC,KLHL5,ANKRD22,SPP1 |
4.667e-02 | -3.06 | Nucleotide GPCRs | WikiPathways | WP80 | 11 | 1 | 5310 | 23 |
ADORA3 |
4.668e-02 | -3.06 | extremity | COSMIC cancer mutations | extremity | 1876 | 10 | 16828 | 50 |
SPP1,ANKRD22,KLHL5,USP53,C1QC,CSF2RA,EPB41L2,HS3ST1,RNASEH1,C1QA |
4.671e-02 | -3.06 | peptidoglycan binding | molecular function | GO:0042834 | 18 | 1 | 18094 | 48 |
TREM2 |
4.671e-02 | -3.06 | heparan sulfate proteoglycan binding | molecular function | GO:0043395 | 18 | 1 | 18094 | 48 |
APOE |
4.671e-02 | -3.06 | CXCR chemokine receptor binding | molecular function | GO:0045236 | 18 | 1 | 18094 | 48 |
CXCL12 |
4.671e-02 | -3.06 | racemase and epimerase activity | molecular function | GO:0016854 | 18 | 1 | 18094 | 48 |
DHRS9 |
4.671e-02 | -3.06 | phosphatidylcholine transporter activity | molecular function | GO:0008525 | 18 | 1 | 18094 | 48 |
ABCB4 |
4.674e-02 | -3.06 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 5 | 19454 | 50 |
AXL,USP53,WDR77,CSF1R,EPB41L2 |
4.686e-02 | -3.06 | epithelial tube morphogenesis | biological process | GO:0060562 | 313 | 3 | 18204 | 47 |
MEF2C,CSF1R,WNT5A |
4.716e-02 | -3.05 | HDAC7 (histone deacetylase 7) | protein interactions | 51564 | 135 | 2 | 19454 | 50 |
PPARD,MEF2C |
4.723e-02 | -3.05 | positive regulation of response to biotic stimulus | biological process | GO:0002833 | 314 | 3 | 18204 | 47 |
WNT5A,HAVCR2,ALPK1 |
4.737e-02 | -3.05 | blood vessel development | biological process | GO:0001568 | 530 | 4 | 18204 | 47 |
APOE,PDGFA,COL18A1,MEF2C |
4.743e-02 | -3.05 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 27 | 16828 | 50 |
C1QA,EPB41L2,ABCB4,USP53,DCBLD1,KLHL5,ACY3,FILIP1L,HAVCR2,RNASEH1,TSPAN15,WNT5A,COL18A1,PPARD,MEF2C,BHLHE41,OSBPL1A,WDR77,DHRS9,RGL3,FOLR2,P2RY13,CSF1R,C1QC,CSF2RA,ALPK1,ADAP2 |
4.751e-02 | -3.05 | determination of left/right symmetry | biological process | GO:0007368 | 135 | 2 | 18204 | 47 |
MEF2C,WNT5A |
4.774e-02 | -3.04 | LTC4S (leukotriene C4 synthase) | protein interactions | 4056 | 19 | 1 | 19454 | 50 |
LTC4S |
4.774e-02 | -3.04 | Trp53 (transformation related protein 53) | protein interactions | 22059 | 19 | 1 | 19454 | 50 |
PDGFA |
4.774e-02 | -3.04 | XCL2 (X-C motif chemokine ligand 2) | protein interactions | 6846 | 19 | 1 | 19454 | 50 |
CXCL12 |
4.774e-02 | -3.04 | DRD1 (dopamine receptor D1) | protein interactions | 1812 | 19 | 1 | 19454 | 50 |
EPB41L2 |
4.774e-02 | -3.04 | CSF1 (colony stimulating factor 1) | protein interactions | 1435 | 19 | 1 | 19454 | 50 |
CSF1R |
4.774e-02 | -3.04 | C14orf178 (chromosome 14 open reading frame 178) | protein interactions | 283579 | 19 | 1 | 19454 | 50 |
WDR77 |
4.774e-02 | -3.04 | ICOSLG (inducible T cell costimulator ligand) | protein interactions | 23308 | 19 | 1 | 19454 | 50 |
AXL |
4.774e-02 | -3.04 | SCGB1D2 (secretoglobin family 1D member 2) | protein interactions | 10647 | 19 | 1 | 19454 | 50 |
ALPK1 |
4.774e-02 | -3.04 | RIT2 (Ras like without CAAX 2) | protein interactions | 6014 | 19 | 1 | 19454 | 50 |
RGL3 |
4.774e-02 | -3.04 | MFSD4B (major facilitator superfamily domain containing 4B) | protein interactions | 91749 | 19 | 1 | 19454 | 50 |
DHRS9 |
4.779e-02 | -3.04 | DNTTIP2 (deoxynucleotidyltransferase terminal interacting protein 2) | protein interactions | 30836 | 136 | 2 | 19454 | 50 |
USP53,SPP1 |
4.779e-02 | -3.04 | ITGB5 (integrin subunit beta 5) | protein interactions | 3693 | 136 | 2 | 19454 | 50 |
PPARD,SPP1 |
4.779e-02 | -3.04 | PYGB (glycogen phosphorylase B) | protein interactions | 5834 | 136 | 2 | 19454 | 50 |
USP53,AXL |
4.787e-02 | -3.04 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 13 | 18204 | 47 |
HAVCR2,ALPK1,MEF2C,TREM2,WNT5A,PDGFA,APOE,PPARD,AXL,CSF1R,TSPAN15,RGS10,CXCL12 |
4.795e-02 | -3.04 | positive regulation of lymphocyte chemotaxis | biological process | GO:0140131 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | excitatory synapse assembly | biological process | GO:1904861 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | leukotriene biosynthetic process | biological process | GO:0019370 | 19 | 1 | 18204 | 47 |
LTC4S |
4.795e-02 | -3.04 | negative regulation of alcohol biosynthetic process | biological process | GO:1902931 | 19 | 1 | 18204 | 47 |
APOE |
4.795e-02 | -3.04 | establishment of epithelial cell apical/basal polarity | biological process | GO:0045198 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | paraxial mesoderm development | biological process | GO:0048339 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | tolerance induction | biological process | GO:0002507 | 19 | 1 | 18204 | 47 |
HAVCR2 |
4.795e-02 | -3.04 | regulation of skeletal muscle cell differentiation | biological process | GO:2001014 | 19 | 1 | 18204 | 47 |
MEF2C |
4.795e-02 | -3.04 | regulation of microglial cell activation | biological process | GO:1903978 | 19 | 1 | 18204 | 47 |
TREM2 |
4.795e-02 | -3.04 | negative regulation of toll-like receptor 4 signaling pathway | biological process | GO:0034144 | 19 | 1 | 18204 | 47 |
TREM2 |
4.795e-02 | -3.04 | negative regulation of amyloid precursor protein biosynthetic process | biological process | GO:0042985 | 19 | 1 | 18204 | 47 |
ITM2B |
4.795e-02 | -3.04 | regulation of hair follicle development | biological process | GO:0051797 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | post-anal tail morphogenesis | biological process | GO:0036342 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | presynapse assembly | biological process | GO:0099054 | 19 | 1 | 18204 | 47 |
WNT5A |
4.795e-02 | -3.04 | detection of temperature stimulus involved in sensory perception of pain | biological process | GO:0050965 | 19 | 1 | 18204 | 47 |
CXCL12 |
4.795e-02 | -3.04 | positive regulation of bone resorption | biological process | GO:0045780 | 19 | 1 | 18204 | 47 |
SPP1 |
4.795e-02 | -3.04 | pericardium development | biological process | GO:0060039 | 19 | 1 | 18204 | 47 |
WNT5A |
4.822e-02 | -3.03 | WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | REACTOME pathways | R-HSA-5140745 | 13 | 1 | 10285 | 39 |
WNT5A |
4.828e-02 | -3.03 | ATP5PB (ATP synthase peripheral stalk-membrane subunit b) | protein interactions | 515 | 318 | 3 | 19454 | 50 |
C3AR1,WDR77,SPP1 |
4.835e-02 | -3.03 | coated vesicle | cellular component | GO:0030135 | 319 | 3 | 19108 | 49 |
WNT5A,ABCB4,APOE |
4.842e-02 | -3.03 | TTF2 (transcription termination factor 2) | protein interactions | 8458 | 137 | 2 | 19454 | 50 |
PPARD,HAVCR2 |
4.877e-02 | -3.02 | cell recognition | biological process | GO:0008037 | 137 | 2 | 18204 | 47 |
TREM2,FOLR2 |
4.884e-02 | -3.02 | clathrin-coated vesicle membrane | cellular component | GO:0030665 | 138 | 2 | 19108 | 49 |
WNT5A,APOE |
4.910e-02 | -3.01 | cognition | biological process | GO:0050890 | 319 | 3 | 18204 | 47 |
APOE,TREM2,MEF2C |
4.912e-02 | -3.01 | the visual cycle I (vertebrates) | BIOCYC pathways | HUMAN_PWY-6861 | 15 | 1 | 902 | 3 |
DHRS9 |
4.930e-02 | -3.01 | nervous system development | biological process | GO:0007399 | 2185 | 10 | 18204 | 47 |
TREM2,ITM2B,WNT5A,APOE,PPARD,C1QA,AXL,MEF2C,CSF1R,CXCL12 |
4.941e-02 | -3.01 | regulation of wound healing | biological process | GO:0061041 | 138 | 2 | 18204 | 47 |
APOE,PDGFA |
4.941e-02 | -3.01 | regulation of protein localization to cell periphery | biological process | GO:1904375 | 138 | 2 | 18204 | 47 |
TREM2,EPB41L2 |
4.968e-02 | -3.00 | CDCA5 (cell division cycle associated 5) | protein interactions | 113130 | 139 | 2 | 19454 | 50 |
WDR77,BHLHE41 |
4.977e-02 | -3.00 | ITGB1 (integrin subunit beta 1) | protein interactions | 3688 | 322 | 3 | 19454 | 50 |
COL18A1,SPP1,AXL |